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Abstract 
The aim of this research was to identify the erythrocyte surface antigens of P. 
falciparum-irffected erythrocytes (lEs) that are expressed following selection of the 
parasite for adhesion to the placental receptor chondroitin sulphate A (CSA). These 
surface antigens are considered potential vaccine targets against pregnancy-
associated malaria (PAM). 
Typically P. falciparum surface antigens are highly sensitive to treatment of the IE 
with the protease trypsin; however, variant surface antigen (VSA) mediated 
adhesion to CSA has often been found to be relatively trypsin-resistant. In this 
study the protease sensitivity of the VSA of CSA binding lEs was determined with 
regard to serum IgG recognition and placental receptor binding. Discordance 
between the protease sensitivity for these phenomena was identified; this may have 
implications for PAM vaccine design. 
The completion of several Plasmodium genome sequences and advances in mass 
spectrometry have opened up the field of proteomics to the study of the malaria 
parasite. Proteomic methods have been applied to the study of Plasmodium VSA. 
However, the initial step of these methods, surface antigen labelling, proved 
problematic. Therefore, this thesis concentrates on the optimisation of these 
techniques. An antibody to the Plasmodium falciparum erythrocyte protein-i 
(PfEMP1) family was raised and characterised. This reagent in combination with the 
advances made for IE surface labelling will be a valuable tool for future studies of 
VSA expression. Western blotting was also applied to investigate the 
developmental regulation, post-translational processing and surface trypsinisation 
sensitivity of two candidate IE surface antigens, Plasmodium falciparum Cysteine 
Repeat Modular proteins 1 and 2. 
During the optimisation of biochemical techniques, a study to investigate the effect 
of mosquito passage on Plasmodium chabaudi variant surface antigen expression was 
initiated. Potential surface antigens whose expression associates with mosquito 
transmission were identified. 
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Chapter 1. Introduction 
Here I introduce the parasite Plasmodium, the causal agent of malaria. I describe the 
parasite's interaction with its mammalian host's immune system through antigenic 
variation. The burden of malaria is discussed with special consideration of the 
syndrome pregnancy-associated malaria. Recent advances in our understanding of 
the molecular mechanisms underlying this syndrome are reviewed and finally the 
aims of this thesis are outlined. 
1.1 The malaria parasite 
Plasmodium is a member of a monophyletic group, the Apicomplexa, which forms 
one of the three major super-groups of highly diverse eukaryotic protozoa 
comprising the Alveolata (Aravind et al., 2003). All —5000 known species of 
Apicomplexan are parasites of animals (Levine, 1988); they share a specialised cell 
invasion apparatus called the "apical complex", from which their name is derived. 
Well over 200 Plasmodium species have been described, which parasitise many 
species of animal, including reptiles, birds and mammals (Rich & Ayala, 2003). 
Plasmodium, like the related apicomplexans Babes ía and Theileria rely on a blood 
sucking dipteran for transmission between vertebrate hosts. Female mosquitoes of 
the genus Anopheles transmit the human malarias, P. vivax, P. ovale, P. malariae, and 
P. falciparum. P. falciparum is the species that is primarily studied in this thesis, 
although experiments have also been carried out using the rodent malaria P. 
chabaudi. 
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1.1.1 The life cycle of Plasmodium falciparum 
With each probe into human skin, a P. falciparum infected mosquito injects tens to 
hundreds of sporozoite stages of the parasite (Rosenberg et al., 1990); these are 
delivered to the liver via the circulation. Following sporozoite invasion of an 
hepatocyte, differentiation and intensive mitotic replication occur, processes taking 
approximately 6 days. The asexual intra-erythrocytic cycle is initiated when a 
mature hepatocyte ruptures, releasing an estimated 30 000 merozoites which upon 
encountering an erythrocyte, utilise their 'apical complex' for invasion. The 
erythrocytic cycle (Figure 1.2) involves erythrocyte invasion, intracellular growth, 
asexual reproduction by schizogony, erythrocyte rupture and reinvasion of new 
erytbrocytes (described in detail in Section 1.1.2). 
Following erythrocyte invasion a small proportion of merozoites differentiate into 
either male or female gametocytes, which can be taken up in the blood meal of a 
mosquito. In the mosquito's midgut male gametocytes undergo three rounds of 
DNA replication and mitosis and produces eight microgametes, each of which 
contains a haploid copy of its genome. Exflagellated male gametes fertilise a female 
gamete that has become primed to develop into an ookinete. Over a period of 5-
18 h the fertilised zygote differentiates into a single motile ookinete. The first two 
meiotic divisions of the genome take place within a single nucleus that does not 
undergo karyokinesis. The motile ookinete then migrates through the mosquito 
midgut wall, but arrival at the basal lamina inhibits migration, and differentiation 
into the oocyst, a trophic and replicative form, occurs. The original polyploid 
nucleus divides approximately once each day such that after 12-18 days there are 
2000-8000 haploid nuclei. When the oocyst bursts, the daughter cells, the 
sporozoites, are released into the haemocoel. Sporozoites migrate into the 
mosquito's salivary glands, to await the next blood-meal taken by the dipteran host 
(Sinden, 2002). 
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1 Figure 1.1: The life cycle of Plasmodium falciparum 
1  Reprinted from Trends in Parasitology, Vol. 19, Bannister & Mitchell, The ins, outs and roundabouts 
of malaria, 209-213, Copyright (2003), with permission from Elsevier 
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1.1.2 A closer look at P. falciparum's erythrocytic cycle 
The only extracellular stage of the asexual cycle is the small (-1.2 i.tm) invasive 
merozoite, but its exposure to the extracellular milieu of the blood stream and 
circulating host immune factors is brief. This compact stage of the parasite contains 
all the cellular machinery for establishing itself within the intraerythrocytic 
environment (figure 1.2A). A number of specialised apicomplexan and Plasmodium 
membranous and organellar cellular structures have evolved to accommodate the 
parasite's intra-erythrocytic niche. The apical complex consists of specialised 
secretory vesicles called the rhoptries, micronemes and dense granules; this 
complex mediates merozoite attachment to a fresh erythrocyte and invasion. The 
outer membrane of the merozoite is coated with short filaments that are thought to 
aid in attachment and invasion. During invasion a deep membrane pit is formed 
which eventually contains the parasite within the erythrocyte. In the 
parasitophorous vacuole (PV) the membrane lining the PV is called the 
parasitophorous vacuole membrane (PVM). Another feature of Apicomplexa is the 
presence of a plastid, thought to have arisen through the secondary endosymbiosis 
of an algal cell (Kohler et al., 1997). The plastid contains a 35 kb circular genome 
such that the parasite bears two extrachromosomal DNA elements, the plastid 
genome like the mitochondrial genome is inherited maternally. 
Following invasion of the erythrocyte the parasite flattens into a thin disc form that 
typically has a thick rim of cytoplasm containing the major organelles. In Giemsa 
stained blood smears viewed under light microscopy this stage appears as a 'ring' 
(figure 1.2B). The parasite begins to feed by engulfing in small aliquots of the 
erythrocyte cytoplasm through a small dense region on the surface of the parasite, 
the cytosome. Digestion of the erythrocyte's haemoglobin releases free haem as a 
toxic waste product which the parasite converts into a non-toxic crystalline material 
called haemozoin (Egan, 2002). Later in the erythrocytic cycle haemozoin is stored 
within another specialised organelle, the pigment vacuole (Bannister & Mitchell, 
2003). Haemozoin appears as dark pigment on blood smears and histological 
sections, and can also be easily detected by polarized-light microscopy. The 
trophozoite and schizont stages of the parasite digest considerable quantities of 
haemoglobin, not only as a source of amino acids, but also to maintain a fine 
homeostatic balance of solutes across the erythrocyte membrane. 
The trophózoite stage (figure 1.2C) is distinguished from the earlier ring stage by 
changes in cell size and shape. At this stage there is also an increase in protein 
synthesis and export of parasite proteins to the erythrocyte cytoplasm and 
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erythrocyte surface (Bannister et al., 2000). Parasite proteins associate with the 
erythrocyte cytoskeleton and membrane to form protrusions at the erythrocyte 
surface that appear as electron dense knob-like structures by transmission electron 
microscopy. Since the erythrocyte lacks organellar and membrane trafficking 
pathways, in order to transport proteins to the erythrocyte membrane the parasite is 
required to synthesis trafficking pathways de novo. Proteins required at the 
erythrocyte membrane for the purpose of solute uptake, secretion or host interaction 
are thought to be trafficked via Maurer's clefts: structures proposed to arise through 
'blebbing' and/or extension and elaboration of the PVM. During trophozoite 
development the number of free ribosomes increases, and the endoplasmic 
reticulum (ER) and putative Golgi complex increase in size and complexity. 
At the schizont stage the parasite undergoes repetitive nuclear division (figure 
1.2D). The parasite nucleus divides around 4 times to produce about 16 nuclei and 
concurrently remodels its cytoskeleton and initiates organelle multiplication to lay 
down the elements of the merozoites. During the last nuclear division, a series of 
merozoite forming loci arrange around the circumference of the infected 
erythrocyte. 
In P. falciparum infections of humans the asexual cycle takes 48 hours to complete 
and replication occurs synchronously. Rupturing P. falciparum schizonts release 
between approximately 8 and 20 merozoites, so that parasitaemias climb rapidly 
and exponentially in the absence of an effective immune response or drug 
treatment. 
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2Figure 1.2: 	Illustratrative depiction of the ultrastructure of P. 
falcIparum 's I ntraeryth rocytic stages 
Part A shows the internal organisation of the merozoite stage of the parasite. Several 
secretory vesicles, the rhoptries, the micronemes and the dense granules group at the apical 
end of the merozoite and release factors to permit erythrocyte invasion. Part B depicts the 
early ring stage; for clarity the red blood cell is not shown. Part C shows the organisation of 
the mid-trophozoite stage. An increase in protein synthesis and feeding is evident through 
the presence of multiple ribosomes, cytosomes and a pigment vacuole. Structures 
associated with the export of proteins (Golgi body and exocytic vesicales) are also apparent. 
Again for clarity the rbc is not shown. Part D shows a maturing schizont. Structures 
involved in protein trafficking (Maurer's clefts) are apparent and parasite-derived 
modifications to the erythrocyte membrane, knobs, are depicted. Developing merozoites are 
shown budding from the surface of the schizont. The relative sizes of the different stages 
have not been preserved. 
1.1.3 An adaptable beast 
The completion of Plasmodium 's life cycle requires many stages of differentiation to 
enable it to replicate in three distinctly different cells in two radically different hosts. 
The intra-erythrocytic stages face continual assault from the vertebrate host's 
immune system; the parasite's response to this is described in the next section (1.2). 
The high level of digestive enzymes in the mosquito midgut also constitutes a 
hostile environment (Billingsley & Hecker, 1991). 
Despite these adaptional capabilities, Plasm odium species are strict in their host 
species range and tissue specificity. A given species is transmitted by a restricted 
number of mosquito species to a limited number or a single vertebrate host species. 
Although some non-human primate malarias can infect humans and vice-versa, in 
generally the zoonotic capabilities of Plasmodium are considered to be limited. 
Recently, however, the macaque monkey parasite P. knowlesi was found to be 
responsible for over half of human malaria cases in a study in the Kapit division of 
Sarawak, Borneo (Singh et al., 2004). Whether P. knowlesi in this region has 
undergone a host switch has yet to be established. 
2  Reprinted from Parasitology Today, Vol. 16, Bannister et al., A Brief Illustrated Guide to the 
Ultrastructure of Plasmodium falciparurn Asexual Blood stages, 427-433, Copyright (2000), with 
permission from Elsevier. 
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Plasmodium is also restrictive in terms of cell selectivity; for example, P. falciparum 
sporozoites and merozoites invade only hepatocytes and mature erythrocytes 
respectively, whereas P. vivax merozoites selectively invade reticulocytes. By 
contrast, a single species of the apicomplexan Toxoplasma can infect virtually any 
nucleated cell of virtually any vertebrate (Roos et al., 2002). 
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1.2 Antigenic variation 
Maintaining chronic infections in the vertebrate host is considered desirable as it is 
thought to increase transmissibility. Chronic infection is a characteristic of many 
vector-borne parasitic protozoa, such Try panosoma, Babesia, and Plasmodium. These 
organisms have evolved at least one common mechanism for evading their host's 
immune system; antigenic variation of molecules that are in direct contact with the 
host immune system. 
During Plasmodium's erythrocytic cycle (figure 1.1) the parasite remains 
intracellular, except for a brief period between the release of merozoites from a 
rupturing schizont and invasion of a new cell. As human erythrocytes lack surface 
major histocompatibility complex molecules and a mechanism for antigen 
presentation, these particular cells of the host constitute a relatively safe haven. 
However, both Plasmodium and the related haemoparasite Babesia bovis (Allred et al., 
2000) disclose themselves to the mammalian immune system by exporting their 
proteins to the erythrocyte surface. Indications of this potentially counterintuitive 
phenomenon were first detected in the 1930s when serum from a monkey infected 
with P. knowlesi was found to agglutinate infected erythrocytes but not uninfected 
cells (Eaton, 1938). Species- and variant-specific antibodies to red cell surface 
antigens were subsequently shown for primate (Brown & Brown, 1965), rodent and 
bird malarias (reviewed in Kyes et al., 2001). In 1983, direct biochemical evidence 
was presented to show that a primate P. knowlesi clone expressed surface antigens 
on the infected erythrocyte (IE) (Howard et al., 1983). 
It is thought that once an immune response has been mounted to one VSA 
phenotype there is selection for parasite clones expressing VSAs that are novel to 
the host immune system. The mechanism behind this 'switching' phenomenon is 
not understood. Recker et al. (2004) have constructed mathematical models to 
suggest that a new sub-population of antigenically dissimilar parasites, selected by 
the immune system, becomes the new dominant population. However, experiments 
with primate models suggest that an induced population-wide 'switch' in 
phenotype occurs (Galinski & Corredor, 2004). 
Regardless of the underlying molecular mechanisms antigenic switches are thought 
to produce the recrudescing waves of parasitaemia that are characteristic of 
infection with many Plasmodium species (figure 1.3). Recrudescing waves of 
parasitaemia are especially apparent, or at least well characterised, in naïve hosts 
(Mackinnon & Read, 2004b). 
Chapter 1: Introduction 	 9 








3Figure 1.3: Recrudescing peaks of parasitaemia 
Graph illustrates the dynamics of a clonal P. chabaudi infection in a malaria naïve laboratory 
mouse. Note that the y-axis is a log scale and therefore the recrudescent peaks of 
parasitaemia are considerably lower than the initial acute peak. 
1.2.1 Parasite subversion and suppression of the host immune system 
In addition to antigenic variation at the IE surface P. falciparum evades and subverts 
the host immune response via other mechanisms. Urban and colleagues (1999) 
have shown that intact lEs can bind to myeloid dendritic cells and furthermore 
modulate their maturation and function in vitro. Exposure to lEs inhibits the 
upregulation of major histocompatibility class II molecules, adhesion molecules and 
co-stimulatory molecules on stimulated dendritic cells. Furthermore, the ability of 
these cells to stimulate T-cell responses was profoundly reduced (Urban et al., 2001). 
Studies in a rodent malaria model suggest that this phenomenon is not restricted to 
P. falciparum. Ocana-Morgnar and colleagues have shown in laboratory mice that 
blood stage infection with Plasmodium yoelii inhibits dendritic cell maturation and 
their capacity to initiate immune responses to the liver stages of the parasite (Ocana-
Morgner et al., 2003). That blood stages of Plasmodium can impair the host's 
immunity to liver stages of the parasite, thus aiding the establishment of re-
infection, illustrates the extent of Plasmodium's adaptations to its mammalian host. 
The ability of Plasmodium infection to suppress the host immune response in general 
has long been suspected. Williamson and Greenwood (1978) found immune 
10 Chapter 1: Introduction 
responses to measles vaccination to be impaired in children with acute malaria. In 
some malarious regions there is a significantly higher incidence of Burkitt's 
lymphoma, an otherwise rare tumour of children in which B cells are transformed 
by the Epstein-Barr virus (Whittle et al., 1984), and also Salmonella infections (Mabey 
et al., 1987). The increase in incidence of Burkitt's lymphoma and Salmonella 
infections in children living in malarious regions suggests that the immune 
surveillance mechanisms responsible for either detecting or eliminating Epstein-
Barr virus transformed B cells and Salmonella infected cells may be dampened by 
malaria infections. Acute blood stage infection has been found to impair cell-
mediated immunity (Brasseur et al., 1983; Ho et al., 1986; Hviid et al., 1991) and 
lymphocyte proliferative responses are inhibited by serum from P. falciparum 
infected patients (Theander et al., 1987). Recently, P. falciparum schizont lysate was 
shown to modulate plasmacytoid dendritic cells, one of the two dendritic cell 
precursor populations in humans, which in addition to antigen presentation are 
though to play an important role in innate immunity. PCDs serve as antigen 
presenting cells for initiating adaptive immune response, but also produce high 
levels of the proinflammatory cytokine interferon-gamma (IFN-o) in response to a 
number of pathogen products, for example viral and microbial DNA, and CpG 
DNA stimulation. Plasmacytoid dendritic cells (PDCs) exposed to schizont lysate 
or intact schizont infected cells have been shown to produce interferon-gamma, but 
not produce tumour necrosis factor-gamma and fail to exhibit a cell morphology 
concomitant with DC maturation (Pichyangkul et al., 2004). Schizont exposed PDCs 
were shown to upregulate the surface expression of the co-stimulatory molecule 
CD86, but did express the costimulatory molecule CD40, a marker of DC 
maturation. Furthermore, schizont exposed PDCs elicited poor T cell responses, but 
promoted 'öT cell proliferation. The work of Pichyangkul et al. suggests that 
schizont exposed PDCs play an important role in mediating an innate immune 
response to P. falciparum through the production of IFN-ô. However, due to the 
failure of the PCDs to complete maturation, may not perform the role of antigen 
presentation efficiently during malaria infections. 
Plasmodium clearly subverts and evades the host immune response at multiple 
levels, probably in order to maintain chronic infections. This may be particularly 
important in areas of seasonal transmission. Unlike P. falciparum, P. vivax 
sporozoites can differentiate into dormant liver stages, called hypnozoites, such that 
the parasite can re-establish a blood stage infection again after up to four years. The 
P. chabaudi infection data kindly shared by J.C. de Roode. 
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importance of chronicity for P. falciparum blood stage infection is illustrated by 
debates over the source of infection following the dry season in regions where 
malaria transmission is highly seasonal. It is known that some individuals 
maintain a very low-grade parasitaemia over the dry season in areas of seasonal and 
unstable transmission, such as parts of Sudan (Babiker et al., 2000; Hamad et al., 
2000). These individuals can provide the pool of transmissible P. falciparum 
gametocytes when rains and mosquitoes return. 
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1.2.2 Variant surface antigens as virulence factors: cytoadhesion 
Of the four species of Plasmodium infecting humans, P. falciparum causes the most 
severe morbidity and the great majority of malaria-related mortality. P. falciparum is 
the most prominent species in tropical Africa; however, this alone does not account 
for its larger clinical impact. P. vivax is widely distributed and causes relatively 
'mild' although distressing and debilitating clinical symptoms such as paroxysm, an 
acute fever typically preceded by chills and rigors (Karunaweera et al., 2003). 
Nonetheless P. vivax infections, like P. ovale and P. malariae infections, rarely cause 
fulminating disease that kills the patient. 
In malaria endemic areas most episodes of P. falciparum infection in adults result in 
'mild' clinical symptoms such as fever, malaise, lethargy and headaches. Severe 
clinical symptoms are most common in young children, first-time pregnant mothers 
and non-immune adults. Cerebral malaria accounts for a significant proportion of 
the severe clinical manifestations and deaths caused by P. falciparum infection and is 
characterised by an unarousable coma, often with convulsions, although syndromes 
with varying degrees of impaired consciousness also occur. Severe anaemia also 
contributes significantly to morbidity and mortality, and probably results from the 
destruction of normocytes (older red blood cells) and reduced levels of 
erythropoiesis. Additional severe symptoms include respiratory distress, renal 
dysfunction or failure and severe haemoglobinuria. However, defining clinical 
syndromes can be difficult due to overlapping symptoms and varying degrees of 
severity. The burden of malaria and the epidemiology of P. falciparum malaria are 
discussed further in Section 1.3. 
P. falciparum differs markedly from the other human malarias in that the VSA 
expressed by mature lEs adhere to the endothelium of the host micro-vasculature 
(Udeinya et al., 1981), such that trophozoites and schizonts are rarely seen in 
peripheral blood smears. The selective driving-force for the cytoadherent 
capabilities of P. falciparum lEs is thought to be avoidance of splenic clearance. The 
spleen-dependent expression of P. knowlesi surface antigens in laboratory primate 
models supports this view (Barnwell et al., 1983). All P. knowlesi blood stage forms 
circulate, but this parasite does exhibit some sequestration in primate models 
(Galinski & Corredor, 2004; Miller et al., 1971). In primate models with P. falciparum, 
PfVSA expression at the IE surface is also modulated by the presence or absence of a 
spleen and by immune pressure (Hommel et al., 1983). The spleen has also been 
shown to play a role in modulating cytoadherence properties in Plasmodium fragile 
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infections of its natural primate host (David et al., 1988; Handunnetti et al., 1987) and 
in Plasmodium chabaudi infections of laboratory mice (Gilks et al., 1990). 
The degree to which the rigidity of the infected cell is altered also differs between 
Plasmodium species. P. vivax infection increases erythrocyte deformability whereas 
P. falciparum decreases deformability (Suwanarusk et al., 2004). Suwanarusk and 
colleagues propose P. vivax lEs escape splenic entrapment by increasing the 
deformability of the infected cell. This would support the need for P. falciparum lEs, 
but not P. vivax lEs, to evolve a mechanism to avoid splenic clearance. 
Cytoadherence of P. falciparum presumably promotes the elevated parasitaemias 
seen in these infections although the importance of alternative mechanisms for P. 
falciparum pathogenesis have been contentious (e.g. Berendt et al., 1994; Clark & 
Rockett, 1994) and remain under review (e.g. Heddini, 2002). It is generally 
excepted that cytoadherence to the microvasulature endothelium and to other 
structures such as the placental syncytiotrophoblast will result in the release of 
cytokines and thereby trigger the pathogenic inflammatory responses associated 
with cerebral malaria (reviewed in Mackintosh et al., 2004) and pregnancy-
associated malaria (Fievet et al., 2001; Fried et al., 1998a; Okoko et al., 2003). As 
PJVSAs mediate cytoadhesion they are thus instrumental in bringing about P. 
falciparum malaria pathogenesis (reviewed in Beeson & Brown, 2002; Craig & Scherf, 
2001), and are thereby considered virulence factors. In support of this view is the 
finding that P. knowlesi lines not expressing VSAs are less virulent in a primate 
malaria model (Galinski & Corredor, 2004). Cytoadherence is also a characteristic of 
P. chabaudi infection in mice: in this model PcVSA-ve lines show the same 
characteristics as PcVSA+ve lines over the acute stage of infection where 
parasitaemias and morbity are highest; PcVSA-ve P. chabaudi does not, however, 
produce recrudescing waves of parasitaemia and chronic infection (Gilks et al., 
1990). 
PfVSAs also mediate rosetting, a cytoadherence phenomenon where infected 
erythrocytes bind two or more uninfected erythrocytes (Handunnetti et al., 1989; 
Udomsangpetch et al., 1989). Studies have indicated that rosetting in P. falciparum 
associates with an increased risk of severe disease (Carlson et al., 1990; Ringwald et 
al., 1993; Rowe et al., 1995; Rowe et al., 2002b); however, some studies have failed to 
find this association (al-Yaman et al., 1995; Rogerson et al., 1999). The rosetting 
cytoadherence phenotype was first described in P. fragile infections of toque 
monkeys (David et al., 1988) and has since been shown to occur in all four human 
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malaria species (Angus et al., 1996; Lowe et al., 1998; Udomsanpetch et al., 1995) and, 
primate and rodent malarias (Mackinnon et al., 2002; Udomsangpetch et al., 1991). 
As discussed in section 1.2.1 recent studies show that PJVSAs can interact and 
modulate immune cells and also suggests that PJVSA might moderate virulence 
(Urban et al., 1999; Urban et al., 2001). Urban and Roberts (2002) propose that 
parasites adhering to immune cells might inhibit immune and inflammatory 
responses which are potentially harmful to both host and parasite. 
Additional differences between P. falciparum and other human malarias such as cell 
selectivity, may influence parasite replication rate and thereby contribute to parasite 
virulence. Invasion of human erytbrocytes by P. vivax seems to be dependent upon 
a single receptor, but P. falciparum, and some other species, can utilise multiple 
alternative invasion pathways (Michon et al., 2002). Decreased cell selectivity has 
been shown to be associated with disease severity in P. falciparum infections (e.g. 
Chotivanich et al., 2000; Simpson et al., 1999). It is likely that parasite virulence is a 
multi-locus trait and plastic depending on factors such as immune status and age of 
the host. Plasticity is certainly reflected in the genes responsible for antigenic 
variation at the infected erytbrocyte surface. 
1.2.3 Molecular mechanisms of antigenic variation 
By far the most extensively characterised PJVSA, and thus far the only one shown to 
mediate adhesion to endothelial receptors, is P. falciparum erythrocyte membrane 
protein 1 (PfEMP1). PfEMP-1 is a large protein encoded by members of the var 
multigene family (Baruch et al., 1995; Smith et al., 1995; Su et al., 1995), which 
consists of around 50-60 copies per P. falciparum genome. Var genes are highly 
divergent in sequence. The variability for certain regions of the gene is found on 
average to be as great within an isolate as between isolates (Kyes et al., 1997). In 
addition, very little cross-hybridisation has been found when a complex probe 
derived from the var genes of a P. falciparum clone was used to probe the genomic 
DNA of a different clone (Taylor et al., 2000). 
Var genes are found at central and subtelomeric loci within the parasite's genome 
(Gardner et al., 2002; Rubio et al., 1996). Telomeric var genes lie within ordered 
repeat sequences, and are flanked by members of other multigene families. In the 
protozoan parasite Giardia duodenalis, genes that mediate antigenic variation are also 
found at the polymorphic ends of chromosomes (Uperoft et al., 1997). It has been 
suggested that the flexibility of chromosome ends during meiosis is exploited as a 
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common tool for generating diversity by several pathogenic agents (Lanzer et al., 
1995). Frequent meiotic recombination within sub-telomeric regions (Taylor et al., 
2000), the large number of var genes per genome and the multidomain structure of 
PfEMP-1 (figure 1.4) provide great potential for generating variation, although some 
PfEMP1 alleles have been found to be relatively conserved in field isolates (Fried & 
Duffy, 2002; Rowe et al., 2002a; Salanti et al., 2003; Winter et al., 2003). Heterologous 
recombination may also occur during mitotic division of P. falciparum blood stages 
(Freitas-Junior et al., 2000). 
TM 
Figure 1.4: Schematic representation of a generic var gene and PfEMP1 
Schematic based on the most common PfEMP1 structure in the genome of P. faiciparum 
clone 3D7 (Gardner et al., 2002); 38 out of 59 var genes encode this basic structure. The 
nomenclature follows that used by Gardner et al (2002). DBL-a: 'Duffy binding like domain 
of the a sub-class; only the a and y sub-classes are present in the PfEMP1 depicted (3 
further distinct DBL sub-classes are seen: ö, 6 , and X); CIDR-cz: 'cysteine rich interdomain 
region' type a (the remaining CIDR sequences do not form distinct tree branches and are 
therefore labelled not-a type); ATS: amino terminal sequence; TM: transmembrane 
sequence. Note this PfEMP1 does not incorporate a 'constant 2' region. 
PfEMP1's cysteine-rich nature is shared by the surface antigens of P. knowlesi 
(Galinski & Corredor, 2004), a related apicomplexan haemoparasite Babesia bovis 
(AlIred et al., 2000), and the unrelated ancient eukaryotic parasite Giardia duodena!is 
(Uperoft et al., 1997). The invasion receptors of P. falciparum and P. vivax from which 
PfEMP1 has arisen, due to gene duplication and diversification, are also cysteine-
rich (Michon et al., 2002). The significance of this is unknown, although a recent 
study by Hensmann et al. (2004) suggests the cysteine-rich nature of the 19 kDa C- 
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terminal fragment of the merozoite surface protein 1 (MSP1(19)), which confers a 
tightly folded structure and aspargine endopeptidase resistance, may impede the 
processing of this fragment by antigen presenting cells. Experimentally high levels 
of antibodies to MSP1(19) confer protective immunity against malaria, but natural 
antibody responses to this protein in human malaria infections are short-lived and 
relatively low, despite repeated exposure to infection. 
PfEMP1 forms part of the Duffy binding-like (DBL) superfamily of proteins. 
Members of this family contain one or more domains with homology to a P. vivax 
merozoite surface protein that binds the Duffy blood group antigen, a host-cell 
invasion receptor (Adams et al., 1992). The complete genome sequence of the P. 
falciparum clone 3D7 has shed more light on this interesting gene family (Gardner et 
al., 2002). The var genes encoded by the 3D7 genome, and all other vars identified, 
thus far, share a similar gene structure (figure 1.4). A 5' exon, between 3.5 and 9.0 
kb in length, encodes the multidomain, extracellular portion of the protein which 
consists of both DBL domains and one or two cysteine rich interdomain regions 
(CIDR). A transmembrane region is also encoded at the 3' end of the 5' exon. A 
second smaller exon of between 1.0 and 1.5 kb encodes the intracellular amino 
terminal sequence (ATS) which is relatively well conserved (Gardner et al., 2002). 
The var intron varies in length between 170 bp and 1.2 kb. Although the PfEMP1 
structure shown in figure 1.4 is the most common in the 3D7 genome, it is the least 
well characterised. Selection for certain established cytoadherence phenotypes 
could explain the bias in the var genes studied thus far. 
1.2.4 More multigene families and putative IE surface exposed proteins 
In addition to the var multigene family, P. falciparum's genome contains two further 
highly variable multigene families: rif and stevor (Cheng et al., 1998). The 3137 
genome encodes 59 var, 149 rif and 28 stevor genes, and additional pseudogenes and 
truncations are present for each family. The rif and stevor gene families encode 
proteins called repetitive interspersed family (rifin), and sub-telomeric variable 
open reading frame (stevor), respectively. Rifin proteins, like PfEMP1, are thought 
to be exported to the erythrocyte surface (Kyes et al., 1999) and although stevor 
proteins have been found in Maurer's clefts (Kaviratne et al., 2002), the IE surface 
has yet to be confirmed as their final destination. 
Unlike the var gene family, homologues of rif genes are present in other Plasmodium 
species and together form the Plasmodium interspersed repeat (pir) gene superfamily 
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(Janssen et al., 2004). The pir superfamily includes cir, bir and yir genes from the 
rodent malarias P. chabaudi, P. bergei and P. yoelii respectively (Canton et al., 2002; 
Janssen et al., 2002), kir genes in P. knowlesi and vir genes in P. vivax (del Portillo et 
al., 2001). 
Finally, the P. knowlesi multi-gene family sicavar (al-Khedery et al., 1999) and the P. 
falciparum var family are analogous in they encode variant surface antigens for 
which homologues have yet to be found in other P!asmodium species. Whether all or 
most Plasmodia possess species-specific VSA genes will soon come to light 
considering the current rate of genome sequencing for this genus. 
In addition to variant multigene families a number of proteins, apparently encoded 
by single copy genes, have been proposed to be exposed at the surface of P. 
falciparum lEs, these proteins are summarised in Table 1.1. A mechanism by which 
proteins encoded by single copy genes would avoid recognition by the mammalian 
immune system and the subsequent destruction of the infected cell has yet to be 
proposed. 
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Table 1.1: Summary of P. falciparum IE surface exposed proteins 
Abbreviations: CIag 9; cytoadherence associated gene 9, PIESP; parasite-infected 
erythrocyte surface protein, ASP; ring surface protein, RAP2; rhoptry associated protein-2 
Protein Gene Function References 
PfEMP1 var family Antigenic variation and (Baruch et al., 1995; 
cytoadherence to a number of Smith et al., 1995; Su et 
endothelial cell and placental al., 1995) 
receptors. 
Rifin rifin family Not known, but most likely (Fernandez et al., 1999; 
antigenic variation due to the Kyes et al., 1999) 
nature of the multicopy gene 
family. 
sequestrin not known Sequestrin is a --270 kda protein (Ockenhouse et al., 
and is thought to be encoded by a 1991) 
single copy gene, the protein has 
been proposed to mediate parasite 
adhesion to CD36. 
Clag 9 clag 9 Naturally occurring clag 9 knock- (Trenholme et al., 2000) 
out parasites lose the ability to (Trenholme et al., 2000) 
cytoadhere, therefore, a role for this (Gardiner et al., 2000) 
gene in cytoadherence has been (Craig, 2000; Gardiner 
proposed. However, recent studies et al., 2004) 
suggest that Clag9 is not on the JE 
surface, but may be necessary for 
the trafficking of VSAs or is 
required for the correct 
conformation of VSAs at the IE 
plasma membrane. 
PIESP1 PIESP1 A single copy gene recently (Florens et al., 2004) 
identified through proteomic 
analysis, the function of this gene is 
currently unknown. 
PIESP2 PIESP2 A single copy gene identified along (Florens et al., 2004) 
with PIESP1, like PIESP2 its 
function is currently unknown. 
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RSP2 	aka RAP2 RAP2 is released from the (Douki et al., 2003; 
RAP2 micronemes of the merozoite Pouvelle et al., 2000) 
during invasion and is transferred 
to the surface of the IE. In CSA 
binding parasite RSP2 is thought to 
mediate ring stage adhesion to the 
placental syncytiotrophoblast. 
How RSP2 would mediate ring 
stage adhesion for CSA binding 
parasites only, when it is present on 
ring stage parasites exhibiting an 
alternative adhesion phenotype is 
presently unclear. 
RSP1 Not known Not known (Pouvelle et al., 2000) 
Modified anion Band III is an abundant host anion- (Crandall et al., 1994; 
band III exchange exchange transporter that is Crandall et al., 1996; 
transporter-i modified by the parasite in situ. Crandall & Sherman, 
Parasite mediated modifications to 1996) 
band III are thought to expose 
regions of the protein, such that 
cryptic adhesive domains are 
revealed. The cryptic binding 
domain has been named pfalhesin. 
Pfalhesin has been shown to bind 
thrombospondin and CD36. 
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1.3 The burden of malaria 
While a single infection with some pathogens, principally viruses, is sufficient to 
elicit long-term 'sterile' immunity, sterile immunity to many parasites, including P. 
falciparum, is probably never achieved. The dynamics of acquired immunity to the 
P. falciparum malaria and the consequent severity of clinical symptoms depend on 
the intensity of transmission (e.g. Marsh & Snow, 1997). In regions of the world 
where malaria transmission is high, new-born infants are protected from severe 
malaria symptoms for their first 6 months of life, most likely due to passive transfer 
of immunity from their mothers (reviewed in Kyes et al., 2001). As this immunity 
wanes children become susceptible to severe clinical symptoms. Severe malarial 
anaemia in areas of high malaria transmission is most frequently seen in young 
children (1-3 years old). Cerebral malaria, which may result in coma and death, is 
predominant in regions of moderate transmission and is often seen in somewhat 
older children (>3-4 years old) (Greenwood, 1997). 
4Figure 1.5: Malaria remains a burden for many parts of the world 
Distribution of malaria from pre-intervention to 2002. Data is presented for circa 1900 and 
for the years 1946, 1965, 1975, 1992, 1994, and 2002. Areas of high and low risk were 
merged to establish all-cause malaria transmission limits (Hay etal., 2004). 
Reprinted from The Lancet, Vol. 4, Hay et a!, The global distribution and population at risk of 
malaria: past, present, and future, pages 327-336, Copyright (2004), with permission from Elsevier 
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Despite severe malaria and malaria related mortality being relatively rare, due to 
the ubiquity of the parasite (figure 1.5), malaria kills up to 3000 children in Africa 
each day (0.57o-17o of all malaria cases) (Snow et al., 1999; UNICEF, 2003). In 
malaria-endemic regions children under the age of five bear the brunt of malaria 
mortality. Immunity to non-cerebral, severe clinical manifestations is postulated by 
some to require few clinical episodes (Gupta et al., 1999). Adults in areas of high 
transmission rarely suffer severe clinical symptoms. There is one exception: 
pregnant women (Menendez, 1995). This special case is discussed in more detail in 
the next section. 
Falciparum malaria has a direct impact on the lives of the patient and their families, 
and its ramifications at the level of community and state, in terms of restraining 
economic growth and development, are also becoming realised (Breman, 2001; 
Russell, 2004). Although malaria has been eradicated from Europe and North 
America, long-term control has thus far proved impossible for many parts of the 
world. Malaria remains endemic in parts of Asia, Africa, Central and South 
America, Oceania, and certain Caribbean islands (figure 1.5, Hay et al., 2004). 
Political and socio-economic factors, healthcare infrastructure, poor education and 
housing, high transmission intensities, drug resistance of the parasite and vector, 
and probably many more factors have played roles in ensuring only short-term 
success, or complete failure, of malaria control initiatives in those countries bearing 
the burden of malaria today. 
1.4 Pregnancy-associated malaria 
1.4.1 Pregnancy-associated malaria is an Important public health 
problem 
The remainder of this introduction is focused on one possible approach to alleviate 
one particular syndrome: pregnancy-associated malaria (PAM). PAM is estimated 
to result in 75 000 - 200 000 infant deaths per year (Steketee et al., 2001). In areas of 
stable transmission, PAM increases the risk of low birth-weight babies, probably by 
intrauterine growth retardation, but possibly also by premature delivery. Although 
premature delivery is more difficult to establish without early prenatal screening 
and healthcare unit attendance by the mother (Menendez et al., 2000; Meuris et al., 
1993; Shulman et al., 1999). In sub-Saharan Africa, low birth-weight is a strong 
predictor of a child's fitness (Guyatt & Snow, 2001a) and PAM is thought to be one 
of the most preventable non-genetic causes of low birth weight in such endemic 
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areas (Brabin & Rogerson, 2001). For the mother there is a higher likelihood of 
severe malaria syndromes such as severe anaemia (Guyatt & Snow, 2001b). In areas 
of seasonal transmission, stillbirth rates are higher than in areas of high 
transmission and the symptoms suffered by mothers more severe (Duffy, 2003). At 
least 50 million pregnancies each year are at risk of malaria infection (Steketee et al., 
2001). 
1.4.2 Pathogenesis of pregnancy-associated malaria 
During pregnancy the immunological status of the mother is modified to prevent 
immune rejection of her allograft: her foetus. Several immunological factors are 
observed to change during gestation, notably a swing towards type 2 responses 
(non-inflammatory). However, epidemiological data indicate that most microbes do 
not pose an increased threat for pregnant women, the exceptions including 
cytomegalovirus reactivation, possibly leprosy relapses and higher parasite loads of 
the intracellular parasites Try panosoma and Plasmodium (reviewed in Guilbert et al., 
2001). P. falciparum infection during pregnancy is characterised by the sequestration 
if lEs in the placenta such that parasite densities can become extreme. 90% 
parasitaemias have been reported (Brabin et al., 2004). Non-falciparum PAM also 
occurs, but is not well documented, thus PAM shall refer to P. falciparum infections 
unless otherwise stated. P. vivax infection during pregnancy has been shown to 
cause lower birth weights and mild maternal anaemia in areas of low transmission 
(Nosten et al., 1999), but the frequency of placental infection and the placental 
parasite densities tend to be much lower when compared to P. falciparum 
(McGready et al., 2002; McGready et al., 2004). 
The hallmark of PAM is the sequestration of lEs on the maternal side of the 
placenta. lEs being detected in rare cases in Giemsa stained smears of chord blood, 
but not in foetal erythrocytes or foetal structures (Ismail et al., 2000; Redd et al., 
1996). Haemozoin has also been found in the foetal trophoblastic cells (McGready et 
al., 2002; McGready et al., 2004), which cover the foetal villi of the placenta and act as 
a barrier between maternal and foetal blood (figure 1.6). 
lEs are usually found in the intervillous spaces of the placenta closely associated 
with the syncytiotrophoblast cell layer (figure 1.6). Mature parasite stages have 
only been detected in the peripheral circulation in severe clinical cases of PAM 
(Beeson et al., 2002a) and it is the accumulation of parasites in the placenta that is 
thought to lead to poor clinical outcomes for mother and child. As placental 
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histological examinations and placental blood smears can only be carried out at 
birth. Since pregnant women in endemic regions often have low peripherial 
parasitaemias, despite harbouring high-density placental infections (Brabin & 
Rogerson, 2001), infections in earlier stages of gestation are usually inferred by the 
presence of malaria pigment in monocytes and/or other immune cells in the 
placenta at birth. 
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Figure 1.6: Schematic of the placental circulation 
The placenta consists of a foetal and a maternal portion, the former consists of repeatedly 
branching villi suspended in an intervillous space. Maternal blood is carried into the 
intervillous space by uterine arteries where it bathes the foetal the villi. Uterine veins return 
maternal blood away from the placenta. A branch of an umbilical artery enters each villus 
and terminates in a capillary plexus from which blood is drained by a tributary of the umbilical 
vein. The foetal vessels within the villus are wrapped in a thin layer of mesoderm and two 
layers of cells derived from the trophoblast. The deeper layer of cells adjacent to the 
mesoderm is the cytotrophoblast layer and the superficial layer in contact with the maternal 
blood the syncytiotrophoblast layer. After the fifth month of gestation a single layer of 
flattened syncytiotrophoblast replaces these two cell layers. (Reproduced from: Gray, 
Henry. Anatomy of the Human Body. Philadelphia: Lea & Febiger, 1918; Bartleby.com , 2000. 
www.bartleby.com/107/.)  
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The infiltration of inflammatory cells into the intervillous space of the placenta 
(intervillousitis) has been closely associated with placental parasitaemia (Ismail et 
al., 2000). This inflammatory infiltrate consists mainly of monocytes and 
macrophages (Bulmer et al., 1993; Ordi et al., 2001), and was found by Ordi et al. 
(1998) to be more prevalent in primigravidae and its occurrence to associate with 
low birth weight. Consistent with the observation of inflammatory cells in infected 
placentae is the imbalance in inflammatory (type 1) and non-inflammatory 
cytokines (type 2). Fried et al. (1998a) found in cases of PAM a decrease in the type 
2 cytokine interleukin-lO and higher levels of the type 1 cytokines interferon-
gamma, interleukin-12 and tumour necrosis factor-alpha in infected placentae. 
PAM-induced type 1 cellular responses are thought to be related to reduced foetal 
fitness (Okoko et al., 2003). 
1.4.3 Placental isolates exhibit a distinct adhesive phenotype 
Sequestration and placental adhesion in the placenta is considered instrumental in 
triggering PAM pathogenesis. The characterisation of the host receptors mediating 
this parasite interaction has progressed significantly over recent years. A number of 
studies have shown that the glycosaminoglycan chondroitin-sulphate A (CSA) can 
support IE adhesion (Chaiyaroj et al., 1996; Robert et al., 1995; Rogerson et al., 1995). 
CSA is a polymer comprising alternating glucuronic acid and 4-sulphated N-
acetylgiucosamine residues. In terms of polymer length and the pattern and degree 
of sulphation biological sources of CSA are highly heterogeneous (Karamanos et al., 
1994). Several studies have shown that placental lEs can bind many sources of CSA 
(Beeson et al., 1999; Fried & Duffy, 1996), but binding is dependent on the degree of 
sulphation (Fried et al., 2000) and molecular size, a tetradecasaccharide being the 
minimum size able to significantly inhibit IE binding. Achur and colleagues (2000) 
isolated placental CSA and identified several distinct types of chondroitin sulphates, 
but found the uniquely low sulphated extracellular CSA that localises to intervillous 
spaces (figure 1.6) bound lEs most efficiently. The validity of earlier studies 
suggesting the glycosaminoglycan hyaluronic acid (HA) is also a placental receptor 
(Beeson et al., 2000; Beeson et al., 2002b) have been questioned due to concerns with 
the purity of HA preparations and contamination with CSA (Duffy & Fried, 2003a). 
Recently, however, Beeson and colleagues (2004) have confirmed that HA can also 
support IE adhesion. HA like CSA can be extracted from placental tissue and is 
composed of repeating disaccharide units. N-acetylglucosamine and glucuronic 
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acid constitute HA, but it is not suiphated and its chemical composition is thus less 
variable than CSA (Smith & Miller, 2004). Interestingly, Beeson and colleagues 
(2004) have recently shown some parasites to express VSA with dual specificity, 
such that parasites can adhere to both CSA and HA. 
Placental isolates also exhibit dichotomy in terms of their adhesive phenotype, in 
that they do not generally bind the endothelial receptors CD36 and ICAM1 (Beeson 
et al., 1999; Beeson et al., 2000; Fried & Duffy, 1996; Maubert et al., 1997), which are 
commonly exploited by lEs isolated from the periphery of non-pregnant persons. In 
vitro binding studies by Maubert et al. (1997) using syncytiotrophoblasts found 
parasites to bind surface expressed ICAM1, but the parasites studied were not 
isolated from pregnant women. 
It had become dogma that only the mature asexual stages of P. falciparum adhere 
and sequester, however, the work of Pouvelle and colleagues (2000) showing ring 
stage adhesion to brain and lung endothelial cells, and placental 
syncytiotrophoblasts challenges this. Interestingly, although ring stage adhesion 
was not inhibited by GSA, ring adherent parasites developed into trophozoites 
expressing exclusively CSA adhesion phenotypes. This was also the first 
demonstration that IEs can sequentially exhibit two distinct adhesion phenotypes 
during a single intraerythrocytic cycle. Ring stage adhesion may explain parasites 
being scarce or at undetectable levels in the peripheral circulation of women with 
PAM despite substantial placental parasitaemias (Ismail et al., 2000). 
1.4.4 Parity dependent acquisition of immunity 
Although the severity of PAM symptoms has been shown to be dependent on 
transmission intensity, duration of infection and timing of infection (Brabin et al., 
2004), the most striking feature of PAM epidemiology is the parity dependence of 
susceptibility (McGregor et al., 1983). Women in their first and second pregnancy 
are more susceptibility to infection and clinical consequences such as maternal 
anaemia (Matteelli et al., 1994), intervilliousitis (Ismail et al., 2000) and low birth 
weight (Watkinson & Rushton, 1983) are more severe than in women in later 
pregnancies. This parity dependent nature suggests immunity to PAM can be 
acquired as a function of parity in an analogous fashion to acquired immunity to 
non-PAM can be acquired with age and exposure. There is also a parity 
dependence for susceptibility to P. vivax infection during pregnancy, but in contrast 
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to P. falciparum, the negative impact of P. vivax infection on birth weight is more 
pronounced in multigravidae (Nosten et al., 1999). 
The findings of a large body of work suggest PAM's parity dependent nature lies in 
the ability of the parasites infecting the placenta to switch VSA expression to 
antigenically distinct variants. The development of the placenta during pregnancy 
is thought to provide novel adhesion receptors such that the. YSA of placental 
binding parasites are structurally different to the VSA structure necessary to bind 
vascular endothelial receptors. The apparent mutually exclusive expression of VSA 
that bind either CSA or' CD36 supports this theory. Immuno-epidemiological 
studies suggest the primigravidae lack substantial levels of antibodies to the VSA of 
placental isolates (VSA,) and anti-VSA PAM antibodies are acquired following P. 
falciparum infections during pregnancy (Fried et al., 1998b; Maubert et al., 1999; Ricke 
et al., 2000). That men living in malaria endemic lack antibodies reactive to the 
surface of CSA-binding parasites further supports that the VSA of placental isolates 
are antigenically distinct (e.g. Ricke et al., 2000). The primary role of VSA PAM 
specific antibodies in protecting multigravidae is thought to be their ability to 
prevent lEs adhering to placental receptors (Fried et al., 1998b; Maubert et al., 1999; 
O'Neil-Dunne et at., 2001; Ricke et al., 2000). 
The potential of anti-VSA antibodies in naturally acquired immunity to malaria in 
general was first investigated in longitudinal studies carried out by Marsh and 
colleagues (1989). Over the duration of a malaria transmission season in The 
Gambia in vitro assays to measure several types of immune response to asexual 
stage lEs were carried out using a large cohort of children. These studies found pre-
existing levels of antibody to the JE surface to be the best predictor of protection 
against infection and clinical symptoms. Further studies in geographically diverse 
malarious areas found that during acute attacks of P. falciparum malaria in children, 
isolate-specific antibodies to the IE surface are developed, further supporting VSAs 
as targets for naturally acquired immunity (Bull et al., 1998; Iqbal et al., 1993). The 
acquisition of anti-VSA?AM antibodies through exposure to infection following one 
or more pregnancies is analogous to the acquisition of immunity to VSA through 
childhood in malaria endemic regions. 
Alternative and or additional immunological aspects of primigravidae such as 
generally dampened humoral and cellular mechanisms may contribute to the parity 
dependent nature of PAM (Fievet et al., 2002). Rasheed et al. (1993) suggest 
primigravidae may be more susceptible to malaria because of physiologic factors, 
such as higher levels of circulating immunosuppressive corticosteroids. 
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1.4.5 A vaccine against PAM? 
PAM is the clearest example in malaria pathology research of a strong association 
between infected erythrocyte sequestration and a particular disease syndrome 
(reviewed in Reeder, 1999). Antibodies against VSA PAM that prevent adhesion to 
placental receptors (Duffy & Fried, 2003b) or at least antibodies that recognise the 
antigenically distinct surface of placental binding isolates (Staalsoe et al., 2004) are 
associated with protection from the clinical symptoms of PAM for both mother and 
child. The VSA epitopes recognised by female-specific, parity-dependent antibodies 
are, therefore, considered rational candidates for inclusion in an experimental 
vaccine to protect women against PAM (e.g. Duffy & Fried, 1999; Duffy & Fried, 
2003a; Fried et al., 1998b; Staalsoe et al., 2002). Since P. falciparum erythrocyte surface 
antigens are of a variant nature, their suitability as vaccines has been questioned. 
However, one of the initial serological studies of placental parasites from diverse 
geographical regions suggests the epitopes recognised by antibodies acquired 
during PAM are relatively conserved (Fried et al., 1998b). Sera from Malawian, and 
Thai secundigravid and multigravid women were equally effective at blocking CSA 
adhesion of Kenyan parasites as Kenyan sera despite the parasite being 
geographically and presumably genetically distinct. These studies suggest that a 
limited number of VSAPAM epitopes may be effective worldwide. As discussed 
earlier the host receptors mediating the interaction of parasite and placentae are 
relatively well defined. However, the identity of the parasite VSA interacting with 
placental CSA and HA in vivo, despite the question attracting the attention of many 
international groups, has remained contentious. 
1.4.6 PfEMP1 and placental adhesion 
The obvious suspect for mediating placental adhesion is PfEMP1 and two 
independent studies of laboratory isolates found two distinctly structured variants 
to bind CSA: FCR3var1CSA (Buffet et al., 1999) and varCS2 (Reeder et al., 1999). 
Binding assays using heterologous expressed domains from both FCR3var1CSA and 
varCS2 showed the DBL-y sequence of both of these genes to encode CSA binding 
domains in vitro (Buffet et al., 1999; Reeder et al., 2000). var DBL-y domains have 
thus received much attention as candidates for an adhesion blocking PAM vaccine. 
However, Reeder et al. (2000) also showed recombinant CIDR1-a of varCS2 to bind 
CSA and their findings were corroborated by Degen et al. (2000), who showed 
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recombinant CIDR1-a domains from two further PfEMP1 variants could also bind 
to cell surface CSA on Chinese hamster ovary (CHO) cells. Only antibodies raised 
to the recombinant varCS2 DBLy domain however, inhibited CSA binding (Reeder et 
al., 2000). 
A number of studies have also described raising antisera to the recombinant DBL-y 
FCR3var1CSA. Although anti-DBL-g sera were generally cross-reactive towards 
CSA-binding isolates and placental isolates, the CSA adhesion blocking capacity of 
different sera was variable. Lekana Douki et al. (2002) tolerised mice B cells to the 
surface of human erythrocytes or Chinese hamster ovary (CHO) cells prior to 
immunisation with CSA binding lEs or CHO cells expressing the DBL31 domain of 
FCRvar1CSA at their surface. 43 IE-surface-reactive monoclonal antibodies (MAbs) 
were derived from these mice, 70.87o of which were of the 1gM subclass. Some of 
the MAbs immunoprecipitated a surface-exposed protein of -400 kDa and several 
recognised the surface of CSA-binding parasites and placental isolates. About a 
third of the MAbs reacted to isolates with CD36 and ICAM1 adhesion phenotypes in 
immunofluorescence assays using fixed cells. The MAb's adhesion blocking 
capabilities were not determined in this study. 
Costa and colleagues (2003) raised mouse MAbs against recombinant DBL3y 
(FCR3var1CSA) produced in insect cells and two were characterised. They 
recognised the surface of a number of peripheral and placental isolates from West 
Africa, Brazil and Cameroon and the FCR3 parasite clone after selection for CSA 
adhesion but not after selection for CD36 adhesion. One of the mouse monoclonal 
antibodies of the IgGi subclass was found to inhibit parasite binding to CSA. 
Despite this apparently strong evidence supporting the expression of FCR3var1CSA 
and varCS2 at the erythrocyte surface of CSA-binding lEs, transcriptional studies 
have led some members of the field to question the involvement of these gene 
products in mediating adhesion of placental and CSA binding parasite. A more 
thorough analysis by RT-PCR and northern blotting of the var genes transcribed by 
the CSA-binding CS2 parasite showed neither FCR3var1CSA nor varCS2 to be the 
dominant transcripts in this parasite clone (Duffy et al., 2002). Neither 
FCR3var1CSA nor varCS2 were up-regulated following CSA selection although a 
13.2-14.0 kb var transcript whose identity was not revealed was significantly up-
regulated. Further transcriptional analysis by Kyes and colleagues (2003) has cast 
more doubt on the role of FCR3var1CSA in placental adhesion as its 15 kb transcript 
was found to be constitutively expressed by several laboratory isolates, including 
FCR3, throughout the erythrocytic cycle and its expression was unrelated to the 
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parasite adhesion phenotype. Like Duffy et al. (2002), Kyes and colleagues (2003) 
also found a 14 kb var to be the only var transcript to be up-regulated following CSA 
selection of the FCR3 parasite clone. The 14 kb var transcript was also expressed 
abundantly in ring stages. Rings are considered the appropriate developmental 
stage in the erythrocytic cycle for var transcripts to be expressed if they are destined 
to be transcribed and expressed at the erythrocyte surface (Kyes et al., 2003). 
Transcriptional studies using field isolates also cast confusion over the role for the 
varCS2 and FCR3var1CSA genes in PAM. A number of studies have found DBL1 
domains to be expressed by placental isolates from geographically diverse regions 
(e.g. Fried & Duffy, 2002; Khattab et aL, 2001; Khattab et al., 2003). However, Rowe 
et al. (2002a) used degenerate primers to the var DBL-a domain and found 
conserved homologues of FCR3var1CSA to occur in the genomes of the majority of 
field isolates examined from around the world. Transcripts of the FCR3var1CSA 
gene were not expressed by placental isolates from Malawian primigravid women. 
Rowe et al. (2002a) did find the 3D7chr5var gene, which within its 3' end (encoding a 
DBL5y and DBL7c) has high homology to the FCR3var1CSA gene, to be expressed 
by 4 out of 5 placental isolates. However, a subsequent study by Winter et al. (2003) 
suggested that 3D7chr5var related genes are also transcribed in non-placental 
isolates. Field studies have, thus far, not identified genes with homology to varCS2 
to be the major transcripts in placental isolates. Transcriptional analysis of field 
samples appears to depend heavily on the design of the var DBL domain primer 
sequences. Combining this with a limited and potentially biased choice of isolates 
thus allows misleading associations to emerge. 
An extensive real-time RT PCR analysis of the NF54 parasite, the parent of the 
completely sequenced 3137 clone, pre- and post-CSA selection found a distinctly 
structured var transcript of 9.2 kb to be up-regulated following CSA selection 
(Salanti et al., 2003). This gene was named var2csa and is highly conserved in field 
isolates. The CSA binding capacity of the domains encoded by this gene was not 
determined in this study. 
It remains contentious as to which PfEMP1 or PJVSA is expressed at the surface of 
the mature stages of CSA-binding parasite clones, and a HA binding PJVSA has yet 
to be described. Recently, one of the molecules expressed at the erythrocyte surface 
of ring stage parasites that acquire a CSA-binding phenotype later in the 
erythrocytic cycle, however, has been identified. A -40 kDa protein called ring 
surface protein-2 (RSP-2) was found to share antigemc similarity to the rhoptry 
associated protein (RAP-2) (Douki et al., 2003). Interestingly, RSP-2 is also present 
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on the surface of uninfected erythrocytes in P. falciparum cultures. Douki et al., 
(2003) suggest that RSP-2 is a remnant of abortive merozoite invasion on uninfected 
cells cultured with P. falciparum. Another surface-exposed protein of —180 kDa was 
also described by Pouvelle et al. (2000) in their first study that reported ring stage 
adhesion; this protein was named ring stage protein—i (RSP-1) but the gene 
encoding this protein remains unidentified. 
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1.5 Thesis aims 
The erythrocyte surface antigens of P. falciparum lEs that mediate adhesion to the 
placenta are considered instrumental in bringing about PAM pathology. Immuno-
epidemiological data supports the candidacy of these antigens for inclusion in a 
vaccine against PAM. The molecular identity of these surface antigens, however, 
remained contentious on initiation of this thesis. Therefore, my central aim was to 
further characterise the molecular nature of the surface antigens expressed by 
'placental-like' P. falciparum laboratory clones and specifically those epitopes to 
which an antibody response is raised during PAM. 
I use in vitro cultures of P. falciparum lEs that have been selected to bind the 
placental receptor CSA as a model for parasites that sequester in the placenta. Since 
CSA and placental binding parasites have previously been shown to express PJVSA 
exhibiting a marked trypsin-resistant binding phenotype, my first set of 
experiments, described in Chapter 2, are aimed at defining the protease sensitivity 
of those surface epitopes recognised by antibodies from malaria-exposed pregnant 
women. The ultimate aim of these experiments is to identify VSA exhibiting 
differential protease sensitivities that might be exploited in subsequent proteomic 
analysis of CSA-binding P. falciparum clones. 
The molecular mechanisms behind the regulation of PJVSA expression are complex 
and not completely understood. The aim of a large part of this thesis, therefore, is to 
develop an alternative method to complement existing molecular techniques, 
ultimately for the identification of VSA PAM. These experiments are described in 
Chapter 3. A non-radioactive cell surface protein labelling technique is sought that 
allows electrophoretic separation and! or the affinity purification of PJVSA prior to 
identification using mass spectrometric techniques. Such a venture was considered 
timely due to the recent advances in mass spectrometry that have made protein 
identification possible when the genome sequence of an organism is available. The 
genome sequence of a P. falciparum clone was in its final stages of completion on 
initiation of this thesis. In Chapter 4 I apply a Western blotting technique 
developed in Chapter 3 to the further characterisation of two novel PfVSA 
candidates, Plasmodiumfalciparum Cysteine Repeat Modular proteins 1 and 2. 
I also apply an erythrocyte surface labelling technique to an in vivo model of 
malaria, using the rodent malaria Plasmodium chabaudi. This work was originally 
initiated to address problems faced with the surface labelling of P. falciparum lEs 
and is described in Chapter 5. 
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My main findings and their context within the field as it currently stands are 
discussed in Chapter 6. Chapter 7 contains a description of the materials and 
methods used during this body of work. 
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Chapter 2. CSA binding Plasmodium falciparum infected 
erythrocytes express trypsin resistant surface epitopes 
2.1 Abstract 
The ability of Plasmodium falciparum-infected erythrocytes to adhere to the 
microvasculature endothelium is thought to play a causal role in malaria 
pathogenesis. Cytoadhesion to endothelial receptors is generally found to be highly 
sensitive to trypsinisation of the infected erythrocyte surface. However several 
studies have found that parasite adhesion to placental receptors can be markedly 
trypsin-resistant. I have investigated this phenomenon in experiments testing 
whether chondroitin sulphate A (CSA)-binding parasites express trypsin-resistant 
variant surface antigens (VSA) and whether these trypsin-resistant VSA bind 
female-specific antibodies that are induced by pregnancy-associated malaria (PAM). 
Fluorescence activated cell sorting (FACS) was used to measure the levels of adult, 
Scottish, Ghanaian male and Ghanaian pregnant female, plasma immunoglobulin G 
(IgG) that bind to the surface of infected erythrocytes. P. falciparum clone FCR3 
cultures were used to assay surface IgG binding before and after selection of the 
parasite for adhesion to CSA. The effect of proteolytic digestion of parasite 
erythrocyte surface antigens on adhesion to CSA and hyaluronic acid (HA) was also 
determined. 
I have shown that P. falciparum-infected erythrocytes selected for adhesion to CSA 
express trypsin-resistant VSA that are the target of naturally acquired antibodies 
from pregnant women living in a malaria endemic region of Ghana. However, in 
vitro adhesion to CSA and HA was relatively trypsin-sensitive. This study 
highlights discordance between the trypsin sensitivity of placental receptor binding 
and surface recognition of CSA selected parasites by serum IgG from malaria-
exposed pregnant women. I conclude that the complete molecular definition of a P. 
falciparum erythrocyte surface protein that could be used as a malaria-in-pregnancy 
vaccine has yet to be achieved. 
2.2 Introduction 
The rapid clearance of parasites when IgG from malaria immune adults is 
transfused into clinically ill recipients illustrates that naturally acquired antibodies 
have a parasite clearing role in human malaria infection (Bouharoun-Tayoun et al., 
1990; Cohen et al., 1961; Sabchareon et al., 1991). Neither the nature of the protective 
immune response nor the target antigens and epitopes recognised by infection 
clearing antibodies are fully understood. Evidence is accumulating to suggest that 
the acquisition of antibodies binding the VSA on infected erythrocytes (lEs) plays a 
major role in the development of age- and exposure-dependent immunity (Bull et 
al., 1998; Dodoo et al., 2001; Marsh et al., 1989; Nielsen et al., 2002; Ofori et al., 2002). 
The evidence for a protective anti-VSA response is particularly strong for the PAM 
syndrome (Duffy & Fried, 2003b; Staalsoe et al., 2004). 
In vitro selection of infected erytbrocytes for adhesion to CSA concomitantly selects 
for expression of VSA that share characteristics with post-natal placental isolates. 
Thus plasma antibodies from malaria-exposed pregnant women, or multi-gravid 
women, recognise the VSA of CSA-binding parasites (here referred to as VSA PAM). 
These sera can also block adhesion of CSA-selected lEs to CSA in vitro (Ricke et al., 
2000). Interestingly, as malaria-exposed males generally do not acquire antibodies 
that bind CSA-selected parasites such that there is a striking female-specific 
antibody response recognising both in vitro CSA-selected parasites (Ricke et al., 2000; 
Staalsoe et al., 2001) and P. falciparum isolates taken from infected placentae at 
delivery (Khattab et al., 2004; Salanti et al., 2003; Staalsoe et aL, 2004). Furthermore, 
the levels of CSA-adhesion blocking plasma IgG have been shown to increase with 
adult female parity. Recent immuno-epidemiological studies show a strong positive 
correlation between the levels of antibodies that recognise the IE surface (Staalsoe et 
al., 2004), the level of CSA-adhesion blocking antibody (Duffy & Fried, 2003b) and 
positive birth outcomes as measured by birth weight. 
Var genes encode large extracellular domains rich in lysine and arginine residues; it 
is therefore not surprising that PfEMP-1 molecules and adhesion to endothelial 
receptors have been reported to be highly sensitive to trypsin treatment (Baruch et 
al., 1995; Biggs et al., 1990; Howard et al., 1988; Leech et al., 1984; Magowan et al., 
1988). Less expected were studies showing parasite adhesion to the placental 
receptor CSA, when immobilized (Beeson et al., 2000; Beeson & Brown, 2004; 
Chaiyaroj et al., 1996) or when cell surface associated (Buffet et al., 1999; Rogerson et 
al., 1995), can be relatively trypsin-resistant. This chapter investigates the protease- 
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sensitivity profile of the VSAp Am  expressed by CSA-selected parasite clone FCR3 
with regard to recognition by antibodies acquired during PAM and adhesion to 
placental receptors. 
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2.3 Results 
2.3.1 Concomitant selection of a trypsin-resistant VSA following 
parasite selection for CSA adhesion 
Erythrocytes infected with parasite clone FCR3 were repeatedly selected for 
adhesion to CSA by panning. Late stage parasites were incubated with CSA 
(Sigma) immobilised on polystyrene Petri dishes for 30 minutes, the non-CSA 
adherent lEs were removed by washing and the adherent population incubated in 
the Petri dish with fresh uninfected erythrocytes for 20 hours overnight to allow the 
parasites to develop and the merozoites from the CSA-adherent parasite population 
to reinvade. Ring stage parasites were then removed from the Petri dish and 
maintained under standard parasite culture conditions (see Chapter 7; Materials 
and Methods). lEs were selected for CSA adhesion on at least a fortnightly basis. It 
was then established that selection of clone FCR3 for adhesion to GSA resulted in 
the concomitant selection of VSA specifically recognised by plasma IgG from 
malaria exposed Ghanaian pregnant women (IgGpreg) (figure 2.1). An increase in 
the binding of IgG from a pool of plasma from malaria-exposed Ghanaian men 
(IgGmale) was not observed. The unselected FCR3 clone expressed VSA that were 
equally well recognised by antibodies in the IgGmale and IgGpreg serum poois 
(figure 2.1). These interactions between serum antibody binding and selection for 
GSA adhesion were highly significant (F 2, 24 =9.5, p = 0.001). 
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Figure 2.1: lgG recognition profiles of parasite clone FCR3 before and 
after selection for adhesion to CSA. 
Totals of 5000-10000 late-stage parasites were gated using ethidium bromide, and FITC 
fluorescence due to serum lgG binging was measured. Serum samples from 6 Scottish 
malaria naïve individuals were pooled and used as a control (lgGcontrol). Sera from 20 
Ghanaian men were pooled for the malaria exposed male serum pool (lgGmale). Sera 
collected at the time of birth from the placentae of 15 Ghanaian women were pooled for the 
malaria-exposed pregnant female pool (lgGpreg). Bar chart shows means (+1 s.e.m.) for 5 
independent experiments. 











• 0 mg/mI trypsin 
















I 70   60 
LL 
50 
IgGcontrol 	IgGpreg 	IgGmale 
U 0 mg/rn I trypsin 
0.1 mg/mI trypsin 
IgGcontrol 	IgGpreg 	lgGmale 
Figure 2.2: Serum lgG from malaria-exposed pregnant women 
recognise trypsin-resistant surface epitopes 
Intact infected erythrocytes were treated with 0.1 mg/mI trypsin prior to FACS analysis. 
Panels A and B show serum lgG binding to the surface of FCR3CSA and FCR3 infected 
erythrocytes respectively. Serum pools are the same as those described in figure 2.1. Bar 
charts show means (+1 s.e.m.) for 2 independent experiments. 
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The trypsin sensitivity of this VSA/IgG binding interaction and of parasite adhesion 
to CSA was then measured. Parasitised erythrocyte surface trypsinisation at a 
concentration of 0.1 mg/mi showed that the IgGpreg binding of FCR3CSA was 
significantly more trypsin-resistant than was binding of the same serum to the 
unselected clone (figures 2.2A&B; F 1 ,4=16.4, p=0.015). Although the mean surface 
fluorescence due to the IgGpreg binding of FCR3CSA was slightly reduced by 0.1 
mg/ml trypsin this reduction was not significant (figure 2.2A; F 1 ,2=11.3, p>0.05). 
The effect of 0.1 mg/mi trypsin on VSA recognition by IgGmale and IgGcontrol was 
comparable before and after CSA selection of the parasite (figure 2). 
The effect of a 10-fold higher trypsin concentration and the effect of the non-specific 
protease, pronase, on IgG recognition of FCR3CSA were also determined. 
Trypsinisation with 1 mg/ml did not significantly reduce the mean surface 
fluorescence due to IgGpreg binding to FCR3CSA; however, treatment of the intact 
infected erythrocyte with 0.1 mg/mi pronase did (figure 2.3; F 1 ,4=0.35, p=0.6). 
Pronase treatment also significantly reduced binding of the IgGmale and IgGcontrol 
serum pools (figure 2.3; F 4, 18 =3.1, p= 0.04). 
Surprisingly, IgGcontrol binding to the infected erythrocyte surface increased 
following CSA selection of the parasite (figure 2.1); however, this non-immune 
recognition was found to be significantly more trypsin-sensitive than IgGpreg 
recognition (figure 2.3; F 4, 18=3.11, p=0.041). This indicates that the epitopes 
recognised by the IgGcontrol serum pooi and the epitopes recognised by the IgGpreg 
serum pool are distinct entities. An increase in apparent non-immune 
immunoglobulin binding to the infected erythrocyte surface has been observed for a 
number of parasite clones after selection for adhesion to CSA (data not shown). The 
source of this background labelling of FCR3CSA by naïve sera was found to be due 
to non-specific binding by the FITC-labelled tertiary rabbit anti-goat antibody. By 
using the modified antibody labelling procedure, which employs a biotin-labelled 
secondary antibody and FITC-labelled streptavidin, binding of malaria naïve IgG to 
FCR3CSA has been found to be comparable to the unselected parasite. Therefore the 
recognition of VSApAm by malaria naïve IgG is abolished (Sharling et al., 2004). 
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Figure 2.3: FCR3CSA expresses surface antigens exhibiting difterential 
protease sensitivity 
Intact infected erythrocytes were treated with 1.0 mg/mI trypsin or 0.1 mg/mI pronase prior to 
FACS analysis. Serum pools are the same as those described in figure 1. Bar chart shows 
means (+1 s.e.m.) for 3 independent experiments. 
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2.3.2 Discordance between the protease sensitivity of the CSA 
adhesion interaction and IgG binding 
Following the identification of trypsin-resistant epitopes that appear to be 
concomitantly selected with CSA adhesion, the trypsin sensitivity of CSA adhesion 
itself was determined. FCR3CSA binding to immobilised CSA was markedly more 
sensitive to trypsin than IgGpreg recognition of the infected erythrocyte surface 
(figure 2.4). Parasite adhesion was reduced by 81% and 917o following treatment 
with 0.1 mg/ml trypsin and 1 mg/mi trypsin respectively (figure 2.4). A trypsin 
concentration of 1 mg/mi reduced binding as efficiently as 0.1 mg/mi pronase, and 
although 0.1 mg/mi pronase significantly reduced cell surface fluorescence due to 
IgGpreg antibody binding, 1 mg/mi trypsin had no significant effect on IgGpreg 
antibody binding. There is, thus, significant discordance between the high trypsin 
sensitivity of CSA adhesion and the relatively trypsin-insensitive binding of IgGpreg 
srum antibodies to the infected erythrocyte surface (F 18 =14.4, p= 0.005). 
Human umbilical cord hyaluronic acid (HA) was also included in these assays to 
investigate the binding capacity of the CSA-selected clone with respect to this 
receptor. FCR3CSA was found to bind both HA and CSA, although binding to HA 
was significantly lower (figure 2.4B; F 3, 19= 20.44, p<O.00l), at 717o that observed for 
CSA. Interestingly, as has previously been shown for other P. falciparum isolates 
(Beeson & Brown, 2004), the trypsin-sensitivity of parasite adhesion to HA and CSA 
differed at low trypsin concentrations. Parasite adhesion to hyaluronic acid was 
found to be more sensitive to trypsinisation than adhesion to CSA (0.01 mg/ml; 
figure 2.413; F 1 ,8= 7.7, p=0.02). 
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Figure 2.4: The effect of increasing concentrations of trypsin on 
parasite adhesion to immobilised CSA and HA. 
Parasite adhesion to 10 p.g/ml human umbilical cord HA and bovine trachea CSA, adsorbed 
onto plastic Petri dishes, was determined following protease treatment of the intact infected 
erythrocyte. Bound cells were Giemsa stained and counted by light microscopy. Panels A 
and B show receptor binding for FCR3 and FCR3CSA infected erythrocytes respectively. Bar 
chart shows means (+1 s.e.m.) for 3 independent experiments. 
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2.4 Discussion 
The acquisition of antibodies to the surface of placental isolates correlates with 
protection from malaria in pregnancy and the targets of these antibodies are 
potential vaccine candidates (e.g. Staalsoe et al., 2001; 2004). Two variants of the 
well characterized VSA PfEMP1 have been shown to have distinct CSA-binding 
domains (Buffet et al., 1999; Reeder et al., 1999). Antibodies raised against these 
domains have been reported to recognise the infected erythrocyte surface (Lekana 
Douki et al., 2002) and in some cases block parasite adhesion (Costa et al., 2003; 
Reeder et al., 2000). However, a recent study by Salanti and colleagues (2003) of var 
gene transcription in CSA-selected clones identified a third potential CSA-binding 
PfEMP1 (var2csa). Var2csa is predicted to encode a number of atypical DBL-
domains and appears to be the major var expressed by CSA-selected parasites that 
are recognised by parity-dependent antibodies (Salanti et al., 2003). Proteomic 
analysis of CSA-selected parasites has also identified four additional potential CSA-
binding PfEMP1 molecules (Fried et al., 2004). The molecular identity of the surface 
antigens expressed at the infected erythrocyte surface remains unclear (Gamain et 
al., 2004). 
Although PfEMP1-mediated CSA adhesion appears to play a role in placental 
malaria, the molecular interactions triggering this syndrome are more complex than 
initially thought. Several studies implicate distinct binding phenotypes, and 
additional host receptors such as non-immune 1gM (Creasey et al., 2003), hyaluronic 
acid (Beeson et al., 2000; Beeson & Brown, 2004; Chai et al., 2001) and non-immune 
IgG (Flick et al., 2001). CSA-binding laboratory clones and placental CSA-binding 
isolates also appear to express parasite-encoded surface antigens other than 
PfEMP1, such as ring surface proteins 1 and 2 (RSP 1 and 2) (Pouvelle et al., 2000). 
Interestingly, a gene 'knock-out' of the CSA binding var (FCR3varCSA) in parasite 
clone FCR3 abolishes CSA binding, but the 'knock—out' parasites still bind the 
syncytio-trophoblast of ex vivo placental cryosections (Andrews & Lanzer, 2002). 
Monoclonal antibodis raised against the CSA-binding DBLy domain also show this 
domain to be sensitive to surface proteolysis using relatively low trypsin 
concentrations (100 .tg/m1) (Lekana Douki et al., 2002). Is it possible that the 
trypsin-resistant VSA described here are not of the PfEMP1 / CSA-binding type? 
My work supports the view that major differences exist between VSAp AM  and 
previously characterised PJVSA. Apart from being recognised only by female sera 
in a parity-dependent manner, VSA PAM show other distinct characteristics such as: 
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(i) VSA Am rarely form infected-erythrocyte rosettes when compared to CD36-
binding VSA (Beeson & Brown, 2004; Maubert et al., 1998; Rogerson et al., 2000); (ii) 
with the exception of rosetting isolates, non-immune 1gM binding is a phenomenon 
only seen with CSA-binding clones (Creasey et al., 2003); (iii) VSApAM  do not 
generally mediate adhesion to CD36 (Beeson & Brown, 2004; Fried & Duffy, 1996); 
and (iv) VSA-mediated adhesion to the placenta and CSA can be resistant to 
concentrations of trypsin known to remove most PfEMP1 molecules from the 
infected cell surface. In combination with the findings of this study, these distinct 
properties of VSAPAM suggest the involvement of either an unusually protease-
resistant structure, such has been shown for the A4tres PfEMP1 molecule (Smith et 
al., 2000), a non-CSA-binding PfEMP1 (Gamain et al., 2002), or an alternative class of 
VSA in placental adhesion. The differential protease sensitivity exhibited by VSAp AM  
could potentially be exploited in comparative proteomic analysis to aid in the 
identification of these molecules. 
Surface epitopes of the FCR3CSA parasite are both highly resistant to trypsin and 
are recognised by antibodies from malaria-exposed pregnant women. However, 
binding assays with the parasite clone used in this study showed CSA and HA 
adhesion to be relatively trypsin-sensitive. This is compatible with a study by 
Beeson and colleagues (2004) demonstrating trypsin-resistant CSA adhesion to-be- a - - 
clone-dependent phenomenon. Another recent study by the same group showed 
naturally acquired human antitsera that are strongly reactive to the surface of CSA-
selected parasites are not always capable of inhibiting CSA adhesion (Beeson et al., 
2004). Therefore, the findings of this Chapter supports the view that erythrocyte 
surface epitopes distinct from those involved in CSA adhesion may also be targets 
of antibodies acquired during PAM. One further implication is for vaccine 
development; a candidate vaccine raising only CSA adhesion-blocking antibodies 
may not mimic protective IE surface-reactive, gender-specific immune responses. 
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2.5 Future work 
Phagocytic cell types are recruited in large numbers to malaria-infected placentae 
(e.g. Walter et al., 1982). It is possible that the antibodies described here are 
cytophilic and aid in monocyte clearance of IE from the placenta. I have carried 
out steps to investigate the role of antibodies to trypsin-resistant  surface epitopes in 
phagocytosis assays. Although cultures of monocytes were derived from whole 
blood time did not allow for a reproducible protocol to be established. 
It would also be of interest to determine which IgG subclasses recognise the trypsin-
resistant VSAPAM epitopes, as previous work suggests specific IgG subclasses are 
important for phagocytosis of non-placental lEs. IgGl has been shown to be the 
predominant subclass to react with the trophozoite surface (Piper et al., 1999); 
however, in vitro antibody-dependent cellular inhibition (ADCI) assays using 
cultures of lEs and monocytes have shown that IgG3 cooperates with monocytes to 
inhibit parasite growth and promote phagocytosis. IgG2 has been found to 
antagonise the cooperation between IgG3 and monocytes (Bouharoun-Tayoun & 
Druilhe, 1992). Groux and Gysin (1990) have carried out phagocytosis assays with 
human monocytes to determine the relationship between the presence of opsonising 
antibodies, their IgG subclass and protective immunity. They found all IgG 
subclasses bound the surface of lEs, as determined by FACS analysis, and that only 
IgGl and IgG3 could mediate opsonisation. Competition experiments also found 
IgG2 and IgG4 to inhibit the opsonising capabilities IgGi and IgG3. Opsonising 
activity was only evident in individuals classified as immune, which were those 
with asymptomatic parasitaemias and subjects residing in endemic regions who 
presented neither symptoms nor parasites. The non-immune cohort included 
individuals who did not present with symptoms or had experienced only one 
malarial infection. 
Although not concerned with antibody responses to the mature IE surface, studies 
by Beck et al. (1995) have monitored IgG subtypes responses to the ring-infected 
erythrocyte surface antigen (RESA) in a cohort of adults from a malaria endemic 
region. Although IgG responses to RESA were frequent for all subclasses, total IgG 
levels did not correlate with protection against re-infection or reduced health centre 
attendance. Only IgG3 responses were acquired in an age-dependent manner and 
only anti-RESA IgGi and IgG3 responses were associated with reduced P. falciparum 
prevalence and reduced health centre attendance. 
L 
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Kinyanjui et al. (2003) have shown the kinetics of antibody response to PJVSA in 
children to be variable and chIldren with short-term weak responses to be less 
efficient at acquiring resistance to re-infection. Isotype profiling suggested that 
short-lived antibody responses are associated with poor antibody class switching 
from 1gM in these children. Since CSA-selected parasite lines bind non-immune 
1gM at the erythrocyte surface (Creasey et al., 2003). it would be interesting to 
determine whether non-immune or parasite-specific 1gM behaves antagonistically in 
phagocytosis assays with CSA-selected parasites. Currently, the significance of the 
co-selection of non-immune 1gM binding when parasites are selected for CSA 
adhesion is not known. Determining which IgG subclasses are important for 
parasite clearance from the placenta and the role of surface bound 1gM will be 
important for subsequent vaccine design. 
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Chapter 3. Towards a proteomics approach for PNSA 
identification 
3.1 Abstract 
Advances in proteomics and the completion of Plasmodium falciparum's genome 
sequence means parasite proteins, in complex mixtures or resolved 
electrophoretically, can be identified using mass spectrometry. These advances 
provide an additional tool with which to mine the static information held in P. 
falciparum's genome in order to understand dynamic events such as antigenic 
variation. A complementary approach to the existing molecular tools would be 
valuable as the variable and multi-copy nature of the genes mediating antigenic 
variation ensures that the design and production of specific molecular reagents is 
not trivial. 
Recent studies suggest that placental P. falciparum isolates express antigenically 
distinct variant surface antigens (VSA PJ ). Results from traditional molecular based 
experiments carried out to ascertain the molecular identity of these antigens remain 
contentious. The aim of this chapter, therefore, was to develop a proteomics based 
technique for the identification of VSA. Here I describe a set of experiments to 
optimise the surface labelling of lEs with a membrane impermeable analogue of 
biotin. Unfortunately, the subsequent identification of biotinylated parasite-specific 
surface proteins by mass spectrometry was not achieved. However, the cellular 
fraction containing candidate biotinylated VSAp Am represents an enriched and 
simple mixture of proteins suitable for future analysis. Specific antisera to the 
variant surface antigen Plasmodium falciparum erythrocyte surface 1 (PfEMP1) was 
also raised and used in the optimisation process. This serum will be a useful tool for 
future studies. 
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3.2 Introduction 
3.2.1 P. falciparum: a molecular biologist's nightmare 
P. falciparum's genome is extremely biased in terms of base composition: 807o of 
bases are either adensosine (A) or thymidine (T). Intergenic regions average more 
than 85% A's and T's. A similar degree of AT richness is also seen for P. yoelii 
(Carlton et al., 2002), but is not the case for all Plasmodium genomes. P. vivax's 
genome, for intance, is composed of approximately 557o A's and T's 
(http://www.tigr.org/tdb/e2kl/pval/intro.shtml) . P. falciparum's AT bias makes 
primer design and stringent PCR amplification problematic and unpredictable 
recombination events often occur during the cloning of parasite DNA due its 
instability in bacterial plasmids. Obtaining the complete genome sequence for P. 
falciparum was therefore a major accomplishment (Doolittle, 2002). 
P. falciparum proteins are on average 50% longer than their yeast orthologs, as they 
tend to be rich in stretches of low-complexity sequence when compared to other 
eukaryotic proteomes (Aravind et al., 2003). Low-complexity sequence is 
characterised by homopolymeric runs of amino acids, runs of asparagine being 
common in P. falciparum protein; such sequence tends not to form globular 
structures. The abundance of non-globular structures in combination with an AT 
rich genome (which biases codon usage and is thought to affect translational rate) 
hampers the heterologous expression of P. falciparum proteins having a native 
conformation. 
3.2.2 The var multigene family 
The molecular challenges posed by the extreme base composition are exacerbated 
by the var multigene family, the candidate receptors for placental adhesion 
(reviewed in Andrews & Lanzer, 2002; Beeson et al., 2001; Craig, 2004; Duffy & 
Fried, 2003a). As discussed in chapter 2 the role of different variants of PfEMP1 in 
CSA remains unclear. The cause of the uncertainty regarding PfEMP1 and CSA 
adhesion lies partly in our poor understanding of the relationship between var gene 
transcription, translation and protein trafficking to the IE surface. In addition 
interpreting experiments on var gene transcription and the expression of their 
protein products is complicated by probe and primer bias (Duffy et al., 2003; 
Gardner et al., 2002) and antibody cross reactivity (Gamain et al., 2004). 
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The expression of recombinant protein domains from PfEMP1 that conserve their 
native structural conformation in heterologous expression systems has proved 
difficult. This is probably due in part to PfEMP1's multi-domain structure and 
cysteine-rich nature. Therefore, anti-PfEMP1 antibodies raised to recombinant 
protein rarely react to the native molecule on the IE surface (critically reviewed in 
Sherman et al., 2003). Furthermore, it is difficult, or at least not always attempted, to 
ascertain antiserum specificity and rule out cross reactivity. The VSA of CSA-
selected clones also bind non-immune immunoglobulins (Creasey et al., 2003; Flick 
et al., 2001). Thus proving a specific antigen-antibody interaction at the IE surface 
for these clones is not a straightforward matter. Studying these molecules with 
existing molecular techniques has not proven to be easy. 
The heterologous expression of PfEMP1 domains at the surface of mammalian cells 
has been used to determine the adhesive phenotype encoded by particular PfEMP1s 
and confirm associations of a transcript with an adhesive phenotype of the IE. 
However, due to the large multi-domain structure of PfEMP1 delineating a 
functional domain, extrapolating the in vivo interactions of that domain with 
neighbouring domains and the role of the overall structure of the intact protein is 
problematic and it has been shown that the adhesive phenotypes of PfEMP1 
domains or fragments are very dependent on their context within the protein. The 
DBL-y domain from the A4tres PfEMP1 surface expressed on a Chinese ovary cell 
line (CHO-745) binds CSA although the IE erythrocytes expressing this PfEMP1 do 
not (Gamain et al., 2002). The CSA binding capacity of a 67 amino acid binding 
motif encoded by the FCR3var1CSA gene, when expressed at the surface of 
mammalian cell lines, is dependent on the extent of neighbouring sequence present 
in the expression constructs (Gamain et al., 2004). Including more of the 
neighbouring sequence did in some instances ablate the CSA binding capacity of the 
binding motif. 
3.2.3 Regulation of PfEMP1 'expression' 
A number of studies have linked the level of a particular var gene transcript directly 
to the adhesive phenotype at the IE surface, however in order to relate a transcript 
to an adhesive phenotype the transcriptional regulation of var genes has first to be 
understood. Studies over the past 6 years on var gene transcriptional regulation 
through progression of the asexual cycle have failed to form a consensus as to when 
in the cell cycle the var transcript that is subsequently translated is transcribed. 
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Initial studies using reverse transcriptase (RT)-PCR suggested numerous var genes 
are transcribed in ring stages, but only the var destined to be translated and 
exported to the IE is transcribed in pigmented trophozoites (Chen et al., 1998; Scherf 
et al., 1998). This work was supported by later studies using single cell RT-PCR 
(Fernandez 2002). A model for the exclusive transcription of a single var was 
proposed. This model suggests that relaxed transcription of multiple vars in ring 
stages is followed by the silencing, in mature trophozoites, of all var transcripts 
except the one encoding the adhesive phenotype. 
However, subsequent studies using RT-PCR on both cell populations (Noviyanti et 
al., 2001) and single cells (Duffy et al., 2002), detected numerous var transcripts in 
pigmented trophozoites. Although these studies identified a dominant var 
transcript, it was proposed that many full-length var genes are transcribed but not 
translated, thus suggesting a defined adhesive phenotype can be selected, but with 
the transcription of multiple vars, and little, or no, gene silencing. 
Biologically, the relevance of var transcripts in mature trophozoite stages is unclear, 
since PfEMP1 protein expression peaks in late ring stages (Waterkeyn et al., 2000) 
and exposure at the IE surface starts from 16 hours post-invasion (Gardner et al., 
1996). This biochemical evidence accords with the electron and atomic force 
microscopy data showing the accumulation of parasite induced knobs at the IE 
surface over the course of intraerythrocytic parasite development (Nagao et al., 
2000). In culture, translocation to the IE surface occurs over a narrow time window 
(16-20 hours post-invasion) and plateaus after 24 hours post-invasion, and there 
appears to be no mechanism for recycling PfEMP1 between intracellular 
compartments and the IE surface (Kriek et al., 2003). 
In closer agreement with patterns of PfEMP1 protein expression, recent findings 
from Northern blot analyses show abundant full-length var transcripts to be 
restricted to ring stages (3-18 hours post-invasion) (Kyes et al., 2000; 2003). These 
findings are now considered to represent the true pattern of var transcription 
through the intraerythrocytic cycle. The alternative patterns reported may be 
explained by the presence of truncated var transcripts (Su et al., 1995), the high 
sensitivity of RT-PCR, slightly asynchronous cultures, and amplification bias. 
Although Northern blotting appears to be the preferred method for analysis, 
particularly for detecting full-length var transcripts, the choice of probe is crucial. A 
commonly used probe to the conserved exon 2 sequence of vars was recently shown 
to have limited cross-reactivity: for example FCR3varCSA and R29varl both require 
specific probes for their exon 2 sequences in order to be detected by northern 
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blotting (Kyes et al., 2003). Also, due to the genome containing numerous var 
pseudo genes, transcriptional analysis can prove biologically misleading (Winter et 
al., 2003). In addition, early studies of CSA-selected parasites identified a full-length 
var transcript by Northern blotting (Buffet et al., 1999), but it appears that this 
transcript may not be translated and/or transported to the IE surface (Gamain et al., 
2004; Kyes et al., 2003). Full-length, developmentally regulated transcripts that are 
not translated have been described for other P. falciparum genes (Taylor et al., 2001). 
Until the relationship between var gene transcription, translation, and translocation 
of PfEMP1 to the erythrocyte surface is understood, studies linking var gene 
'expression' at the RNA level to adhesion phenotypes and the clinical outcome of 
infection (Ariey et al., 2001; Fried & Duffy, 2002; Jensen et al., 2004; Kirchgatter & 
Portillo del, 2002; Rowe et al., 2002a; Vazquez-Macias et al., 2002) remain difficult to 
interpret. 
3.2.5 Is VSAPAM a PtEMP1? 
Several groups internationally are working towards the characterisation of the 
surface antigens expressed by CSA-binding parasites and these studies have 
focused predominantly on PfEMP1. As discussed in Chapter 2, the VSA of CSA-
selected and placental isolates in some respects do not exhibit PfEMP1-like 
characteristics. Therefore, the aim of this chapter was to develop an alternative 
approach for the study of VSA cSA. A proteomics approach was considered attractive 
as it could potentially detect members of the relatively poorly characterised VSA 
family, rifin, whose potential in terms of CSA-binding and PAM has received little 
attention, and in addition any as yet uncharacterised VSA. If indeed PfEMP1 is the 
only VSA that is expressed by late stage placental isolates, then proteomics data 
should complement the existing data on PfEMP1 and CSA-adhesion. 
3.2.6 MALDI-TOF mass spectrometry 
The completion of a P. falciparum genome sequence along with advances in mass 
spectrometric technologies (Brancia et al., 2000; Chalmers & Gaskell, 2000) has 
opened a proteomics toolbox for the study of PJVSA expression. The potential to 
identify parasite proteins, separated by SDS-PAGE or in complex mixtures, means 
the static information held in the parasites' genome could in theory be mined to 
help understand dynamic events such as antigenic variation. 
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When this work was initiated the opportunity to gain training in protein 
identification using matrix assisted laser desorption/ionisation (MALDI) time-of-
flight TOF) mass spectrometry (MS) was established with York University. To 
identify a protein resolved electrophoretically on SDS-PAGE gels using MALDI-
TOF the protein spot is first excised from the gel and digested to completion with a 
sequence specific protease, for example trypsin. Tryptic peptides derived from a 
protein are then mixed with an excess of a proton rich matrix to prevent clumping, 
and the mixture is spotted onto a sample plate. 
Within the spectrophotometer a vacuum is pulled such that the solvent of the matrix 
is drawn off. The tryptic peptides co-crystalise with the matrix molecules to create a 
homogeneously dispersed layer of peptide and matrix molecules. Short pulses of 
UV laser are then focused through a prism onto the sample spot to volatise the 
peptides and matrix. Since the matrices used contain a chromophore and are 
present in excess they absorb essentially all of the laser radiation. The matrix 
effectively isolates the tryptic peptides in a microenvironment that enhances the 
probability of peptide ionization (by the matrix donating a proton to the peptide), 
but not fragmentation. lonised peptides are accelerated by a high voltage supply 
and are then allowed to drift down a flight tube where they separate according to 
their mass and charge (figure 3.1). The time taken (time-of-flight) for ions tobe 
detected by a high-speed recording device at the end of the flight tube is recorded. 
In some circumstances the protonated peptides are reflected by an electrostatic 
mirror and subsequently detected with a reflector detector. When MALDI-TOF MS 
is performed in the positive mode (which is generally the case for peptides), with a 
suitable matrix, protonated molecular ions are the dominant species and all 
peptides are presumed to have a charge of +1. 
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Figure 3.1: Simplified schematic of a MALDI4OF mass spectrometer 
By measuring the time-of-flight and using a set of peptide standards to obtain a 
number of constants for the spectrophotometer the mass of unknown ions can be 
determined using the following equation: 
m/Z = B(t-A)2 
t 	=time 
in = mass 
A & B = calibration constants derived from a number of peptides with known 
m/Z values 
Z 	= charge of ion (all ions are presumed to have the same charge, +1) 
Since, trypsin cleaves at the carboxyl side of lysine and arginine residues the tryptic 
peptides produced from a protein can be predicted from its sequence alone. 
Therefore an experimentally determined set of tryptic peptide masses from an 
unknown protein can be used as a fingerprint and searched against in silicO 
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fingerprint predictions for proteins and potential open reading frames in genome 
sequence databases. 
MALDI-TOF MS can also be applied in tandem to gain more information about a 
mixture of peptides. A small selection of tryptic peptides, usually the most 
abundant, are selected in real time and diverted into a collision cell where they are 
bombarded with a gas mixture to induce peptide fragmentation. The mass of 
fragmented peptides can then be determined in a similar fashion as described above 
for MALDI-TOF MS. 
3.2.7 Outline of proteomics approach 
A gel-based comparative proteomics approach was initiated using the parasite clone 
FCR3. This clone has been well relatively characterised with respect to CSA binding 
and associated surface antigen expression (Andrews et al., 2003; Buffet et al., 1999; 
Gamain et al., 2004; Kyes et al., 2003) and demonstrates a serological phenotype 
similar to placental isolates following CSA-selection (Chapter 2; figure 2.1). The 3D7 
parasite clone used for the genome sequencing project would have been the  ideal 
choice for proteomic analysis, however, this clone had proven difficult or impossible 
to select for CSA adhesion; the serological phenotype of CSA-selected 3137 is also 
not particularly marked and isstable (Salànti et al., 2003). 
The experimental plan was to label erythrocyte surface antigens with a 
commercially available analogue of the vitamin biotin (figure 3.2) that is predicted 
to be impermeable across cell membranes. Sulpho-NHS-LC-biotin contains a group 
that is reactive to primary amino groups and is predicted to label the lysine residues 
of surface proteins. PfEMP1 and rifins are lysine rich (Appendix 2), and lysine 
residues are relatively uniformly distributed throughout the proteins. Therefore, it 
was predicted that surface-expressed PfEMP1 and rifin molecules would have 
exposed lysine residues available for labelling. Biotin is a relatively small molecule 
(244 daltons) and can be conjugated to many proteins without altering their 
biological characteristics. 
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Figure 3.2: The reaction of. sulpho-succinimidyl-6-(biotinamido) 
hexanoate with proteins 
An amine group (B) of the protein to be labelled reacts with the ester group of sulpho-
succinimidyl-6-(biotinamido) hexanoate (A) by nucleophilic attack to add a biotin label to the 
target protein (C). This reaction releases sulpho N-hydroxysulphosuccinimide (C) as a by -
product. Sulpho-succinimidyl-6-(biotinamido) hexanoate (sulpho-NHS-LC-biotin) includes a 
spacer arm to minimise steric hindrance in antibody recognition of the biotinylated proteins. 
Surface biointylation was chosen over surface iodination using j1  partly because it 
avoids the safety concerns associated with using high-energy radioactive isotopes. 
Combining 1125  with the biohazard precautions necessary to work with live P. 
falciparum lEs was not feasible in the facilities available. Furthermore, biotinylated 
proteins can be detected by western blotting using a short chemiluminescence 
technique (Meier et al., 1992) as opposed to the potentially long exposure times 
required for j125  labelled proteins. Detection methods for biotinylated proteins can 
also be very sensitive (Neumaier et al., 1986). Biotin is a naturally occurring vitamin 
that binds the hen egg protein avidin with high avidity. This was considered one of 
the primary advantages of the sülpho-LC-NHS reagent, as biotin can be used as a 
tag for purification or enrichment using avidin (or streptavidin, a biotin-binding 
protein isolated from Streptomycetes) conjugated to a solid support. 
As PfEMP1, is not present in abundance at the IE surface, a step for the enrichment 
of membrane-associated proteins by detergent extraction or membrane fractionation 
was included. Protein fractions were separated by 2D gel electrophoresis and 
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differences in the biotin-labelled proteins detected by western blotting, using 
horseradish peroxidase conjugated streptavidin. Those proteins showing 
differences in labelling patterns between the CSA-selected and unselected clone 
would be identified using tryptic peptide mass finger printing and database mining. 
58 Chapter 3: Towards a proteomics approach for PfVSA identification 
3.3 Results 
3.3.1 IE erythrocyte biotinylation and MALDI-TOF mass spectrometry 
Following steps to optimise the separation of biotin labelled proteins using 2DGE, 
silver stained protein spots were extracted from 2D gels for identification using 
MALDI-TOF mass spectrometry. Loosely synchronised trophozoite cultures of 
FCR3 and FCR3CSA at 10 % parasitaemia were cell surface labelled with sulpho-
NHS-LC-biotin as described in section 7.3.1. Specifically, the biotinylation reaction 
was carried out using the sulpho-NHS-LC-biotin label at 0.25 mg/mi, with an 
incubation time of 30 minutes at 4 °C. The cells from one third of a 25 ml culture at 
5% haematocrit were used for each labelling reaction. Cells were lysed and proteins 
extracted with triton-X100 as described in section 7.3.2 and both the soluble (figure 
3.3) and insoluble fractions (figure 3.4) were separated by 2DGE. Protein extracts 
separated on duplicate gels were either stained with silver nitrate or transferred to 
PVDF for western blotting with horse radish peroxidase (HRP)-conjugated 
streptavidin. Figures 3.3 & 3.4 are representative of the labelling patterns seen for 
FCR3 and FCR3CSA. 
York University's mass spectrometry facilities were used initially, as an automated 
tandem MALDI-TOF/TOF (Proteome Analyzer ABI 4700) instrument was available 
to trained users. Tandem MALDI-TOF MSMS identified proteins with a 30 % 
success rate; unfortunately, these did not include any clearly resolved labelled 
proteins. Furthermore, 927o of these proteins were identified using only MALDI-
TOF (MS1) data. In only one case was MALDI-TOF MSMS data necessary. 
Therefore, training on the MALDI-TOF mass spectrometer (Voyager Applied 
Biosystems) available at Edinburgh University through the Scottish Instrumentation 
& Resource Centre for Advanced Mass Spectrometry (SIRCAMS) was sought. 
Although this instrument requires more user time than the automated MALDI-
TOF/TOF proteome analyser at York University, due to manual acquisition, spectra 
processing, and database mining, since relatively small numbers of proteins were 
processed and a success rate of 507o' was achieved, the user time required at 
Edinburgh was not considered a limitation. Table 3.1 shows a summary of the 
proteins identified using MALDI-TOF both at York and Edinburgh University. 
MALDI-TOF analysis identified a number of host intracellular proteins, none of 
which were labelled, and biotin labelled host erythrocyte surface proteins such as 
band 3 and band 4.1 (Table 3.1). However, the parasite-specific biotin-labelied 
proteins identified were not surface antigens. Two labelled proteins in the 
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FCR3CSA triton-X100 soluble extract were identified as P. falciparum glycophorin 
binding protein 130 (P.JGBP130) and P. falciparum heat shock protein 70 (figure 3.3 
ii). GBP130 (aka Ag78/96tR) resides within the erythrocyte cytosol, the vacuole and 
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Figure 3.3: Triton-X100 soluble protein extracts resolved by 2DGE 
Proteins were separated in the first dimension using an IPG strip with a pH range of 4-7; 
here the acidic end of the strip was placed adjacent to the molecular weight marker lane. 
Panels i & iii show silver stained gels and panels ii & iv duplicate gels of i and ii respectively 
transferred to PVDF and probed with HRP conjugated streptavidin to detect biotinylated 
proteins. Proteins were resolved in the second dimension using 4-12% bis-tris SDS-PAGE 
gels (Invitrogen). 
Since a number of abundant intracellular host proteins such as spectrin and globin 
(figure 3.4) were not labelled, it seemed that the sulpho-NHS-LC-biotin reagent was 
not freely diffusing into intracellular milieu of the infected erythrocyte but that a 
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restricted number of parasite-derived proteins were labelled. To confirm that the 
biotin labelled parasite-specific proteins were not surface exposed the trypsin 
sensitivity of these proteins to trypsin treatment of the intact IE was investigated. 
However, before doing so, an alternative to detergent extraction was considered. 
An alternative extraction method was sought due to inconsistencies observed in the 
proteins represented in different batches of detergent extracted proteins (data not 
shown) and the overnight dialysis step required to remove SDS from detergent 
extracts prior to 2DGE prolonged the time required for sample preparation 
considerably. 























Figure 3.4: Triton-X100 insoluble protein extracts resolved by 2DGE 
Proteins were separated using an IPG strip from pH 4-7, the acidic end of the strip was 
placed adjacent to the molecular weight marker lane. i & iii silver stained 4-12 % bis-tris 
SDS-PAGE gels (Invitrogen), ii & iv show western blots of duplicate gels of i and iii 
respectively. Blots were probed with HA- conjugated streptavidin to detect biotinylated 
proteins. 
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Table 3.1: Summary of mass spectrometric Identification from 2DGEs 
1 University of York Technology facility, 2  Scottish Instrumentation & Resource Centre for 
Advanced Mass Spectrometry (SI RCAMS). TS: triton-X 100 soluble fraction, TI; triton-X1 00 
insoluble fraction, ND: not determined, P.f P. falciparum, H.s: Homo sapien, Y: yes, N: no, 
*low  mouse score due to keratin contamination. A MSFIT score of over 105  or a MASCOT 


















P.f gil1221507 2.7e 07 ND 71 90.0 TS Y 
2heat shock protein 70 Pj PF08_0054 4.3&'° ND 36 73.9 IS Y 
'acidic basic repeat antigen Pf gil 113007 Ni) 52 ND 69.3 TS N 
'serine rich protein Pj gil 160687 ND 142 ND 110.0 IS N 
'elongation factor la Pj gi 1119153 ND 108 ND 49.0 TI N 
'ornithine Pj 
aminotransferase  
gil 585604 ND 107 ND 46.06 IS N 
'G3PDH Pj gil 19401842 ND 68 ND 36.64 TI N 
'phosphoglycerate kinase Pj gil 129926 ND 57 ND 45.4 TI N 
2heat shock protein 86 Pf PF07_0029 1.4 e ° ND 71 86.1 TS N 
21g binding protein (hsp 70) Pj PFI0875w 8.7e ND 31 72.4 IS N 
2N-methyltransferase Pj gil 21542912 1.1e °7 ND ND 31.0 IS N 
2actin Pj gil 27159630 2.2e ND NI) 42.5 TS N 
2enolase Pf gil 22794081 1.8e ND ND 48.7 TS N 
2band 3 H.s gil 4507020 1.1e °' ND ND 101.8 TI Y 
2band 4.1 H.s gil 42716288 *6702 ND ND 86.6 TI Y 
2spectrinachain(K12) I-I.s gi11174412 2.1e ND ND 280.0 TI N 
'spectrin l chain H.s gil 134798 ND 143 ND 242.5 TI N 
2ankyrin 1, isoform 2 I-Is gi:10947041 2.5e ND ND 189.0 TI N 
'frglobin H.s gil 1066765 ND 261 ND 16.0 TS N 
actin, yl  propeptide (E7) H.s gil 4501887 ND 75 ND 41.8 IS N 
2actin binding protein I-Is gil 6273777 4.3e ND ND 61.4 TS N 
'catalase H.s gi 17245758 ND 202 ND 56.6 15 N 
2heat shock protein 70 i-Is NP_006588 4.6e" ND 43 70.9 TS N 
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An erythrocyte membrane preparation method involving a simple lysis step in a 
hypo-osmotic buffer was compared directly to detergent extraction with triton-
X100. The two methods were used to extract proteins from the same labelling 
reaction. The lysis step for each method was performed in equal volumes and an 
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Figure 3.5: A comparison of detergent extraction and membrane 
fractionation 
Panel A shows a western blot probed with streptavidin- HAP. Lanes 1 -3 are fractions from 
detergent extraction, lane 1: TS fraction, lane 2: wash from TI fraction and lane 3: TI fraction. 
Lanes 4-7 are fractions from membrane preparations, lane 4: lysate, lane 5: wash from 
membrane fraction, lane 6: membrane fraction, lane 7: ammonium acetate precipitated 
membrane fraction. Panel B shows a duplicate gel stained with silver nitrate. The 
arrowhead highlights biotin labelled band 3 and a pair of asterisks a ci/3 spectrin doublet. 
Proteins were separated on a 3-8 % Tris-acetate gel. 
The complexity of proteins in the detergent extracts and membrane preparation was 
revealed by silver staining (figure 3.5B), and the biotin-labelling patterns detected 
by western blotting (figure 3.5A). This experiment showed that membrane fractions 
prepared by centrifugation following osmotic lysis enriched for a number of 
additional labelled proteins as detected by western blotting (figure 3.5, lanes 3 and 
6). Although, the triton-X100 insoluble fraction enriched more for spectrin whose 
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location on the silver stained gel is highlighted by asterisks (figure 3.5B), biotin 
labelled erythrocyte surface exposed band 3 (figure 3.5A, lane 3) was more 
efficiently extracted in the membrane preparation procedure (figure 3.5A, lane 6). 
After establishing that membrane preparation was a more reproducible method for 
enriching for host membrane proteins and biotin-labelled proteins, the protease 
sensitivity of the biotin-labelled proteins was investigated. Prior to biotinylation 
intact IE and non-IE were exposed to 1 mg/mi trypsin for 10 minute. This had no 
effect on the parasite specific biotin-labelled proteins (figure 3.6A, lanes 3 & 4), 
confirming that these proteins are indeed intracellular. At this point in the project a 
paper was published that also demonstrated that lEs but not UEs are permeable for 
the membrane 'impermeant' biotin label sulpho-NHS-LC-biotin (Nyalwidhe et al., 
2002). Fortunately the same group promptly published another paper showing that 
the labelling of IE intracellular proteins by sulpho-NHS-LC-biotin could be 
eliminated using a number of compounds that inhibit the parasite's novel 
permeation pathway (NNP) (Baumeister et al., 2003). The NNP is responsible for 
the IE's increased permeability for small solutes. Furosamide was one of the NNP 
inhibitors found to prevent intracellular protein labelling, therefore, the effect of 100 
.tM furosamide on the biotinylation of FCR3CSA lEs was determined. 
Figure 3.6 shows that in the presence of furosamide, no parasite specific biotinylated 
proteins are labelled (lanes 7&8). Unfortunately, it was impossible to determine 
whether the biotin labelled membrane proteins, detected by Baumeister and 
colleagues (2003), that remain labelled in the presence of NPP inhibitors are parasite 
derived, as a comparison of UEs and lEs was not presented. Although, the labelling 
conditions used by Baumeister and colleagues (2003) were followed in the 
experiment shown in figure 3.7, differences were found with regard to the labelling 
of host intracellular proteins. Baumeister and colleagues (2003) found spectrin and 
haemogiobin to be labelled in the absence of NNP inhibitors where as this was not 
the case in these experiments (figure 3.6A&B, lane 3 and figures 3.3 & 3.4). The 
restricted pattern of intracellular protein labelling seen in figure 3.6 may indicate 
that these protein are directly associated with the pore and/or channels that make 
up the NPP. 
Although furosamide eliminated the problem of intracellular protein labelling, it 
became apparent that although furosamide did not inhibit host erythrocyte surface 
labelling parasite specific trypsin sensitive proteins were not present (figure 3.6A, 
lane 7). At this point it was considered that perhaps the western blotting technique 
was of insufficient sensitivity to detect low abundant PJVSA, therefore, the surface 
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labelling of lEs was repeated in the presence of furosamide using a considerably 
higher parasitaemia. 
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Figure 3.6: The effect of furosamide on biotin labelling of intact IE 
Intact FCR3CSA lEs and UEs were labelled with 0.25 mg/mI sulpho-NHS-LC-biotin for 30 
minutes at 4°C, in the presence or absence of 100 tLM furosamide. Cells were fractionated 
following hypo-osmotic lysis. Membrane fractions were separated on 3-8% tris-acetate SDS-
PAGE gels. (A) A western blot probed with HRP-streptavidin. (B) A duplicate gel where 
proteins were stained with silver nitrate. Parasite specific biotin-labelled proteins are 
highlighted with an asterisk. Sample loading is indicated in the table above. 
Intact UEs and lEs were treated with either trypsin or pronase before labelling to 
test whether, if lower molecular weight PfVSA were being labelled, they could be 
revealed using an alternative protease, pronase. The supernatant formed following 
osmotic lysis and centrifugation of the membrane fraction was also analysed to 
determine whether labelled PJVSA had become disassociated from the erythrocyte 
plasma membrane. Neither by increasing the parasitaemia by plasmagel flotation of 
late stage cultures (figure 3.7A), nor by pronase treatment (figure 3.7A), nor 
analysing the IE lysate fraction (figure 3.7B) revealed biotinylated candidate PJVSA. 
To confirm the presence and abundance of parasite material in the membrane 
fractions a duplicate western blot was probed with a pooi of purified plasma IgG 
from malaria exposed individuals (figure 3.7C). This confirmed that high molecular 
weight parasite proteins characteristic of PfEMP1 indeed could enter the gels used. 
Malaria immune IgG was also used in an attempt to reveal low molecular weight 
protease sensitive proteins that may have been masked by the heavily biotinylated 
host erythrocyte surface proteins. This however was unsuccessful. 
It was considered at this point that it was necessary to have specific reagents to 
characterise the protein fractions. Therefore, an anti-peptide antibody to the 
conserved amino terminus sequence (ATS) of the PfEMP1 family of surface antigens 
was raised. 
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Figure 3.7: Biotin labelling of enriched lEs in the presence of 100 plV1 
furosamide 
Intact UEs (lanes 1-3) and plasmagel enriched FCR3CSA lEs (lanes 4-6) were labelled with 
0.25 mg/mI sulpho-NHS-LC-biotin for 30 minutes at 37°C, and were then fractionated 
following hypo-osmotic lysis. Membrane fractions were separated on 3-8% tris-acetate SDS-
PAGE gels (Bots A &C) and the lysate fraction was separated on a 4-12% tris-bis SDS-
PAGE gel (Blot B). The blots shown in panels A and B were probed with HRP-streptavidin. 
The blot shown in panel C was probed with pooled lgG from malaria immune sera. Lane 1: 
UEs, lane 2: UEs treated with 1 mg/mI trypsin, lane 3: UEs treated with 0.1 mg/mI pronase, 
Lane 4: FCR3CSA lEs, lane 5: lEs treated with 1 mg/mI trypsin, lane 6: lEs treated with 0.1 
mg/mI pronase. 
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3.3.2 Raising an anti-peptide antibody to the ATS region of PfEMP1 
For the purpose of raising a universal anti-PfEMP1 antibody an anti-peptide was 
considered preferable since the heterologous expression of recombinant P. 
falciparum proteins can be problematic. A number of conserved regions within the 
C-terminal ATS of PfEMP1 were identified by constructing an alignment of 3D7 
PfEMP1 sequences (figure 3.8A). Consideration of a hydrophobicity screen based 
on a Hopps-Woods plot of the 3D7 PfEMP1 PF13_0003 helped to identify a stretch 
within the ATS that was predicted to be both antigenic and conserved (figure 3.9A). 
The Hopps-Woods scale assigns values greater than zero to hydrophilic residues 
and positive peaks that are considered likely to be surface exposed segments of the 
folded protein. The highly conserved 14 mer, DITSSESEYEELDI, was predicted to 
be very hydrophilic (figure 3.9A) and although the residues MDI, that follow this 
sequence are not included in the predicted hydrophilic peak, they were included in 
the synthesised immunising peptide. Not only did this triplet complete an 
extremely well conserved sequence, it was encompassed in one of ten antigenic 
determinants predicted by a second antigenicity plot (figure 3.9B). The Antigenicity 
software programme used in figure 3.9A uses the method of Kolaskar and 
Tongaonkar to predict stretches in a protein sequence that are most likely to elicit an 
antibody response. Predictions are based on whether segments of a sequence have 
similarities to experimentally confirmed segmental epitopes. An alignment of the 
region containing the chosen immunising peptide for 3D7 PfEMP1 sequences is 
shown in figure 3.8A. A further alignment of PfEMP1 sequences from 
geographically diverse isolates was performed to ensure that the chosen peptide 
was not peculiar to the 3D7 done (figure 3.8B). 
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MCvar3 1951 P 	TIIrnt SSDEIKYMPL8DITD SS SSEYE1ID1NDIYII 
IT4var2 3021 - SGTDSYTDHYSDIT-- SS ESEYEEDINDIYi? 
Dd2var4 3307 TYMGD3SDE KYAPMSD TD 	SS RSEYEE:DINDIYVP 
MCvar4 2656 TK 	TYYI4GDSDE KYMPLSD TD SS ESEYESODINDIYIP 
PCR3-varTll-1_ 2195 KYRGK0'YTYLEaD'LTDSYTDHYSDITSS -- ESEYEEI4DINDIYVP 
PCR3var2 2236 ICYRGYL 	DfTDSGYTDHYSDITSS-- -  SSEYEEMDINDIYP 
varCS2 2268 Dy 	K:Y:Y4EGD9DSG-HYYEDT DITSS--- - SEYEE:DINDIYP 
PCR3var3 2635 RGYYI4 SI)SG-HYYEDT DVTSS-- ESEYEE:DINDIYD 
(Cvar5 960 R 	IC 	T 	V T--DE XThP12DTDASf SEyEEMDINDIy:2 
(Cvar6 2744 T P 	I M TGDD KYIWDLSS3DZ1Si SRYEEVDINDIYVP 
IT4var4 2713 1 	1 	I TSUG EYICGLSSSDSS R SFYRRT DTNDTY 
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Figure 3.8: Multiple sequence alignment of a conserved region of the 
ATS region of PfEMP1 
Panel A shows an alignment of 55 PfEMP1 sequences from the genome of the P. fa/ciparum 
clone 3D7 (PlasmoDB.org ). Panel B shows an alignment of 11 PfEMP1 sequences from 
three geographically diverse P. falciparum isolates, Malayan Camp, Dd2 and a parasite 
clone from the IT/FCR3 lineage. The immunising peptide is underlined. The Biology 
Workbench 3.2 (http://workbench.sdsc.edu ) was used as an interface to access databases 
and sequence analysis tools. Multiple sequence alignments were compiled with ClustalW 
(Thompson etal., 1994) using the Gonnet series weight matrix. Alignments were coloured 
using BOXSHADE version 3.1.1, where background shading in yellow highlights conserved 
residues; green identical residues, cyan similar residues, white different residues. Boxshade 
default settings were used for similarity definitions. 
The peptide DITSSESEYEELDINDIC conjugated to KHL was used to immunise 2 
white New Zealand rabbits as described in section 7.6.1. Initial screening of pre-
immune sera highlighted cross reactivity to both uninfected and P. falciparum 
infected human erythrocytes (figure 3.10A&B). The cross reactivity to lEs was 
apparent as a punctate staining throughout the erythrocyte cytosol, a pattern similar 
to the anticipated pattern of reactivity following immunisation. Naturally 
occurring rabbit antibodies that recognise uninfected and P. falciparum human lEs 
have previously been reported (Crandall et al., 1996). The immune sera was, 
therefore, affinity purify on the immunising peptide. For affinity purification, 
serum from rabbit SG-1780 was selected due to its lower cross-reactivity to 
uninfected cells, as detected by immunofluorescence assay (figure 3.10B). Although 
the intensity of staining in IFA increased following immunisation an ELISA was 
carried out to confirm that an antibody response specific to the immunising peptide 
had been raised and the efficiency of affinity purification. The ELISA confirmed 
that the pre-immune sera did not cross-react to the immunising peptide, that an 
antibody response specific to the peptide was raised and that peptide specific 
antibodies had been isolated by affinity purification (figure 3.11A). No reactivity 
was found to remain in the flow through from the affinity column used for 
purification (figure 3.11A). The optical density (OD) values for this ELISA were 
extremely low and serum dilution had no effect on reactivity. However, due to the 
small values of deviation between duplicate wells and consistent negative controls 
the small OD readings above the control values were considered to represent true 
reactivity. The low OD readings and lack of effect of serum dilution presumably 
resulted from the inefficient adsorption of the peptide to ELISA plate, such that the 
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small quantity of peptide adsorbed was completely bound by the highest dilutions 
of sera. 
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Figure 3.9: Antigenicity screening of the ATS sequence from 3137 
PfEMP1 PF13_0003 
Panel A shows a Hopp-Woods plot carried out using HYDROPHOBICITY 1.0 software 
(http://wwwbmm.icnet.uk ) with a window size of seven. Boxed residues highlight the 
hydrophilic 14 mer included in the immunising peptide. For panel B an antigenicity plot was 
constructed using Antigenicity software (Kolaskar & Tongaonkar, 1990) 
(http://mifdfci.harvard.edu ). The sequence of the second antigenic determinant is shown 
above the corresponding peak. The first four residues highlighted in bold type were included 
in the immunising peptide. 
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Figure 3.10: immunofluorescence assay with anti-ATS rabbit antisera 
Panels A-F show FCR3CSA-lEs and panel G A4-IEs. Nuclei are stained with DAPI (blue), 
red fluorescence shows rhodamine red-X-conjugated donkey (Jackson Laboratories) 
reactivity to rabbit immunoglobulins. A: pre-immune sera from rabbit 1779, B: pre-immune 
sera from rabbit 1780, C: Immune sera from rabbit 1779, D Immune sera from rabbit 1780, 
E secondary conjugate alone control, F&G: affinity purified sera from rabbit 1780. White 
arrows highlight uninfected cells. 




















Figure 3.11: Peptide ELISA to establish specificity of rabbit sera 
Rabbit immunoglobulins bound to the immunising ATS peptide immobilised to a microtitre 
plate were detected using HRP conjugated goat anti-rabbit Ig immunoglobulins. Panel A 
shows sera reactivity to 200 pg of peptide and panel B sera reactivity to coating buffer alone. 
The key denotes the serum dilution factors used. Pt: pre-immune serum, I: immune serum, 
AP: affinity purified immunoglobulins, FT: flow through from affinity column. 
In IFA affinity purified sera recognised erythrocytes infected with both FCR3CSA 
and A4 P. falciparum clones (figure 3.10 F&G), reactivity towards the later clone 
being of greater intensity (figure 3.10 G). A punctate pattern of staining was evident 
throughout the erythrocyte cytosol in a pattern previously reported for PfEMP1 and 
other proteins that are transported to erythrocyte plasma membrane. This staining 
pattern appeared in a developmental manner, whereby staining became more 
intense and filled more of the erythrocyte cytosol with increasing maturity of the 
parasite (data not shown). 
The affinity purified anti-ATS antibody was then used in western blotting of 
membrane fractions from lEs prepared by osmotic lysis. The antibody consistently 
failed to recognise parasite specific proteins (data not shown) and blotting was 
complicated by consistent cross-reactivity to erythrocytic a and 0 spectrin, and an 
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additional host protein of 50 kDa, by the HRP-conjugated secondary antibody 
(figure 3.12A; I & ii). These spectrin isoforms span the predicted molecular weight 
of more than 507o' of the PfEMP1s in the 3137 genome (Appendix 3). Therefore 
alternative secondary detection methods were investigated along with steps to 
solubilise the pigmented nuclear pellet fraction that forms following osmotic lysis 
and membrane fractionation by centrifugation. An A4 infected culture was 
fractionated for this purpose due to its higher reactivity to the peptide antibody in 
IFA (figure 3.10G). HRP-conjugated to protein A, a bacterial immunoglobulin-
binding protein, along with biotinylated affinity-purified anti-ATS antibody with 
HRP-conjugated streptavidin, as alternative secondary detection reagents were used 
in western blotting. To confirm that biotinylation of the affinity-purified antibody 
had been a success, the labelled and unlabelled immunoglobulins were analysed by 
SDS-PAGE and western blotting (figure 3.12B). This also confirmed that the 
immunoglobulins had not been excessively biotin labelled as their molecular 
weight, as determined by SDS-PAGE, was unchanged. Both HRP-conjugated 
protein A and streptavidin proved to be more suitable secondary reagents. Neither 
reagent was reactive towards high molecular weight host proteins, although slight 
reactivity to a host protein of approximately 75 kDa in the pigmented fraction was 
observed. HRP conjugated protein A was used for all subsequent western blotting, 
although the affinity purified biotin labelled antibody could potentially be a 
valuable reagent for future double labelling immunofluorescence assays. 
In these experiments, the small, pigmented pellet than forms beneath the layer of 
red cell ghosts when IE cultures are fractionated was also analysed. This parasite 
pigment rich pellet also contains parasite nuclei and could not be loaded onto SDS-
PAGE gels without nuclease treatment. The nuclease benzonase was used as it 
degrades genomic DNA rapidly at room temperature, therefore, avoiding the 
increased incubation times or temperatures required for alternative nucleases at 
which protease activity might increase. Erythrocytes infected with A4 schizonts 
expressed three protein species that are detected by the anti-ATS antibody, and 
these localise exclusively to the pigmented pellet fraction following osmotic lysis. 
Although membrane fractionation effectively enriches for band 3 and other host 
erythrocyte surface proteins (figure 3.5), PfEMP1 could not be detected in this 
fraction. The anti-ATS reactive proteins migrate on a SDS-PAGE gel above the 100 
kDa, 150 kDa and 250 kDa molecular weight markers (figure 3.12A; iii & vi). The 
highest molecular weight band of over 250 kDa is the approximate size reported for 
PfEMP1, the two smaller bands however are not, although the genome of parasite 
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clone 3137 does encode for one PfEMP1 with a predicted molecular weight of 150 
kDa. 
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Figure 3.12: Secondary detection reagents for the detection of PfEMP1 
Panel A, for blots i, iii, and v affinity purified anti-ATS immunoglobulins were used at 1:500 
dilution and for blots ii, iv and vi the secondary reagent indicated was used alone. Lane 1: 
UE membrane fraction, lane 2: A4 IE membrane fraction, and lane 3: A4 lE pigmented 
fraction. Panel B, SDS-PAGE using 4-12% bis-tris gels. Lane 1: unlabelled affinity purified 
immunoglobulins, lane 2: biotinylated affinity purified immunoglobulins. For gel i proteins are 
stained with silver nitrate and ii is a western blot using HRP-streptavidin. For blots i-vi SDS-
PAGE was performed using 3-8% tris-acetate gels. 
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Following confirmation that the anti-ATS antibody reacted cleanly in western blot 
it was used to follow changes in PfEMP1 expression in the FCR3 parasite following 
selection for CSA binding (figure 3.13). The antibody failed to react to protein of 
over 250 kDa in FCR3, however, the lower molecular weight proteins of - 150 kDa 
and -100 kDa were consistently detected in A4, FCR3 and FCR3CSA schizonts 
(highlighted with asterisk). A protein of > 250 kDa was detected in FCR3CSA, 
which showed size heterogeneity when compared to the largest protein species 
detected in A4 schizonts (figure 3.13; lanes 1 and 6). These higher molecular weight 
species detected by the anti-ATS peptide antibody will now be referred to as 
PfEMP1. An uninfected erythrocyte sample was not included as a negative control 
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Figure 3.13: Anti-ATS antibody detects a size polymorphic high 
molecular weight protein 
A western blot of pigmented pellet fractions from schizont-infected erythrocytes probed with 
anti-ATS antibody and HRP-streptavidin. Pigmented pellet fractions from A4 lEs were 
loaded in lanes 1 and 2, from FCR3 lEs in lanes 3 and 4, and from FCR3CSA lEs in lanes 5 
and 6. For lanes 2, 4 and 6 intact lEs were treated with 1 mg/mI trypsin prior to osmotic 
lysis. 
The surface expression of PfEMP1 species was investigated, by treating cells with 1 
mg/ml trypsin prior to protein fractionation. Surface trypsinisation did not affect 
the band intensity of the PfEMP1 expressed by either A4 or FCR3CSA schizonts 
(figure 3.13; lanes 2 and 6). This is likely due to the fact that a large proportion of 
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PfEMP1 has been shown to remain within the infected erythrocyte such that only a 
small proportion of the total cell PfEMP1 is actually exposed to surface 
trypsinisation (Haeggstrom et al., 2004; Kriek et al., 2003). The SDS-PAGE gel used 
in figure 3.13 was silver stained post electrophoretic transfer. From the residual 
protein remaining in the gel it was possible to confirm the activity of trypsin, as 
proteolysis of host erythrocyte surface proteins was clearly apparent. This silver 
stained gel also confirmed that protein loading per lane was equivalent and efficient 
transfer across the gel had occurred. In addition, the lower molecular bands 
detected by the anti-ATS antibody also indicate that protein loading was equivalent 
(data not shown). 
3.3.2 Identification of biotin labelled high-molecular weight candidate 
PNSA 
Having localised PfEMP1 to the pigmented pellet fraction, FCR3CSA late 
trophozoite stages were labelled with biotin and the pigmented pellet fraction was 
included in western blot analysis. Figure 3.15 shows membrane fractions from an 
uninfected mock culture, and two FCR3 cultures that had been independently 
selected for CSA binding, and the pigmented pellet fractions for the two FCR3CSA 
cultures. Biotin-labelled, high molecular weight proteins that were also sensitive to 
cell surface trypsinisation were indeed also localised to the pigmented fractions 
(figure 3.15; lanes 7-10). Unfortunately the labelling appeared quite diffuse but 
asterisks highlight the clearest labelled proteins and shows variation in the labelling 
pattern between the two FCR3CSA cultures. Although these cultures were selected 
and synchronised in parallel there may have been slight variation in the parasite 
stages, or this variation may indicate that alternative proteins can be upregulated 
following selection for CSA adhesion. As previously mentioned the pigmented 
fraction does not form following membrane fractionation of uninfected erythrocyte 
cultures, but to address more closely the parasite origin of these proteins and their 
stage specific expression surface biotinylation was carried out over a time course of 
intraerythrocytic development. 

















Figure 3.14: Parasite-specific biotinylated proteins 
Panel A shows proteins extracts from surface-biotinylated UEs and late stage trophozoite 
and schizont lEs (FCR3CSA) separated by SDS-PAGE, transfered to PVDF membrane and 
probed with HRP-conjugated streptavidin. Panel B shows the SDS-PAGE gel post-
electrophoretic transfer stained with silver nitrate. Cells were labelled with 0.5 mg/mI 
sulpho-NHS-LC-biotin in the presence of 100 fiM furosamide. 
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A synchronised trophozoite culture of parasite clone FCR3CSA was used to seed 
three daughter flasks with equivalent numbers of parasites such that the 
parasitaemia in the next asexual cycle reached 107o. At the appropriate time points, 
flasks containing either ring, trophozoite or schizont stages were harvested for 
surface biotinylation and membrane fractionation. (The culture was synchronised 
and flasks harvested in parallel to the A4 cultures of which Giemsa stained slides 
are shown in figure 4.3A.) High molecular weight biotinylated proteins were not 
present in ring stage parasites (figure 3.15; lane 1). Although it was not possible to 
load an uninfected control for the pigment pellet fraction, the labelling pattern for 
ring stages is comparable to that seen for the membrane fraction from uninfected 
erythrocytes in this experiment (data not shown) and in an independent labelling 
experiment (see figure 3.14; lanes 1 and 2). A number of high molecular weight 
biotin labelled proteins that were sensitive to surface trypsinisation were apparent 
in the young trophozoite culture (figure 3.15; lanes 3 and 4) and the complexity of 
the labelled proteins increased in the schizont culture (figure 3.15; lanes 5 and 6). 
This time course experiment showed the anticipated stage specific expression of 
surface exposed biotinylated proteins, if indeed these proteins are PJVSAs. The 
pattern of biotinylated proteins that migrate around the 250 kDa marker in the 
schizont extract (figure 3.15; lane 5) is also comparable to the pattern seen in an 
independent labelling experiment of trophozoites and schizont stages (figure 3.14; 
lane 9), thus reflecting the reproducibility of this technique. 
The SDS-PAGE gel used for preparation of the western blot shown in figure 3.15 
was again silver stained post electrophoretic transfer to confirm that the integrity of 
the extracts prepared from trypsin treated samples was comparable to the non-
trypsinised samples. The blot shown in figure 3.15 was also re-probed with the anti-
ATS antibody to confirm the integrity of high molecular weight parasite proteins in 
trypsinised samples (data not shown). This showed that the highest molecular 
weight biotinylated protein in the schizont extract (figure 3.15; lanes 5, white 
asterisk) co-localises with the PfEMP1 expressed by this done. 











Figure 3.15: lntraerythrocytic developmental regulation of biotin 
labelled proteins 
A western blot of pigmented pellet fractions prepared from synchronous cultures of 
FCR3CSA: ring lEs lanes 1 and 2, trophozoite lEs lanes 3 and 4 and schizont lEs lanes 5 
and 6. In lanes 2, 4 and 6 intact lEs were treated with 1 mg/mI trypsin prior to osmotic lysis 
and protein extraction. Biotin-labelled proteins were detected using HAP-conjugated 
streptavidin and ECL detection. Proteins were separated by SDS-PAGE using a 3-8% tris-
acetate gel. Cells were labelled with 0.5 mg/mI sulpho-NHS-LC-biotin in the presence of 
100 j.tM furosamide. 
Finally, parasite specific, developmentally regulated, surface trypsinisation sensitive 
proteins were identified in a CSA selected parasite clone. Unfortunately time did 
not allow for further proteomic analysis of these proteins. Attempts were made to 
affinity purify biotin labelled proteins on immobilised streptavidin, for subsequent 
identification using mass spectrometry, however, despite numerous experiments to 
optimise this technique (data not shown) bands corresponding to the appropriate 
molecular weight could not be isolated. Upon further consideration of these 
experiments, blocking of non-specific protein and biotin binding sites may have 
been the main problem, in combination with the small quantities of extract available 
and the low abundance of the labelled proteins. Considering the undetectable effect 
of trypsin on the cell's pooi of PfEMP1 suggests that for FCR3CSA at least, this VSA 
is exposed at the erythrocyte surface in relatively small amounts. Alternative 
approaches for the identification of the biotin labelled proteins identified here are 
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discussed in the discussion section of this chapter. That the pattern of high 
molecular weight biotinylated proteins appears more complex than the PfEMP1 
species detected in FCR3CSA is also discussed. 
Chapter 3: Towards a proteomics approach for PJVSA identification 	 83 
3.4 Discussion and future work 
Initial analysis of 'surface' biotinylated cell extracts using 2DGE and MALDI-TOF 
mass spectrometry unfortunately did not identify any PJVSA (Table 3.1). The major 
problem was considered at the time to be the biotin labelling of internal proteins. 
Therefore a labelling protocol was optimised that detected biotinylated parasite 
specific, surface trypsinisation sensitive, developmentally regulated proteins by 
western blotting, however, time did not allow for the separation of these proteins by 
2DGE and their subsequent identification. However, considering the average 
percentage identification rate for protein spots extracted from 2D gels only reached 
50% using MALDI-TOF mass spectrometry, together with the recent exciting 
advances in non-gel based proteomic alternatives, a non-gel based technique is 
likely to be the way forward in this analysis. Such a technique is especially 
attractive in the case of PfEMP1 and the biotin-labelled proteins identified as they 
are both large molecular weight membrane-proteins (figure 3.14) and these are 
notoriously difficult to resolve by 2DGE (Santoni et al., 2000). 
Developments in the methods and instrumentation for automated, data-dependent 
tandem electrospray ionisation (ESI) mass spectrometry in combination with in-line 
microcapillary liquid chromatography (LC) means large-scale identification of 
proteins in complex mixtures without prior gel electrophoretic separation has 
become more routine. ESI mass spectrometry can measure the mass of both 
positively and negatively charged ions, when used in tandem it can provide more 
information than tandem MALDI-TOF MS that only determines the mass of 
positively charged ions. Therefore, tandem ESI MS is considered the more 
powerful tool for identifying peptide sequence tags. 
When analysing complex mixtures of proteins by .tLC and tandem ESI MS a 
fractionation or partial purification step to enrich for candidate proteins of interest is 
considered advantageous to simplify the automated data analysis. The proteins that 
make up the pigmented pellet fraction represent a small fraction of the proteins 
present in the crude cell extract. This pellet fraction is quite a simple mixture and 
most of the highly abundant host cell proteins, that would create a significant 
amount of 'noise' in tLC and tandem ESI MS analysis, have been removed. The 
proteins of interest are also biotin labelled. Although affinity purification on 
immobilised streptavidin or monomeric avidin was not accomplished during this 
project, such a chromatographic purification step has been applied for isotope-
coded affinity tag (ICAT) technology (Gygi et al., 1999) to enrich for biotinylated 
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peptides following tryptic digestion of biotin labelled protein extracts (Ranish et al., 
2003). ICAT is a quantitative proteomics approach that uses LC-MSMS in 
combination with an isotope-coded biotin tag. Instead of separating by 2DGE the 
biotin labelled proteins I have identified by 1D SDS-PAGE it might be feasible and 
preferable to digest the entire biotin labelled pigmented pellet extract and use 
avidin chromatography steps similar to those used in ICAT technology, in 
combination with tLC and tandem ESI mass spectrometry, as is applied in the ICAT 
approach. Although, FCR3 infected erythrocytes that had been 'mock selected' for 
CSA binding were used as a control for early surface biotinylation experiments, 
during the steps to optimise the labelling technique this control was not always 
included. This was due to the time necessary to culture FCR3 and FCR3CSA lEs in 
parallel while maintaining equivalent parasitaemias and synchronicity. Therefore, 
for initial analysis using tLC-MSMS a comparison of pigmented pellet extracts from 
the surface trypsinised FCR3CSA lEs and untreated lEs (figure 3.14) might be 
informative, at least for confirming that these biotin labelled proteins are indeed 
surface expressed, if not upregulated after CSA selection. FCR3 and FCR3CSA 
along with additional pairs of clones pre- and post CSA selection could be labelled 
to look for the up-regulation of specific biotinylated proteins following CSA 
selection. Ideally, a clone would be selected for an alternative adhesive phenotype, 
such as CD36 binding, to confirm any up-regulated proteins are not ubiquitously 
expressed by lEs following selection for any adhesive phenotype. Alternatively, 
analysis might be simplified by cutting slices from 1D SDS-PAGE gels at the 
molecular weights that correspond to the sizes of biotin labelled bands detected by 
western blotting and then attempting to analyse those quite simple mixtures of 
proteins by LC-MS/MS. 
During this project considerable time was invested in developing the surface 
biotinylation technique and detection of biotinylated proteins by western blotting. 
One could ask whether, in light of recent advances in high-throughput 
multidimensional protein identification technologies (MuDPIT) such LC in 
combination with tandem electrospray ionisation mass spectrometry whether this 
optimisation will prove to be applicable. However, review of the studies that have 
applied MuDPIT-like proteomics approaches to P. falciparum during the course of 
this work suggests there are limitations, a major one being reproducibility. 
Screening labelled pigmented fractions prior to MuDPIT by western blotting would 
allow the reproducibility of independently labelled and extracted fractions to be 
determined. I am of the opinion that by enriching for specifically labelled surface 
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exposed proteins and having an estimation of their molecular weight will aid in 
refining the starting mixture of proteins to be analysed and thus reduce the 
complexity of data produced by MuDPIT. Perhaps a more stringent and thorough 
analysis of a smaller data set would then be feasible. 
Over the course of this project four large-scale proteomic analyses of P. falciparum 
material have been carried out. The first two studies concentrated on defining the 
proteomes of different developmental stages for the parasite clone 3D7/NF54 
(Florens et al., 2002; Lasonder et al., 2002). Lasonder and colleagues (2002) analysed 
trophozoites/schizont preparations, gametocyte and gamete preparations using a 
combination of 1D electrophoretic separation and in-line, high resolution iLC with 
tandem mass spectrometry. Their analysis identified 1289 parasite proteins, which 
comprised approximately 23% of the predicted P. falciparum proteome at that time. 
Also, 1000 human proteins and, importantly, a set of P. falciprum derived peptides 
that are not predicted by computational gene finding software were identified. A 
second study by Florens and colleagues (2002) used multidimensional protein 
identification technology (MuDPIT) using a method based on Washburn et al. (2001) 
which also involved in-line, high resolution tLC and tandem mass spectrometry. 
Relatively homogeneous preparations of merozoites, trophozoites, gametocytes and 
sporozoites were analysed which lead to the identification of 2425 parasite proteins 
(437o' of predicted P. falciparum proteome). 
Florens et al. and Lasonder et al. successfully described sets of stage specific 
proteins, however, a comparison of their findings highlights discrepancies with 
regard to the number of proteins and protein families found at different life cycle 
stages. Of interest to this work, there were discrepancies with regard to PfEMP1 
and rifin proteins. Florens et al. (2002) reported that a repertoire of PfEMP1s and 
rifins are expressed by cultured gametocytes and that a preparation of sporozoites 
contained 21 different rifins and 25 PfEMP1 variants. They also detected PfEMP1s 
but not rifins in trophozoite extracts. Likewise Lasonder et al. (2002) did not detect 
rifins in their trophozoite I schizont preparation, however, unlike Florens et al. they 
did not detect PfEMP1 either. 
The differences regarding stage specificity for PfEMP1 and rifin expression in 
Lasonder's and Florens' analyses may partly be explained by different stringency 
levels used for data filtering. For example the sequence coverage reported for 
PfEMP1s detected in any developmental stage by Florens et al. (2002) only reached 
0.1%, although three of the rifins identified in the sporozoite extracts reached 80% 
sequence coverage. Because PfEMP1 is such a large protein and var genes are 
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present in multiple copies per genome the chance of hitting a peptide sequence 
within a PfEMP1 with similarity to a query peptide might be considered more 
likely, than for example an average sized single copy gene. Florens et al. (2002) also 
include haif-tryptic peptides in their analysis, this may also increase the. likelihood 
of mis-assigning peptides to proteins. These analyses, however, highlight the 
importance of considering the stringency levels applied to the analysis of MuDPIT 
data. Lasonder et al. (2002) also suggest that extraction methods may be responsible 
for their analysis not detecting PfEMP1 in preparations from asexual blood stage 
parasites. 
PfEMP1 has primarily been studied in the asexual blood stages of the parasite, 
however, young gametocytes sequester so it will be interesting to discover whether 
a specific subset of PfEMPs are expressed at this stage or whether the expression 
pattern is analogous to that seen in asexual stages. The expression of PfEMP1 in 
sporozoites is supported by transcriptional microarray analysis of this 
developmental stage, Le Roch et al. (2003) identified transcripts for 22 of the 23 
PfEMP1 variants identified by Florens et al. (2002). 
More recently Florens et al. (2004) have used MuDPIT to analyse extracts from 
'surface' biotinylated lEs. In this study lEs were bitoinylated with sulpho-NHS-LC-
biotin and a biotin analogue that labels free sulfhydryl groups; however, an 
inhibitor of the parasite's novel permeation pathway, such as furosamide, was not 
included in the labelling step. Considering the findings of this chapter (figure 3.7), 
and those of Nyalwidhe et al. (2002) and Baumeister et al. (2003), the labelling 
conditions used by Florens et al. would have allowed for significant labelling of 
internal proteins. Especially considering their long incubation times for labelling (6 
hours). Despite the internal labelling that occurred, following avidin affinity 
purification of biotin- labelled proteins, two novel P. falciparum erythrocyte surface 
antigens were identified by MuDPIT analysis and have been designated parasite-
infected erythrocyte surface protein 1 and 2 (PIESP1 and 2). Interestingly, PIESP1 
and 2 are encoded by single-copy genes, which are conserved across Plasmodium 
species, and show little sequence diversity between different P. falciparum strains. 
Florens et al. (2004) confirmed erythrocyte surface expression by raising antisera to 
PIESP1 and 2 and performing IFA on live lEs. The work of Florens et al. (2004) 
suggests that ensuring surface specific labelling with biotin may not be crucial for 
proteomic analysis of surface proteins. Interestingly, despite Florens et al. 
confirming by western blotting that their 'surface preparations' contained PfEMP1 
and rifin proteins they do not report detecting these proteins in their MuDPIT 
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analysis, although they did identify the secreted proteins (Expi and 2) and the 
rhoptry proteins (RAP-i & 2 and RhopH-2 & —3). 
Finally, the last proteomic study that has been published focused on the analysis of 
PfEMP1 variants expressed by both CSA selected clones and placental isolates. 
Fried et al. (2004) carried out tLC-MS/MS on tryjtic peptides from PfEMP1 
enriched detergent extracts that had been further fractionated on a strong cation 
exchange column. PLC-MS/MS analysis was also performed on tryptic peptides 
extracted from gel slices cut out from 1D SDS-PAGE gels loaded with the PfEMP1 
enriched detergent extracts. The PfEMP1 variants detected in extracts from CSA 
selected and unselected lEs were compared to extracts from a number of placental 
isolates. A transcript encoding the PfEMP1 var2csa (PFL0030c) has recently been 
shown to be up-regulated following CSA-selection using real-time RT-PCR analysis 
(Salanti et al., 2003), however, the MS/MS analysis of Fried et al. (2004) suggests 
var2csa is not associated with CSA-binding parasites. Peptides from FCR3varCSA-
like PfEMP1 variants were detectedin one parasite clone; however, this clone had 
not been selected to bind CSA. This analysis failed to support the role of any 
current candidate CSA binding PfEMP1s, but highlighted an additional four 
PfEMP1 molecules MAL6P1.4, PF070051, PFL1960w, and PF10005w as being 
associated with CSA-binding. 
However, Fried et al. (2004) point out that the reproducibility between independent 
extracts from the same parasite clone or isolate was poor. For example, for an 
unselected and CSA-selected parasite clone, only 1 of 9 and 2 of 13 PfEMP1 variants 
respectively were detected in repeated assays. A comparable level of 
irreproducibility was also seen in Florens et al. (2002) MuDPIT analysis of the 3D7 
parasite. None of the seven PfEMP1 variants identified were detected in more than 
one of four repeat assays. Also, as was the case with the analysis by Florens et al. 
(2002), Fried et al., (2004) only achieved low sequence coverage (ranging from 0.57o-
3.87o) for PfEMP1 variants. The PfEMP1 sequence coverage was particularly low 
compared to other membrane proteins, where coverage reached 26.77o for example. 
The proteins I found to be selectively labelled during biotinylation of intact lEs in 
the absence of furosamide may be those proteins that are directly involved or 
associated with the NNP and transport of solutes in and out of the IE. The 
molecular components of the NNP pathway are currently not characterised, 
therefore, identification of these biotinylated proteins may aid in the delineation of 
this pathway. The apparent slight upregulation of some of these intracellular 
proteins, such as GBP-130, in the triton-soluble, FCR3CSA extract (figure 3.3) may 
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reflect a response to the selection for an adhesive phenotype and the upregulation of 
VSA transport to the IE surface. 
The anti-ATS raised in this study will be a useful reagent for future studies, 
especially since the antibody appears to be relatively specific and versatile (working 
in IFA and western blotting). If conditions can be optimised to use this antibody for 
immunoprecipitation purposes, uLC-MSMS analysis could be performed on the 
precipitated PfEMP1 species to obtain peptide sequence tags for identification. By 
immunoprecipitating from extracts prepared from surface biotinylated lEs selected 
for CSA adhesion and western blotting the precipitated PfEMP1s with HRP-
streptavidin this would confirm the surface expression of the precipitated PfEMP1 
species. An effect of treating intact lEs with trypsin or pronase would also be 
anticipated to be evident for precipitated biotinylated PfEMP1 species. 
Although the anti-ATS antibody was affinity purified on the immunising peptide 
two lower molecular weight proteins, one running just over 100 kDa and the other 
just over 150 kDa were consistently detected in trophozoite / schizont extracts from 
A4, FCR3 and FCR3CSA. A more tightly synchronised culture of A4 lEs revealed 
that only the schizont preparations contained these 2 proteins (See Chapter 4). 
Interestingly, no size polymorphism was apparent for these lower molecular weight 
species between A4 and FCR3, unlike the larger PfEMP1 species (>250 kDa) 
expressed by these two clones (figure 3.13). The genome of the 3D7 parasite clone 
contains 4 var genes that are predicted to encode proteins of less than 200 kDa; 
PF11820, PFA0015c, and MAL6P1.314 are predicted to encode PfEMP1s of 
approximately 150 kDa and PRB0010w is predicted to encode a 200 kDa protein 
(Appendix 3). However, to see the pattern of recognition seen in the in figure 3.13 
similar genes would have to be conserved in the genomes of the A4 and FCR3. It 
would be interesting to determine whether these two lower molecular weight 
proteins are expressed in other parasite clones. 
An alignment of putative truncated var genes, from the 3D7 genome was also 
constructed to determine whether any of these genes might explain the lower 
molecular weight species that were recognised by the anti-ATS antibody. A number 
of putative truncated var genes and var pseudo genes were found to encode the 
sequence of the immunising peptide for the anti-ATS antibody (An. alignment of 
truncated and pseudo var genes is included in Appendix 4). The lower molecular 
weight protein species detected by the anti-ATS antibody, however, did not 
correspond to the predicted molecular weights of the truncated var genes. Neither 
was a protein corresponding to the well-conserved single copy Pf60.1 protein (that 
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runs at about 74 kDa Bischoff et al., 2000) detected by western blotting despite the 
immunising peptide being present in this protein (the final 3' exon of the transcript 
encoding Pf60.1 shows considerable similarity with the exon 2 of var genes). As the 
Pf60.1 gene is well conserved between P. falciparum isolates the anti-ATS antibody 
was expected to be cross-reactive. However, Pf60.1 is a nuclear protein expressed in 
schizont stages and reactivity to the nuclei of schizont stages with the anti-ATS 
antibody was not apparent in IFA either (figure 3.10; F&G). 
The literature was reviewed to determine whether on published western blots of 
PfEMP1 using an anti-ATS antibody lower molecular weight species of --150 kDa 
and - 200 kDa are typically seen. In most publications a small molecular weight 
window is shown around the PfEMP1, presumably because the antibodies used do 
not cross-react to additional proteins (e.g. Florens et al., 2004). Although in an 
immunoprecipitation by Kriek et al. (2003) of metabolically labelled PfEMP1 using 
an anti-ATS monoclonal antibody, a smaller molecular weight species (<220 kDa) is 
co-precipitated along with the larger molecular weight PfEMP1 protein (>220 kDa). 
A discernable effect of surface trypsinisation could not be detected on PfEMP1 
levels by western blotting (figures 3.13). This might be explained by the fact that 
only a small portion of the cells PfEMP1 is exposed at the erythrocyte surface. 
However, an intracell4lar fragment of PfEMP1 that is not accessible to surface 
trypsinistion that remains following trypsin treatment should be detected with an 
antibody to the intracellular ATS region of the protein. Such a tryptic fragment was 
not detected by western blotting however. This maybe due to the low avidity of the 
antibody and therefore overall low sensitivity of the western blotting method or due 
to the intracellular portion exhibiting different solubility characteristics to the intact 
PfEMP1 molecule and is, therefore, diluted to undetectable levels in the cell lysate 
fraction. 
It is possible trypsin sensitive bands would have been apparent sooner had I 
continued to analyse detergent extracts following the revelation that furosamide 
could inhibit the parasite's novel permeation pathway and, therefore, the labelling 
of intracellular proteins of lEs. It was assumed that, since osmotic lysis produces 
red cell ghosts, PfEMP1 and other cell surface proteins would remain imbedded in 
the red blood cell membrane and remain in the membranous fraction. It became 
apparent, however, that PfEMP1 and potentially additional biotin labelled PJVSA 
dissociated from the erythrocyte membrane and are found in the pigmented pellet 
fraction following centrifugation. This is most probably due to PfEMP1's poor 
solubility. 
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Chapter 4. Plasmodium falciparum Cysteine Modular Repeat 
Protein 2: a candidate erythrocyte surface antigen 
4.1 Abstract 
In Chapter 3 considerable effort was invested into the introduction of a reproducible 
method for western blotting high-molecular weight parasite proteins. These 
techniques were applied to a collaborative project with Dr. Thompson to further 
characterise two large molecular weight membrane proteins encoded by a novel 
gene family encoding the Plasmodium Cysteine Repeat Modular Proteins (PCRMP). 
Several interesting features of this gene family suggests the proteins they encode 
may be expressed at, or secreted from, the IE surface. 
Rabbit serum raised against peptides from PfCRMP1 and PfCRMP2 was used for 
Western blotting to determine the intraerythrocytic developmental regulation of 
these proteins. Since they are predicted to possess several transmembrane regions 
and several distinct structural domains, evidence of post-translational processing of 
the nascent peptides was also anticipated. The sensitivity of PfCRMP1 and 
PfCRMP2 to cell surface trypsinisation was also determined. 
This analysis showed both PfCRMP1 and PfCRMP2 expression is regulated in a 
similar fashion through intraerythrocytic development, of the parasite and supports 
immunofluoresence data to suggest PfCRMP2 is translocated to the IE surface. The 
nascent PfCRMP2 polypeptide also appears to be cleaved during post-translational 
processing. 
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4.2 Introduction 
Western blotting procedures optimised for the detection of candidate PJVSA were 
applied to an exciting gene family encoding the Plasmodium falciparum cysteine-
repeat modular proteins 1-4 (PfCRMP 1-4). A number of conserved structural 
features suggest these proteins are either present on the surface of the IE and / or 
parasite, or secreted. P. falciparum contains four genes encoding Plasmodium 
Cysteine Repeat Modular (CRM) regions, a schematic of the predicted features of 
these proteins is shown in figure 4.1. Sequence analysis of PfCRMP1 identified 
modularity with many reiterations of distinct types of cysteine-rich repeat giving 
rise to a characteristic recurrent C-x-C and C-x-x-C motif (Thompson et al., In Prep.). 
The modular arrangement of PfCRMP1 is largely conserved in PfCRMP2-4 and the 
four genes encoding these proteins are highly conserved in all Plasmodium species 
examined so far. Furthermore, analyses of sequences released from the genome 
sequencing projects of the Apicomplexan parasites, Theileria annulata, Theileria parva, 
Toxoplasma gondii and Eimeria tenella suggests hornologues of some PCRMPs are 
present throughout the phylum. In addition a low degree of polymorphism is 
found within the sequence for the CRM domain when seqiences from P. falciparum 
isolates from geographically diverse regions are analysed. The predicted secondary 
structure of the CRM region of PfCRMP1 suggests that it comprises an alpha-beta 
fold and disuiphide-bonding to form a complex three dimensional structure. 
Interestingly, the tandem repeats of two or four cysteine modules are reminiscent of 
cysteine-repeat motifs that are a common feature of the TNF receptor family, 
members of this family generally form tight disulphide-bonded 3-dimensional 
structures and form either dimmers or trimers. The possibility that PCRMPs may 
have a role in molecular mimicry is interesting. 
In addition to the CRM region, PfCRMP1-4 share; (i) an N-terminal cysteine-rich 
region, that in PfCRMP3 and 4 is interrupted by stretches of low complexity 
sequence, (ii) a hydrophobic leader sequence, which is encoded on a discrete exon in 
PfCRMP2, 3, and 4, (iii) multiple stretches of hydrophobic residues that are 
presented as putative rnultipass-transmembrane (rn-TM) domains in figure 4.1, and 
(iv) a predicted epidermal growth factor (EGF)-like domain which lies adjacent to 
the most N-terminal putative transmembrane domain. Another unifying feature of 
the PfCRMPs is their large size; the predicted molecular weights of PfCRMP1-4 
respectively are 389, 294, 428 and 687 kDa. PfCRMP1 is distinct from PfCRMP2-4 
due to a putative Kringle domain in the N-terminal, cysteine-rich region. 
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5Figure 4.1: Plasmodium falciparum Cysteine Modular Repeat Proteins 
1-4 
Schematic showing the predicted features of PfCRMP1 (PF10550w; chromosome 9), 
PfCRMP2 (MAL7P1.92; chromosome 7, PfCRMP3 (PFL0410w; chromosome 12), and 
PfCRMP4 (PF14_0722; chromosome 14). The proteins' predicted molecular weights are 
indicated and a key defines the symbols used; TM - transmembrane region; EGF - epidermal 
growth factor like domain. Due to the large size of PfCRMP4 the N-terminal region of the 
protein is drawn looped, this does not reflect a predicted structure, but merely allows the C-
terminal portion of the protein to be shown while maintaining resolution of the PCRM 
containing C-terminal region. 
4.1 was a kind gift from J. Thompson 
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4.3 Results 
4.3.1 Western blot analysis supports PfCRMP2 being an erythrocyte 
surface exposed protein 
Several structural features of the recently described Plasmodium gene family PCRMP 
that encodes the P. falciparum proteins PfCRMP14 suggests that these proteins may 
be transported to the erythrocyte or parasite surface and! or secreted. IFA using 
affinity purified anti-peptide antibodies raised in rabbits against two of the these 
proteins, PfCRMP1 and PfCRMP2 reveals that both l'fCRMPl and 2 colocalise with 
PfEMP1 in structures that appear punctate and dispersed throughout the 
erythrocyte cytoplasm of the infected cell (data not shown). This pattern of staining 
in IFA is characteristic of proteins exported to the erythrocyte surface. This 
intriguing result supports the hypothesis that these proteins are trafficked to the 
erythrocyte surface. To confirm the specificity of these antisera and investigate the 
developmental regulation of these proteins through the erythrocytic cycle and the 
possibility of post-translational processing Western blot analysis was performed 
with extracts from synchronous asexual cultures. The effect of trypsinisation of the 
surface of intact infected erythrocytes was also determined. 
Rabbits were immunised with 2 peptides for both PfCRMP1 and 2, the peptide 
sequences and their positions within the prptein is shown in figure 4.2. Synchronous 
cultures of A4 and FCR3CSA infected erythrocytes were used to seed three 
daughter flasks, with equivalent numbers of parasites, such that the parasitaemia in 
the next asexual cycle would reach 10%. Flasks containing ring, trophozoite or 
schizont stages were harvested, half of each flask was exposed to surface 
trypsinisation and both halves were then processed for membrane fractionation. 
Giemsa stained smears of the A4 cultures prior to harvesting are shown in figure 
4.3A to illustrate the stage and synchronicity of these cultures. A mock culture of 
uninfected cells was established using the same aliquot of uninfected erythrocytes 
used for the parent and daughter parasite cultures. The lysate, membrane and 
pigmented pellet fractions from the time course were analysed by western blotting. 
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Figure 4.2: Schematic showing peptides used to raise anti-PfCRMP 
antisera 
Sera against two KHL-conjugated peptides from PfCRMP1 and two from PfCRMP2 were 
raised in rabbits by Eurogentec S. A. The sequence of the peptides and their position within 
the proteins is shown in the schematic above. Peptides were chosen considering possible 
cross reactivity to other members in the family. Antisera were affinity purified against 
neighbouring pairs of peptides. Scissors highlight predicted proteolytic cleavage sites in 
PfCRMP2. 
PfCRMP1 and PfCRMP2 anti-sera detected proteins in both the membrane fraction 
(figure 4.3C; i) and pigmented pellet fractions (figure 4.3B; i & ii) although reactivity 
to the pigmented pellet was more intense. The predicted molecular weight of 
PfCRMP1 is 389 kDa and although a large molecular weight protein of over 250 kDa 
was detected with the anti-PfCRMP1 antisera the exact molecular weight was not 
determined. Anti-PCRMP2 antisera detect a protein of approximately 200 kDa, this 
is roughly 100 kDa smaller than the predicted size of 294 kDa. This smaller 
molecular protein could be explained by the presence of a number of predicted 
proteolytic cleavage sites that lie adjacent to the CRM domain in PfCRMP2. These 
sites could be involved in post-translational processing of the protein. 
Neither PfCRMP1 nor PfCRMP2 were detected in A4 ring stages (figure 4.3B; & C i), 
although a small amount of PfCRMP2 was detected in the FCR3CSA ring stage 
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cultures (figure 4.3C; ii, lane 1). PfCRMP1 was expressed in comparable amounts in 
both trophizoite and schizont stages. In neither the membrane fraction pool (figure 
4.3C; i) nor the pigmented pellet fraction pooi (figure 4.3B; i) could an effect of 
surface trypsinisation be detected. However, PfCRMP2 protein expression 
appeared to be upregulated in schizont stages when compared to the trophozoite 
stages (figure 4.313, ii) and following surface trypsinisation an additional lower 
molecular weight band of 150 kDa was apparent for the schizont stage of the A4 
culture (figure 4.3B; i, lane 6). The effect of trypsin was more marked in the 
pigmented pellet fractions analysed from FCR3CSA trophozites and schizonts 
(figure 4.3C; ii, lanes 3 and 5). In both the A4 and FCR3CSA schizont extracts a 
lower molecular weight band of approximately 40 kDa was also detected (e.g. figure 
4.3C; ii, lanes 4 and 5). 
Western blots of A4 pigmented pellet fractions were also probed with the anti-ATS 
PfEMP1 antibody, this showed the developmental regulation of PfCRMP1 and 2 to 
be similar to PfEMP1 (figure 4.3B; iii). It was also apparent that the protein of 
approximately 150 kDa detected by the anti-ATS antibody is limited to later stage 
parasites and is not present in early trophozoites (figure 4.313; iii, lanes 5 and 6). 
Silver staining of the gel used for blotting in figure 4.313 confirmed the positive 
effects of trypsin (data not shown). That a trypsin sensitive pool of PfCRMP2 and 
PfEMP1 localise to the pigmented pellet fraction may suggest that the additional 
biotinylated proteins (identified in Chapter 3) that localise to this cell fraction are 
parasite derived and associated with the IE surface. 
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Figure 4.3: Characterisation of PfCRMP1 and PfCRMP2 by western 
blotting 
Panel A shows Giemsa stained blood smears of sychronised A4 cultures immediately prior 
to harvesting: (I) ring lEs, (ii) trophozoite lEs and (iii) schizont lEs. White arrowheads in panel 
(I) highlight ring infected erythrocytes. Panel B shows a western blot of pigmented pellet 
fractions prepared from the synchronous cultures of A4 shown in panel A. Ring lEs lanes 1 
and 2, trophozoite lEs lanes 3 and 4 and schizont lEs lanes 5 and 6. In lanes 2, 4 and 6 
intact lEs were treated with 1 mg/mI trypsin prior to osmotic lysis and protein extraction. The 
blot was probed initially with an affinity purified anti-CRMP1 antibody and subsequently 
probed with both an affinity purified anti-CRMP2 antibody and the anti-ATS antibody. 
Antibodies were stripped from the blot between antibody incubations. The arrowhead in blot 
ii in panel B highlights a faint band that appears following trypsin treatment of the intact lEs 
prior to osmotic lysis. This band appears more strongly in the equivalent extract from from 
trypsin treated FCR3CSA lEs (panel C ii). Panel C (i) shows membrane fractions prepare 
from the synchronous cultures of A4 parasites shown in panel A. Membranes from; ring lEs 
were loaded in lanes 1 and 2, UE extracted at the trophozoite time point were loaded in 
lanes 3 and 4, trophozoite IEs were loaded into lanes 5 and 6, UE extracted at the schizont 
time point were loaded in lanes 7 and 8, schizont lEs were loaded into lanes 9 and 10. The 
blot was probed initially with an affinity purified anti-CRMP1 antibody and then with an anti-
CRMP2 antibody as in panel B the blot antibodies were stripped from the blot between 
incubations. All SDS-PAGE gels were 3-8% tris-acetate. Panel C (ii) shows a western blot of 
pigmented fractions from a FCR3CSA time course, the blot was probed with the anti-CRMP2 
antibody. Loaded into lane 1 was an extract from ring stages, lanes 2 and 3 extracts from 
trophozoites and lanes 5 and 6 exrtracts from schizionts. Extracts loaded into lanes 3 and 5 
were prepared from intact lEs that had been treated with 1 mg/mI trypsin prior to lysis. 
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4.4 Discussion and future work 
Western blotting with anti-PfCRMP2 antibodies suggests the protein is processed, 
as the major band detected is about 100 kDa smaller than, the predicted molecular 
weight. A protein of the predicted full-length nascent polypeptide was not 
detected. The anti-peptide antibody was raised against peptides in the CRM 
domain of PfCRMP2, to investigate how the protein is processed. Antibodies against 
the carboxyl region and the amino terminal region of the PfCRMP2 protein would 
provide valuable tools for investigating the fate of the full-length protein. Western 
blotting with the anti-PfCRMP1 antibody suggests that the antibody used in IFA, 
which reveal a similar punctate staining in the erythrocyte cytosol, is specific to a 
large molecular weight protein. Although, anti-peptide antibodies avoid the 
potentially time consuming step of optimising recombinant protein expression and 
peptides being quite easily used for the affinity purification of sera, short stretches 
of peptide are unlikely to raise antibodies that are reactive to the native 
conformation of the protein. A panel of antibodies recognising several regions of 
native conformation along these large proteins would be ideal for live cell 
immunofluorescence assays to confirm that these proteins are transported to the IE 
surface. Such antisera would also be useful for revealing the membrane topology 
of these interesting proteins. Of course because the PfCRMP gene family show 
reasonable sequence identity selecting suitable regions of the protein that would not 
illicit cross-reactive antibodies might be difficult. In addition several regions of 
PfCRMP1 and 2 are predicted to be highly cysteine rich, it therefore may prove 
difficult to get portions of the proteins containing cysteines to fold correctly. 
A complementary approach to raising a panel of antisera to these proteins might be 
tLC-MSMS. My work on these proteins has determined the mobility of the protein 
species detected by the anti-PfCRMP1 and 2 antisera, and therefore, it would now 
be possible to cut slices from the appropriate molecular weight sizes on 1D SDS-
PAGE gels firstly to confirm that peptides derived from these proteins are present at 
the molecular weights indicated by the antisera. As was the case for taking such an 
approach for investigating the protein species that are biotinylated, by virtue of the 
cellular fractionation steps and 11) gel electrophoresis the complexity of peptides 
present in a gel slice incorporating the molecular weight of interest would be 
limited. Depending on the success of this approach it might be possible to explore 
the processing of PfCRMP2, especially as it appears that a substantial portion of this 
large protein (100 kDa) is cleaved from the predicted full-length polypeptide. 
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Although, it might be difficult to interpret the absence of tryptic peptides, positive 
peptide identifications by LC-MSMS would be informative. Although, it appears 
that only a small portion of PfCRMP2 is affected by surface trypsinisation it may be 
possible to look at the lower molecular weight species, that appear following surface 
trypsinisation, by .tLC-MSMS also. 
The developmental regulation of PfCRMP1 and 2 through the intraerythrocytic 
cycle would suggest that these proteins are not transporters for, essential metabolic 
intermediates, since the proteins are not expressed in ring stage lEs. PfCRMP1 and 
2 protein expression commences at the trophozoite stage, therefore it may be 
possible that the predicted seven transmembrane regions produce some kind of cell 
surface receptor, on either the parasite or the IE that is important for development 
through the schizont stage. 
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Chapter 5. Biotin tagging of P. chabaudi erythrocyte surface 
antigens 
5.1 Abstract 
Experiments described in Chapter 3 showed biotin-labeled Plasmodium falciparum 
VSA expressed by cultured lEs were not detectable in membrane fractions. At that 
time, the possibility that lEs maintained under in vitro culture conditions may not 
express VSA at detectable levels was considered. Another concern was that the 
large molecular weight of PfEMP1 might perturb the entry of the protein into SDS-
PAGE gels. An in vivo model of malaria infection was therefore considered, as host 
factors, such as the absence of a spleen, have been shown in a number of malaria to 
reduce VSA expression. The surface biotinylation procedure described in chapter 3, 
has thus been applied to Plasmodium chabaudi-infected mouse erythrocytes, as not 
only does P. chabaudi infection of laboratory mice replicate many aspects of P. 
falciparum infection of humans, but all current candidate P. chabaudi VSA genes (as 
predicted from genome sequencing) are small compared to PfEMP1. 
Initial P. chabaudi labeling experiments identified two erythrocyte surface exposed 
parasite specific proteins in membrane preparations. One is a 120 kDa protein. 
Another candidate, of approximately 30 kDa, approximates to the molecular weight 
of the candidate PcVSA multigene family cir. Neither cir proteins nor any other 
candidate PcVSA have definitively been proven to be exposed at the IE surface. 
Tryptic peptides were prepared from candidate PcVSA for future identification 
using recently developed mass spectrometric techniques. 
An experiment to investigate changes in the expression of biotin labeled parasite 
specific proteins following mosquito passage was also initiated. Mosquito passage 
of three P. chabaudi lines had been shown to result in a marked increase in rosetting 
rate. Surface labeling of these lines prior to and post-mosquito passage highlighted 
the differential expression of a biotin-labeled protein of —120 kDa. This protein also 
displayed a pattern of expression in erythrocytic stages that is characteristic of 
PcVSA-mediated traits, such as sequestration and rosetting. 
These experiments using P. chabaudi lEs have confirmed that a biotin label can be 
used to tag Plasmodium-specific cell surface exposed proteins. This work spurred 
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further critical assessment of the failure of this approach in P. falciparum. In 
addition, this work has identified two candidate P. chabaudi VSA. 
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5.2 Introduction 
During the optimisation work on the detection of biotin-tagged candidate PJVSAs, a 
transient mystery was the absence of biotinylated candidate PJVSA in membrane 
enriched fractions from enriched P. falciparum cultures (figures 3.6 & 3.7). Prior to 
the realisation that PfEMP1 and biotinylated parasite specific proteins were 
sedimenting with a small, insoluble, pigmented pellet, consideration was given to 
applying the technique to an alternative model of Plasmodium infection. This 
addressed two concerns. Firstly, whether failing to detect biotinylated candidate 
Plasmodium VSA in membrane fractions was specific to P. falciparum. My primary 
concern was that, despite parasites being selected for an adhesive phenotype, in 
vitro culture did not mimic the necessary conditions for the full expression of higher, 
more detectable levels of PJVSA. For example, the spleen has been demonstrated to 
play a role in the modulation of Plasmodium VSA expression in a number of systems 
(David et al., 1983; Gilks et al., 1990; Handunnetti et al., 1987; 1983) and is perhaps a 
more significant factor in P. falciparum PfEMP1 expression than has been 
appreciated. Another concern was that due to the large molecular weight of 
PfEMP1 the protein may have failed to enter SDS-PAGE gels efficiently. This, in 
combination with only a small portion of cellular PfEMP1 being transported to the 
erythrocyte surface (Haeggstrom et al., 2004; Kriek et al., 2003), may have led to the 
levels of biotinylated PfEMP1 being below the detection limits of the Western 
blotting methods. To investigate these concerns I applied the surface biotinylation 
procedure and membrane fractionation method described in Chapter 3 to an in vivo 
mouse malaria model; P. chabaudi. This model system was especially attractive 
because not only do P. chabaudi infections of mice reflect many aspects of P. 
falciparum infections of humans, but also P. chabaudi material was readily available 
through collaboration within the department. 
5.2.1 P. chabaudi infections of the laboratory mouse 
The thicket rat Thamnomys rutilans is the natural host of P. chabaudi; however, this 
rodent malaria has been used extensively as a model for in vivo malaria infection 
using a number of strains of laboratory mouse. P. chabaudi infections in mice show 
numerous similarities to P. falciparum infections of humans: (i) P. chabaudi 
undergoes rapid asexual growth in naïve hosts; (ii) mature erythrocytic stages 
sequester from the circulation and can form rosettes; (iii) P. chabaudi exhibits 
antigenic variation in the laboratory mouse (Phillips et al., 1997); and (iv) immunity 
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to infection is incomplete and, partly, strain- and variant-specific (Cox, 1988; Mota 
et al., 2001). There are differences in the sites of sequestration however; for the P. 
chabaudi clone AS, schizont stages have been shown to sequester in the liver (Gilks et 
al., 1990), an organ not reported as a site for sequestration for P. faiciparum infections 
of humans. Despite differences in organ specificity, P. chabaudi lEs bind purified 
CD36 (Mota et al., 2000), which is a major endothelial receptor for P. falciparum (e.g. 
Baruch et aL, 1995; Baruch et al., 1996). Like P. falciparum, P. chabaudi also 
preferentially invades older red blood cells; however, the acute stage parasitaemias 
often achieved in P. chabaudi infections of laboratory mice are considerably higher 
(>30%) than those generally reached in human P. falciparum infections (Taylor-
Robinson, 1995). P. chabaudi infections of its natural host are generally less acute 
during the early stages of infection and chronic infections are more persistent. P. 
chabaudi infection may persist for the entire life of the natural host (Phillips et al., 
1997). 
The course of P. chabaudi infection in malaria naïve laboratory mice is typified by an 
acute peak of parasitaemia, lasting approximately 10-15 days, followed by 
recrudescing peaks of parasitaemia, characteristic of waves of antigenic variants 
(McLean et al., 1982). Using immune sera against parasites isolated from the acute 
peak and sera raised to parasites isolated from subsequent recrudescent peaks, 
Phillips and colleagues (1997) established that parasites in recrudescing peaks 
express antigenically distinct VSA when compared to those expressed by the same 
clone during the acute stage of infection. The importance of the spleen for surface 
antigen expression and sequestration by P. chabaudi in mouse infections was 
demonstrated by the work of Gilks and colleagues (1990). The kinetics of the acute 
stage of infection in splenectomised mice was indistinguishable from infections of 
intact animals. However, in splenectomised mice, chronic recrudescing peaks were 
not apparent. Sequestration-associated variant antigen expression in P. chabaudi 
seems to enable the establishment of chronic infections in the presence of a spleen. 
Mouse models of rodent malaria have increased our understanding of many aspects 
of Plasmodium, including the pathology induced by the erythrocytic stages of the 
parasite (Li et al., 2001). Interestingly, a large molecular weight protein comparable 
in size to PfEMP1 (- 250 kDa) has been identified either at the surface of P. chabaudi 
and P. bergei lEs or at the merozoite surface (Newbold et al., 1982). This antigen was 
also proposed to be important in the induction of antibody-mediated immunity to P. 
chabaudi infection (Boyle et al., 1982). However, the P. chabaudi proteins expressed at 
the erythrocyte surface of mature asexual stages that interact with the mammalian 
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host's immune system and microvasculature endothelium have yet to be identified. 
Due to the similarities P. chabaudi infections share with Falciparum malaria, P. 
chabaudi infections of mice thus provide an accessible in vivo malaria model for 
dissecting the molecular mechanisms underlying VSA switching at the cellular and 
population level, and the role of VSA in pathology and parasite virulence. 
5.2.2 P. chabaudi multigene familes: candidate VSA genes 
Although the genes encoding the VSA of P. chabaudi lEs have not been definitively 
characterised, a number of gene families identified through analysis of P. chabaudi's 
genome are strong candidates. Through sequencing 80 kb from the end of a P. 
chabaudi chromosome Fischer and colleagues (2003) identified ten variant multigene 
families. These families are exclusively located at the subtelomeric regions of 
chromosomes (a characteristic of genes mediating antigenic variation) and their 
copy numbers range from four to several hundred per genome. One of these gene 
families the cir family, which is present in -130 copies per genome, was initially 
described by Janssen and colleagues (2002). The cir coding sequences are quite 
variable with only short stretches exhibiting high sequence conservation although 
the non-coding sequences surrounding dr genes are relatively well conserved. 
Long stretches of intergenic regions that neighbour cir genes reach 757o identity. As 
discussed earlier (section 1.2.4) cir genes belong to the Plasmodium interspersed 
repeat (pir) superfamily, members of which have been found in several rodent, 
human and non-human primate malarias (Janssen et al., 2004). Cirs encode 
relatively small proteins of -30 - 40 kDa and their transcripts are regulated through 
the asexual blood stages. 
Fischer et al. (2003) proposed that two further P. chabaudi multigene families encode 
variant surface proteins. The first of these families includes three genes labelled 5c, 
7c and lOc and there are an estimated 75 copies of related genes per genome. 
Fischer et al. (2003) have not named this gene family, and for simplicity I shall refer 
to the protein products of this family as P. chabaudi cir-like proteins (PcCLP). 
Although the 5c, 7c, and lOc genes vary considerably in size, they share a similar 
gene structure, not only with each other, but also to cir genes. They possess three 
exons, the small 5' exon and the 3' exon are conserved in size, but the second is 
variable. The second exon of the 7c gene is considerably larger than that observed 
in cir genes. The first 200 amino acids and last 140 amino acids of 5c, 7c and lOc 
show high sequence conservation and the central part of the protein, encoded by the 
3' end of exon 2, contains varying lengths of low complexity amino acid 
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composition and internal repeats. The 3' end of exon 2 also encodes a conserved 
putative transmembrane domain. It is the relatively conserved 5' end of exon two 
which shows similarity to cir proteins, this cir-like region contains four conserved 
cysteine residues and a number of conserved rare amino acids such as tryptophan 
and tyrosine. Considering their subtelomeric location, a single putative 
transmembrane sequence and regions of similarity to cir proteins Fischer et al. (2003) 
propose the PcCLP family is derived from the same common ancestral genes that 
gave rise to all members of the pir superfamily. Like cirs and other VSA, such as 
PfEMP1, a signal sequence is not apparent at the amino terminus of the PcCLPs. 
Two genes, given the identities 1w and 14w,define the third putative PcVSA 
multigene family proposed by Fischer et al. (2003). There are an estimated 13 copies 
of related genes in the P. chabaudi genome. These genes again vary considerably in 
size (-2 fold), but are clearly related and show similarities to the P. chabaudi 
erythrocyte membrane antigen 1 (EMA1) protein (Deleersnijder et al., 1992). EMA1 
itself is not thought to belong to a multigene family although a related gene called 
EMA1-R has been identified (Favaloro & Kemp, 1994). The EMA1 protein contains 
a major tandem repeat array of 16 octapeptides and has a predicted molecular 
weight of 50 kDa. EMA1 is associated with the erythrocyte membrane of the IE 
throughout the intraerythrocytic cycle, but is thought to reside on the cytoplasmic 
face (Deleersnijder et al., 1992). Members from the three families described above 
were found to be transcribed in blood stages (Fischer et al., 2003). 
Initially, I have applied the biotin surface labelling technique to erythrocytes 
infected with the AS clones of P. chabaudi as parasite material was available 
following a large-scale transmission study in the department. As the AS clone was 
used for the P. chabaudi genome sequencing project, this clone was ideal for any 
subsequent mass spectrometry analysis of candidate PcVSA. AS infected and 
uninfected control mice were bled when parasites were ring stages, serum was 
removed and the cells kept in short term culture until they had developed into 
trophozoite stages. Cultures were then surface labelled with biotin and the 
membrane fractions analysed by western blotting. This approach successfully 
identified two candidate PcVSA in the equivalent membrane fraction to that in 
which PJVSA could not be detected in analogous labeling experiments of P. 
falciparum. Success at the initial stage of the originally planned multi-step 
proteomics approach (detailed in section 3.2.7) with the P. chabaudi model led to 
experiments to investigate the expression of candidate PcVSA in a model of 
rosetting in P. chabaudi. 
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established. Tryptic peptides were extracted from fine gel slices and prepared for 
analysis by 1.tLC and tandem ESI MS. Figure 5.2 shows the primary MALDI-TOF 
quality control screen of a selected number of extracts to confirm the presence and 
quality of tryptic peptides. Although this quality control step suggests these 
samples are suitable for further analyses, the collaboration to analyse the tryptic 
peptides by pLC and tandem ESI MS unfortunately did not come to fruition. 
Attempts were made to find alternative facilities for the analysis of these peptides. 
However, since such multidimensional mass spectrometric technologies are costly 
to establish, and have only recently been applied to complex protein mixtures, 
suitable facilities are scarce and an alternative could not be found. 
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Figure 5.1: Surface labelling of P. chabaudi (clone AS) infected 
erythrocytes using sulpho-NHS-LC-biotin 
Panel A shows a western blot of membrane extracts separated on a 4-12% gradient bis-tris 
SDS-PAGE gel and probed with HAP-conjugated streptavidin. Panel B shows a duplicate gel 
of that shown in A stained with silver. Lanes containing extracts from uninfected erythrocytes 
are indicated in the table by U, and extracts from C57 mouse erythrocytes infected with the 
AS clone of P. chabaudi are indicated by I. Surface exposed potential P. chabaudi derived 
proteins are highlighted with an asterisk. 
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Figure 5.2: MALDI-TOF spectra of tryptic peptides form P. chabaudi IE 
membrane fractions 
Tryptic peptides were prepared from gel slices from lane 8 of the silver stained gel shown in 
figure 5.1B, the exact locations are shown in Appendix 5. Spectra A, B and C were obtained 
for tryptic peptides extracted from 1.5 mm gel slices cut from —120 kDa, —100 kDa and —37 
kDa respectively. 
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5.4.2 Candidate PcVSA expression, mosquito transmission and 
rosetting 
The identification of two candidate PcVSAs led to the application of the surface 
labeling technique to study the expression candidate PcVSA in rosetting clones of P. 
chabaudi. Mackinnon and colleagues (In Press) have recently shown that mosquito 
transmission of P. chabaudi isolates selects for significant increases in rosetting 
frequencies. Three related clones CWA, CWO and CWV used by Mackinnon et al. 
(In Press) which were shown to increase their rosetting frequencies following 
mosquito transmission were surface labeled with biotin to follow any associated 
changes in surface antigen expression. The rosetting frequencies for clones CWA, 
CWO and CWV pre and post mosquito transmission are shown in figure 5.3. 
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Figure 5.3: Rosetting frequencies of CW isolates pre- and post-
mosquito transmission 
The rosetting frequencies of P. chabaudi isolates on days 5-7 post-infection were assayed 
as described in Mackinnon et al. (2002). The mean rosetting rate is shown and the number 
of observations indicated in brackets above the error bars. Error bars indicate standard 
deviation. 
114 Chapter 5: Biotin tagging of P. chabaudi erythrocyte surface antigens 
Clones CWA and CWV had very low rosetting rates prior to mosquito transmission 
(-2%), but post-mosquito transmission rosetting frequencies were - 40% and 30% 
respectively. Clone CWO exhibited a moderate rosetting frequency (-207o) prior to 
mosquito challenge (CWOpre). This may reflect CWO being recently derived from 
the natural host and consequently having been recently transmitted through 
mosquitoes. Both CWApre and CWVpre were derived from CWOpre by extensive 
serially blood passage through mice (the passage history of CWA and CWV is 
described in more detail in section 7.7.3). Despite CWOpre exhibiting a moderate 
rosetting frequency, mosquito transmission increased this further and by a 
comparative degree to that seen as a result of mosquito transmission of the CWApre 
and CWVpre clones. The rosetting frequency of CWO post-mosquito challenge 
(CWOpo) was -60 %. 
The experimental design for the surface labeling of CW derived isolates pre- and 
post-mosquito transmission is outlined in figure 5.4. The experiment was carried 
out in duplicate and prior to surface biotinylation half of the erythrocytes from each 
infected and control uninfected mouse were treated with 1 mg/ml trypsin. Both 
ring infected and schizont lEs were labeled to determine the stage specificity of 
candidate PcVSA. Figure 5.5, panels A-C show western blots of membrane extracts 
from surface biotinylated ring lEs. Parasite specific biotinylated proteins similar to 
those identified in the membrane extracts of AS trophozoite lEs were not detected in 
extracts of ring stage parasites for any of the six CW isolates. Western blots of 
membrane extracts from surface biotinylated schizont lEs are shown in figure 5.6. A 
biotinylated parasite-specific trypsin-sensitive protein having a similar molecular 
weight to the 110 kDa protein seen in AS membrane extracts (figure 5.1) was 
identified in schizont extracts (figure 5.6B; lanes 3,7 & 9 and 5.6C; lanes 3,5,9 & 11). 
However, this band was intense in only the three CW isolates that had recently been 
transmitted through mosquitoes and was less intense in the CWOpre schizont 
extract. The presence and intensity of the biotinylated 110 kDa protein correlated 
with the rosetting rates of the CW clones. The stage specific expression of the 
biotinylated 110 kDa protein is also in agreement with PcVSA mediated 
cytoadherence phenotypes, such as sequestration and rosetting, being restricted to 
the mature erythrocytic stages of the parasite (Gilks et al., 1990). Membrane extracts 
from duplicate mice were also consistent with regard to the pattern of biotinylated 
proteins and the presence or absence of the 110 kDa protein. 
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Clones CWA and CWV had very low rosetting rates prior to mosquito transmission 
(-2%), but post-mosquito transmission rosetting frequencies were 407o and 307o 
respectively. Clone CWO exhibited a moderate rosetting frequency (-207o) prior to 
mosquito challenge (CWOpre). This may reflect CWO being recently derived from 
the natural host and consequently having been recently transmitted through 
mosquitoes. Both CWApre and CWVpre were derived from CWOpre by extensive 
serially blood passage through mice (the passage history of CWA and CWV is 
described in more detail in section 7.7.3). Despite CWOpre exhibiting a moderate 
rosetting frequency, mosquito transmission increased this further and by a 
comparative degree to that seen as a result of mosquito transmission of the CWApre 
and CWVpre clones. The rosetting frequency of CWO post-mosquito challenge 
(CWOpo) was -60 %. 
The experimental design for the surface labeling of CW derived isolates pre- and 
post-mosquito transmission is outlined in figure 5.4. The experiment was carried 
out in duplicate and prior to surface biotinylation half of the erythrocytes from each 
infected and control uninfected mouse were treated with 1 mg/ml trypsin. Both 
ring infected and schizont lEs were labeled to determine the stage specificity of 
candidate PcVSA. Figure 5.5, panels A-C show western blots of membrane extracts 
from surface biotinylated ring lEs. Parasite specific biotmylated proteins similar to 
those identified in the membrane extracts of AS trophozoite lEs were not detected in 
extracts of ring stage parasites for any of the six CW isolates. Western blots of 
membrane extracts from surface biotinylated schizont lEs are shown in figure 5.6. A 
biotinylated parasite-specific trypsin-sensitive protein having a similar molecular 
weight to the 110 kDa protein seen in AS membrane extracts (figure 5.1) was 
identified in schizont extracts (figure 5.6B; lanes 3,7 & 9 and 5.6C; lanes 3,5,9 & 11). 
However, this band was intense in only the three CW isolates that had recently been 
transmitted through mosquitoes and was less intense in the CWOpre schizont 
extract. The presence and intensity of the biotinylated 110 kDa protein correlated 
with the rosetting rates of the CW clones. The stage specific expression of the 
biotinylated 110 kDa protein is also in agreement with PcVSA mediated 
cytoadherence phenotypes, such as sequestration and rosetting, being restricted to 
the mature erythrocytic stages of the parasite (Gilks et al., 1990). Membrane extracts 
from duplicate mice were also consistent with regard to the pattern of biotinylated 
proteins and the presence or absence of the 110 kDa protein. 
Chapter 5: Biotin tagging of P. chabaudi erythrocyte surface antigens 	 117 
Using immune sera in live cell immunofluorescence assays it has been shown that 
PcVSA are sensitive to trypsin (Gilks et al., 1990). This is in agreement with the 
trypsin sensitivity exhibited by the parasite specific biotm labelled proteins detected 
in membrane extracts from both AS and CW clones (figures 5.1 and 5.6). A lower 
molecular weight parasite specific protein equivalent to the —30 kDa protein 
identified in AS IE extracts was not detected in any of the membrane extracts from 
CW isolates. This may reflect the different developmental stage at which 
membranes were extracted. AS infected erythrocytes were cultured for 6 hours after 
bleeding infected mice and the CW isolates were cultured overnight. Biotinylated 
proteins characteristic of PcVSA were not detected in extracts from CWA and CWV 
isolates pre-mosquito passage. 
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Figure 5.5: Membrane extracts from P. chabaudi ring lEs labelled with 
sulpho-N HS-LC-biotin 
Ring stage parasites isolated directly from C57B1/6J mice were washed and labelled with 
sulpho-NHS-LC-biotin. Membrane extracts were extracted and separated on 4-12% gradient 
bis-tris SDS-PAGE gels. Western blots of these gels probed with HRP-conjugated 
streptavidin are shown. Lanes labelled A, 0, and V contain extracts from clones CWA, CWO 
and CWV respectively pre-mosquito transmission. Lanes Ap, Op, and Vp contain extracts 
from clones CWA, CWO and CWV respectively post-mosquito transmission. Lanes loaded 
with extracts from uninfected erythrocytes are labelled U. Extracts from intact lEs treated 
with 1 mg/mI trypsin or not were loaded into lanes labelled with + or - respectively. Panel A 
shows duplicate extracts from CWA and CWV lEs pre-mosquito transmission, panel B 
shows duplicate extracts from CWO lEs pre and post-mosquito transmission and panel C 
shows duplicate extracts from CWA, and a CWV extract, post mosquito transmission. 
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Figure 5.6: Membrane extracts from P. chabaudi schizont IE labelling 
with sulpho-NHS-LC-biotin 
Late ring stage infected erythrocytes were isolated from C57B1/6J mice and matured in short-
term culture overnight. Cultured cells were washed and labelled with sulpho-NHS-LC-biotin. 
Membrane extracts were prepared and separated on 4-12% gradient bis-tris SDS-PAGE 
gels (Invitrogen). Western blots of these gels probed with HRP-conjugated streptavidin are 
shown. Lanes labelled A, 0, and V contain extracts from clones CWA, CWO and CWV 
respectively pre-mosquito transmission. Lanes Ap, Op, and Vp contain extracts from clones 
CWA, CWO and CWV respectively post-mosquito transmission. Lanes loaded with extracts 
from uninfected erythrocytes are labelled U. Extracts from intact lEs treated with 1 mg/mI 
trypsin or not were loaded into lanes labelled with + or - respectively. Candidate PcVSA 
bands are highlighted with an asterisk. Panel A shows duplicate extracts from CWA and 
CWV lEs pre-mosquito transmission, panel B shows duplicate extracts from CWO lEs pre 
and post-mosquito transmission and panel C shows duplicate extracts from CWA and CWV 
post-mosquito transmission. 
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5.5 Discussion 
Surface labelling experiments using P. chabaudi lEs were initiated to address 
concerns regarding the detection of biotinylated P. falciparum erythrocyte surface 
antigens following the fractionation of red blood cell ghosts. Trials of the 
biotinylation protocol with P. chabaudi lEs from mice led to the identification of two 
parasite specific biotinylated proteins. These experiments confirmed that sulpho-
NHS-LC-biotin could successfully label Plasmodium-specific, surface-trypsinisation-
sensitive proteins. These candidate PcVSAs were present in the equivalent 
membrane fraction for which biotin tagged PfVSA could not be detected. 
Following further experiments with P. falciparum lEs it was apparent, however, that 
the original concerns regarding the abundance of PJVSA at the IE surface and the 
large molecular weight of PfEMP1 were not warranted. As discussed in chapter 3, 
the dissociation of PfEMP1 from the red blood cell membrane and PfEMP1's 
insoluble nature is most likely responsible for the absence of biotin tagged PJVSA in 
membranous fractions. However, it was partly the successes with the labelling of P. 
chabaudi lEs that fuelled the continuation of experiments to investigate the small, 
pigmented pellet fraction that forms following osmotic lysis and centrifugation. The 
pigmented pellet was the fraction in which biotin labelled PJVSA were subsequently 
found. 
Parasite specific biotinylated proteins of -110 kDa and -30 kDa were detectedin 
extracts from P. chabaudi clone AS clone (figure 5.1). A protein with similar 
characteristics to the AS 110 kDa protein was also identified in extracts from CW 
isolates (figure 5.6), however, this protein is larger than the predicted molecular 
weights of any members of the multigene families described by Fischer et al. (2003). 
The largest PcCLP identified is predicted to encode a 74 kDa protein, although, 
considering the extent of size polymorphism for the three members of the PcCLP 
family described by Fischer et al. (2003), it is possible that one or more of the 75 
predicted copies of PcCLP genes encodes a larger protein. The lower molecular 
weight protein of -30 kDa detected only in AS extracts has characteristics of a cir 
protein. Slight size polymorphism in the 100 kDa and 30 kDa proteins is congruent 
with these proteins being encoded by variant multigene families. Using CW 
infected mice the -110 kDa protein was also expressed in an appropriate stage 
specific manner for a PcVSA. - 
In 1982 Newbold and colleagues (1982) identified a candidate VSA of approximately 
250 kDa in P. chabaudi and another rodent malaria P. bergei. I did not identify a 
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protein of equivalent size, although it is possible that the antigen described by 
Newbold et al. (1982) lacks surface exposed lysine residues to which the suipho-
NHS-LC-biotin reagent would have access. That the gene encoding the 250 kDa 
candidate PcVSA has yet to be identified further illustrates the challenges faced 
when studying Plasmodium VSAs. However, considering the speed at which 
Plasmodium genome sequences are becoming available, it is anticipated that the pace 
at which the molecular mechanisms underlying the biology of this parasite are 
revealed will continue to accelerate. Indeed, the P. chabaudi genome sequence aided 
the description of the prime PcVSA candidates, cirs. However, further 
characterisation of the cir proteins will face some of the difficulties evidenced in 
recent studies of var gene transcription and expression (reviewed in sections 3.2.2 
and 3.2.3). The design of specific molecular probes for cir genes and an appreciation 
of reagent cross-reactivity will be important issues. The surface biotinylation 
technique described labelled proteins with cir characteristics (figure 5.3.1) and may 
offer a complementary approach to current molecular biology techniques. 
Although P. chabaudi's genome does not encode PfEMP, this parasite still exhibits 
cytoadherence phenotypes, such as rosetting, sequestration, CD36 binding and 
antigenic variation. I have followed the expression of candidate PcVSA for three 
related clones that had been selected for high rosetting frequencies via passage 
through Anopheles stephensi mosquitoes (Mackinnon et al., In Press). This analysis 
suggests a surface exposed protein of —110 kDa is associated with rosetting and/or 
mosquito challenge. Although the contribution of rosetting to parasite virulence 
remains unclear, anti-rosette vaccines have been considered for P. falciparum malaria 
to protect against severe disease (e.g. Chen et al., 2004). Naturally acquired antibody 
responses to the IE surface seem to be important for the acquisition of protective 
immunity to P. falciparum, but the relative importance of surface reactive antibodies, 
versus invasion blocking antibodies for example, is not known. 
Mota and colleagues (1998; 2000; 2001) have carried out a number of studies to 
characterise the acquisition of antibodies to the surface of P. chabaudi erythrocytes. 
Their work suggests P. chabaudi infections of mice are analogous to P. falciparum in 
respect to acquired immunity to VSAs. The P. chabaudi model could circumvent 
many of the experimental limitations of human malaria in order to further 
characterize the mechanisms of naturally acquired immunity to the IE surface and 
their relative importance for protection. The whole life cycle of P. chabaudi can be 
studied with relative ease in the laboratory and the genetic background, age, sex, 
immune status of the host controlled and contrasted. The diversity of mice with 
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genetically manipulated jmmune systems also allows for the contribution and 
importance of different immune factors to be addressed. 
When the host and parasite molecular 'players' behind rosetting in P. chabaudi are 
revealed, this in vivo mouse model might provide a suitable system for investigating 
the effect of rosette disruption on the course and severity of. infection. Anti-sera 
against recombinant rosette mediating domains of PfEMP1 have been shown to 
disrupt rosettes (Chen et al., 2004). Mice could be immunised with P. chabaudi 
rosetting ligands to raise antibodies that inhibit rosetting and the effects of an anti-
rosetting vaccine on the selection of alternative PcVSA variants determined. Such 
experiments would be a criterion for assessing the effects of such a vaccine for P. 
falciparum. Assaying the protective effects of the passive transfer of purified 
immunoglobulins from mice, immunised with a P. chabaudi anti-rosetting vaccine, to 
naïve mice prior or during P. chabaudi infection could help determine the protective 
properties of anti-VSA antibodies alone. Mota et al. (1998) have demonstrated that 
naturally acquired anti-PcVSA antibodies are important for phagocytosis in vitro. It 
would be interesting to carry out similar experiments to address the mechanism of 
anti-IE surface antibody mediated parasite clearance of rosetting versus non-
rosetting parasite clones to address whether rosette formation effects parasite 
clearance. As P. chabaudi has a relatively less AlT biased genome in terms of base 
composition, the heterologous expression of P. chabaudi recombinant proteins, for 
the purpose of binding studies and raising antibodies, should be more 
straightforward than with P. falciparum. Also the candidate PcVSA proteins are 
significantly smaller than PfEMP1 thus potentially easier to characterise. 
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5.6 Future work 
A collaboration to analyse tryptic peptides, prepared for P. chabaudi surface extracts, 
by 1tLC-MSMS was established during this project, but unfortunately it did not 
come to fruition. Therefore, the first experiments to carry out in the future would be 
the analysis of tryptic peptides to determine the identity of the proteins present in 
gel slices containing biotin labelled candidate PcVSA. There is currently no 
evidence that the parasite-specific biotin-labelled proteins are parasite derived and 
it is possible that host serum proteins bound to PcVSA have been labelled. Whether 
host or parasite derived these biotinylated surface exposed proteins warrant further 
investigation. 
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Chapter 6: Main Discussion 
The central aim of this thesis was to apply proteomics to investigate PfVSAp Am  
expression. In Chapter 2 I have shown for parasite clone FCR3 that CSA selection 
results in the concomitant expression of trypsin resistant VSA epitopes that are 
recognised by IgG in a pool of sera from malaria exposed pregnant women. While 
adhesion of this parasite to the placental receptors CSA and HA was comparatively 
trypsin sensitive. My findings suggest that antibodies acquired during PAM are not 
simply recognising the IE surface epitopes involved in CSA adhesion. Whether 
distinct genes in the FCR3 genome encode for the CSA binding epitopes and the 
trypsin resistant epitopes has yet to be determined. It was my intention that the 
differential protease sensitivityexhibited by VSA PAM epitopes would be exploited in 
comparative proteomic analysis. Although this was not achieved in the course of 
this project, it is possible that the trypsin resistant phenotype may still prove 
valuable in the future. 
The surface labelling and gel-based proteomic approach that was developed has 
proven unsuccessful in terms of VSA PAM identification. However, the initial step of 
cell surface specific labelling has been optimised. Several, large molecular weight, 
surface trypsinisation sensitive, biotinylated proteins were detected in extracts of 
FCR3CSA from surface labelled lEs. The largest of these proteins co-localised with a 
variant of PfEMP1 in Western blotting. That the other high molecular weight species 
are PfEMP1 variants that are not reactive to the anti-ATS antibody is a possibility. 
Increasingly sophisticated mass spectrometric techniques are being developed for 
the identification of proteins in complex mixtures, circumventing the need for 
absolute electrophoretic separation and isolation from gel matrices. I had a 
relatively poor success rate (-50%) when identifying proteins by MALDI-TOF mass 
spectrometry of tryptic peptides extracted from proteins resolved by 2D SDS-PAGE, 
and considering the large molecular weight of the biotin labelled candidate PJVSA, a 
non-gel based technique combining micro-liquid chromatography (PLC) and 
tandem ESI MS might prove a more appropriate alternative. The cell fraction 
(pigmented pellet) to which parasite-specific labelled proteins sediment represents a 
rather small portion of the IE total protein, but is enriched for PfEMP1, surface 
trypsinisation sensitive PfCRMP2, and additional biotin labelled candidate PJVSA. 
1D SDS-PAGE then provides yet another round of separation, such that Western 
blotting of the pigmented pellet fraction with streptavidin can identify fine gel slices 
containing the biotinylated surface trypsinisation sensitive candidate PJVSA. 
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Therefore these gel slices should prove relatively simple to analyse by tLC and 
tandem ESI MS. The differential protease sensitivity of the VSAp AM  epitopes would 
also allow for the treatment of the infected erythrocyte surface with relatively low 
concentrations of trypsin to remove trypsin sensitive CSA-binding eptiopes, but 
leave the more trypsin resistant epitopes intact. This protease treatment would 
simplify the surface complexity, and potentially provide a marker for the 
identification of the trypsin resistant VSA PAM epitopes described in Chapter 2. It 
would therefore be interesting to look at the effect of titrating the concentration of 
trypsin on the pattern of IE surface labelling. During my experiments to optimise IE 
surface biotinylation only high concentrations of trypsin (1 mg/ml) were employed 
solely in order to ascertain whether labelling was cell surface specific. 
6.1 PfEMP1 and PAM 
The decision to develop a proteomics method for the study of VSAp AM  expression 
was made in part due to conflicting data regarding the identity of the var gene 
transcribed and expressed at the erythrocyte surface of CSA selected parasite clones 
and placental isolates. However, over the last few months, two particularly relevant 
papers have been published that have cleared the fog of confusion surrounding this 
matter slightly. The group that initially identified the FCR3var1CSA gene published 
the first of these. Gamain et al. (2004) have further defined a 67 amino acid (aa) CSA 
binding motif that is relatively well-conserved between varlcsa homologs from 
different parasite isolates. However their paper also states that a monoclonal 
antisera against the recombinant FCR3var1CSA DBL-b domain, that inhibits CSA 
binding (Costa et al., 2003), and antisera raised against the 67 aa binding motif, may 
not specifically recognise their immunising antigens. Cross-reactivity is evidently 
possible as a monoclonal anti-sera raised against the DBL-ö domain of 
FCR3var1CSA recognises the surface of FCR3var1CSA-knockout parasites (after 
reselection on CSA) (Andrews et al., 2003). Interestingly, antisera raised against the 
67 aa CSA binding domain recognises CSA selected clones specifically but does not 
inhibit binding (Gamain et al., 2004). Since the role of anti-VSAp AM  antibodies in 
opsonisation dependent phagocytosis and / or alternate parasite clearing pathways 
in the placenta is unknown, it is therefore difficult to predict the efficacy of a vaccine 
raising surface reactive antibodies that do not block CSA adhesion. The findings of 
chapter 2 and work by Beeson et al. (2004) certainly suggest that non-adhesion 
blocking antibodies are raised naturally to VSA. The paper by Gamain et al. 
(2004) further supports the view that FCR3var1CSA may not be expressed by CSA 
130 Chapter 6: Discussion 
binding parasites and that additional or alternative genes in FCR3's genome can 
support CSA adhesion. 
The second papers provides evidence for the involvement of the var2csa gene in 
PAM (Salanti et al., 2004). This unusually structured var gene lacks a conventional 
CIDR1 domain and is also relatively well conserved. It was originally shown to be 
transcriptionally up-regulated in the parasite clones NF54 and FCR3CSA, following 
selection for adhesion to CSA (Salanti et al., 2003). Salanti and colleagues (2004) 
demonstrate that antibodies raised in rabbits to two of the six DBL domains (DBL1-
X and DBL5-s) encoded by var2csa recognise both of the CSA selected clones in 
which the gene was originally found to be transcriptionally upregulated. 
Furthermore, their ELISA data suggests recombinant DBL1-X and DBL5-c domains 
are well recognised by IgG from serum of a group of term pregnant women residing 
in an area of hyper-endemic stable malaria transmission, but not by sera from 
sympatric males. They also found high levels of var2csa-specific IgG to associate 
with favourable birth outcomes. Salanti et al. (2004), however, did not report on the 
CSA binding capacity of the recombinant DBL1-X and DBL5-E domains nor on the 
anti-adhesion properties of the antisera they raised against these domains. 
Interestingly, Gamain et al. (2004) report that the minimal 67 aa CSA binding motif 
from the DBL-8 of FCR3var1CSA is related to the DBL1-X of var2csa. Since genes 
closely related to var2CSA are commonly found, and a homolog occurs in the 
genome of FCR3 (Salanti et al., 2003), it is possible that this may explain the antisera 
cross-reactivity seen by Gamain et al. (2004). 
Interestingly the 13-14 kb var transcripts shown to be up-regulated in the CSA 
selected FCR3/IT lineage and the FCR3 clone, by Duffy et al. (2002) and Kyes et al. 
(2003) respectively are too large to be a close homolog of var2csa. The identity of 
these transcripts is still unknown. Thus, development of an alternative 
complementary method, and perhaps further development of the approach I have 
worked towards here, for the study of VSAp, J remains justified, especially 
considering a concluding statement of Gamain et al. (2004); 'Given the uncertainties 
about FCR3-CSA protein translation and the complete lack of knowledge about 
what is expressed at the surface of placental isolates, the precise targets of these 
antibodies are still not known'. 
Recent, quantitative proteomics studies in P. falciparum again highlight that mRNA 
levels do not generally correlate with protein abundance in this parasite. Nirmalan 
and colleagues (2004b) found patterns of mRNA expression and protein levels for 
different genes differed significantly, which indicates differences in mRNA stability, 
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and I or different efficiencies and timing of translation. Although these studies were 
not concerned with PfEMP1 they further support the need to look at the level of 
protein expression. Nirmalan et al. (2004b) designed a rather elegant quantitative 
proteomics method specifically for P. falciparum that relies on the metabolic labelling 
of parasite proteins with alternatively labelled isoleucine which contains different 
numbers of stable isotopes of carbon and hydrogen (Nirmalan et al., 2004b). Their 
method allows for experimental cultures of the parasite, for example a drug treated 
culture, to be compared directly to a control untreated culture (Nirmalan et al., 
2004a). Although this approach was considered for studying VSAp AM  expression, 
the method of Nirmalan and colleagues requires that you know the position of your 
protein(s) of interest on a 2D SDS-PAGE gel. 
6.2 Is PfEMP1 everything in the case of VSA PAM? 
Since the identification of the var multigene family, studies of P. falciparum VSA 
involving assaying naturally acquired antibody responses and / or binding 
phenotypes have generally presumed that PfEMP1 is solely responsible for 
mediating these traits. However, considering: (1) members of the rifin family are 
now known to be expressed on the IE surface (Kyes et al., 1999); (2) the recent 
discovery of Plasmodium infected erythrocyte surface proteins 1 an 2 (Florens et al.); 
and (3) the possibility that members of the PfCRMP family are surface exposed 
(Thompson et al. In Prep), it seems PfEMP1 is not alone on the IE surface. The 
VSAPAM of mature stage lEs exhibits several qualities uncharacteristic of PfEMP1; 
however, studies to define the molecular identity of VSAp AM  have focused solely on 
this protein (discussed in section 1.4.6). 
It seems that many species of malaria can exhibit cytoadhesion phenotypes, such as 
sequestration (e.g. P. knowlesi and P. chabaudi) and rosetting (all Plasmodium spp 
studied so far) without PfEMP1. Var gene homologs have yet to be found outside of 
P. falciparum. With respect to malaria in pregnancy, P. vivax infection can bring 
about negative birth outcomes, albeit to a lesser extent than P. falciparum (McGready 
et al., 2004). In the small number of studies looking at malaria animal models 
during pregnancy, higher parasitaemias, accentuated pathology, and immuno-
pathological changes comparable to that of P. falciparum infected human placentae, 
have been recorded (reviewed in Desowitz, 2001). Furthermore, a presentation at 
the Molecular Approaches to Malaria 2004 conference reported 30 out of 30 P. vivax 
isolates examined bound specifically to immobilised CSA and HA (Abstract 
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published as Chotivanich et al., 2003). P. vivax adhesion to these placental receptors 
was reported to begin -16 hours post invasion and peak 32 hours post invasion. P. 
vivax lEs were not found to adhere to CD36, ICAM1 or thromospondin, which are 
major endothelial receptors for P. falciparum. It will be interesting to investigate 
whether members of the P. vivax interspersed multigene family, vir (del Portillo et 
al., 2001), mediate adhesion to CSA and HA. 
6.3 A small animal model of antigenic variation in a post-genomics era 
In Chapter 4 I have applied a surface biotinylation technique to P. chabaudi lEs. This 
project was initiated partly to test the ability of the technique to label Plasmodium 
VSA, but also to detect surface exposed proteins having similar characteristics to the 
P. chabaudi interspersed repeat family, cirs (Fischer et al., 2003; Janssen et al., 2002). 
Surface labelling of the P. chabaudi AS clone highlighted a surface exposed protein of 
the anticipated molecular weight (-30 kDa) for members of this family (Janssen et 
al., 2004). A similar protein was not seen in subsequent studies using isolates 
derived from the clone CW. However, when three isolates derived from CW were 
surface labelled pre- and post transmission through Anopheles stephensi mosquitoes, 
a 120 kDa surface exposed protein was upregulated in the clones that had been 
mosquito transmitted when compared to the isolates that had previously undergone 
several rounds of serial blood passage. The hypothesis that mosquito transmission 
selects for a general up-regulation of surface antigen expression has not been 
directly tested. However, that rosetting rates also increase following mosquito 
transmission of these P. chabaudi clones (Mackinnon et al., In Press) supports this 
hypothesis. 
As discussed in chapter 5, P. chabaudi infections of laboratory mice reproduce many 
of the features of P. falciparum infections of humans. In in vivo experiments in mice 
lend themselves to manipulation and controlled experimentation far more easily 
then their equivalent in humans. Although, P. chabaudi's genome does not encode 
the infamous var gene family, this parasite exhibits several VSA mediated 
phenotypes, such as, antigenic variation, sequestration and rosetting. The P. 
chabaudi sequencing project is well underway (Janssen et al., 2001) and nearing 
completion, a combination of increasingly sophisticated molecular and proteomic 
approaches is now possible for this in vivo malaria model. P. chabaudi now offers a 
powerful accessible model with which to further our understanding of the 
molecular mechanisms of VSA 'switching', VSA associated pathogenesis, and the 
impact of adhesion blocking vaccines. 
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Chapter 7: Materials and Methods 
7.1 P. falciparum culture and manipulation 
7.1.1 P. falciparum parasite isolates and culture 
Parasites were maintained in group 0 erythrocytes under standard conditions 
(Trager & Jensen, 1976), using RPMI 1640 medium containing 25 mM HEPES, 
supplemented with 20 mM glucose, 2 mM glutamine, 25 .tg/ml gentamycin and 
107o pooled normal human serum. The pH was adjusted to between 7.2 and 7.4 
with 1 M NaOH. Culture flasks at 57o haematocrit were gassed with 967o' nitrogen, 
37o carbon dioxide and 17o oxygen. The laboratory clone FCR3 originates from 
peripheral blood collected in the Gambia. FCR3CSA was obtained from the Malaria 
Research and Reference Reagent Resource Centre (ATCC) (Scherf et al., 1998), and 
was confirmed using genetic markers to be identical to the laboratory clone FCR3 
kept in the original W.H.O. strain registry collection in Edinburgh (pers. Comm. D. 
Walliker). 
7.1.2 Giemsa staining of thin blood smears 
Thin blood smears were prepared using a pipette to transfer approximately 10 tl of 
the cell layer that settles at the bottom of the culture flask to a microscope slide and 
then spreading the cells thinly with a clean microscope slide. Blood smears were 
air-dried and fixed with 1007o methanol for about 30 seconds and then air-dried 
again. Slides were stained by immersion for 20 minutes in a 10% Giemsa stain 
solution (BDH) diluted in Giemsa buffer (prepared using Giemsa buffer tablets; 
BDH). Slide were washed thoroughly under tap water and then air-dried. Slides 
were observed by light microscopy using a lOOx objective under immersion oil 
(BDH). 
7.1.3 Sorbitol synchronization of P. falciparum infected erythrocytes 
Sorbitol synchronisation was to obtain only ring stage parasites was performed 
following the method of Lambros and Vanderberg (1979). Parasite cultures 
containing ring stage parasites were transferred to centrifuge tubes and centrifuged 
for 5 minutes at 500 xg. Culture medium was removed and the cell pellet 
resuspended in 5 ml of 57o' sorbitol (w/v; Sigma) and incubated at RT for 5 minutes. 
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Cells were then centrifuged again for 5 minutes at 500 xg, washed with 10 ml of 
RMPI-1640 and returned to standard culture conditions. 
7.1.4 Enrichment of trophozoite and schizont stages 
Trophozoite and schizont stages were enriched by sedimentation using a 
commercially available high-molecular-weight polymer Plasmagel (Cellular 
Products, Inc., Buffalo, N.Y.). 5 ml 5% haematocrit IE cultures were washed once 
with RPMI-1640 in a 15 ml centrifuge tube. The washed pellet of cells were 
resuspended in a 5 ml of Plasmagel pre-warmed to 37°C and the tube incubated 
upright at 37°C for 15-20 minutes or until a clear layer of late stage IE erythrocytes 
was evident above the sediment of uninfected and ring stage parasites. The upper 
layer of lEs was carefully transferred to a fresh tube and washed twice with 10 ml of 
RPMI-1640. 
7.1.5 Selection of P. falciparum infected erythrocytes for adhesion to 
CSA 
CSA binding was maintained by panning late stage infected erythrocytes on bovine 
tracheal CSA (Sigma) immobilized on polystyrene Petri dishes (Falcon) essentially 
as described by Chaiyaroj et al. (1996). 2 ml of CSA (10 tg/m1) prepared in PBS (pH 
7.2) was adsorbed onto 2.5 cm diameter petri dishes (Falcon) overnight at 4°C. 
Immediately prior to panning CSA was removed from the dishes and overlaid with 
2 ml of 2% BSA (essentially immunoglobulin free; Sigma) prepared in PBS to block 
non-specific protein binding site. Dishes were blocked for 30 minutes at RT. 
Following the removal of this blocking solution, late-stage parasites, suspended in 
2m1 of complete RPMI-HEPES medium (generally 8-10 17o parasitaemia, 57o' 
haematocrit), were added to the Petri dish. Parasites were incubated with the 
immobilised receptor for 1 hr at 37 °C with occasional agitation. Then unbound 
cells were removed by four gentle washes with incomplete RPMI-HEPES medium. 
Bound lEs were cultured with 2m1 of complete RPMI-HEPES medium and 50 itl of 
packed erythrocytes for 20- 24 hours at 37 °C in an atmosphere of 967o nitrogen, 37o 
carbon dioxide and 1% oxygen. Ring stage infected erythrocytes were removed 
form the dishes the following day and returned to standard culturing conditions. 
The maximum time interval between panning was two weeks but on averaged was 
performed weekly. Prior to protease treatment and analysis by flow cytometry, 
cultures were synchronised at least twice by sorbitol treatment. 
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7.1.6 Binding assays 
Human umbilical cord hyaluronic acid (Sigma) and bovine trachea CSA (Sigma) 
were used at a concentration of 10 .tg/ml in PBS (pH 7.2). 20 tl of each receptor was 
spotted in triplicate onto 5 cm diametei petri dishes (Falcon). Receptors were 
adsorbed onto the plastic petri dishes overnight at 4°C. 10 .tg/ml BSA in PBS was 
similarly adsorbed as a negative control. Plates were then blocked by removing the 
receptor solution and adding 20 tl of 2% BSA in PBS. Following the removal of this 
blocking solution, late-stage parasites, suspended in 2m1 of complete RPMI-HEPES 
medium (8-10% parasitaemia, 57o haematocrit), were added to the petri dish. 
Parasites were incubated with the immobilised receptor for 60 minutes at 37 °C with 
occasional agitation. Unbound cells were removed by four gentle washes with 
incomplete RPMI-HEPES medium; bound cells were fixed with 0.57o (vlv) 
glutaraldehyde in PBS for 10 minutes and Giemsa stained. Bound cells were 
assayed by light microscopy. Protease treatment of intact cells was carried out as 
described in section 7.1.7. 
7.1.7 Cell surface protease treatment 
Protease treatment of infected erythrocytes was carried out as previously described 
(Chaiyaroj et al., 1996). Samples, containing 3 x 106  cells from sorbitol-treated late-
stage cultures of 8-10 % parasitaemia were washed twice with phosphate-buffered 
saline (PBS; pH7.2) and then incubated with the appropriate concentration of 
trypsin-TPCK (Worthington Biochemicals) or pronase (Boehringer-Marinheim) in a 
final volume of 1.0 ml in PBS, for 10 minutes at 37 °C. The reaction was terminated 
either by adding soybean trypsin inhibitor (Worthington Biochemicals) to a final 
concentration of 1 mg/ml or by adding 107o human serum. Cells were washed 
twice with PBS before further use. 
7.2 Fluorescence activiated cell sorting 
7.2.1 Plasma donors 
Serum samples from 20 men living in a malaria endemic region of Ghana were 
pooled to produce the male serum pool. Serum samples collected at the time of 
birth from the placentae of 15 women living in a malaria endemic region of Ghana 
were pooled to produce the pregnant female serum pool. This pool included five 
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primigravidae, nine secundigravidae and one multigravid woman. Serum samples 
from six Scottish malaria naïve individuals were pooled and used as a control. 
7.2.2 Analysis of VSA specific antibodies by flow cytometry 
Flow cytometry was used to measure the levels of plasma IgG binding to the VSA of 
late stage parasites essentially following the method previously described by 
Staalsoe et al (1999; 2001). 3 x 106  cells from late stage P. falciparum cultures of 8-10 % 
parasitaemia were washed twice with PBS. Cells were incubated sequentially with 
plasma antibodies diluted 1:20 in PBS, goat anti-human IgG diluted 1:200 in PBS 
(Dako Cytomation) and fluorescein isothiocyante (FITC)-conjugated rabbit anti-goat 
(Dako) diluted 1:25 in PBS. All incubations were in a total volume of 100 t! for 30 
minutes at room temperature and were followed by two washes with 1 ml of PBS. 
Samples were analysed immediately on a FACSCAN apparatus (Becton-Dickinson). 
FITC fluorescence due to cell surface antibody recognition was determined for 5000-
10000 ethidium bromide gated infected erythrocytes. 
7.2.3 Statistical analysis 
Statistical analyses were performed using Analyses of Variance in Minitab 13.30 
(Minitab Inc.), using protease, protease concentration and serum pool as 
explanatory variables. Statistical models were tested for homogeneity of variance 
and normality of error distributions. Where possible, maximal models with 
interactions between these variables were fitted first, after which models were 
minimised by removing non-significant (p>0.05) terms. 
7.3 BiOtinylation and cell fractionation 
7.3.1 Labelling of surface proteins using sulpho-NHS-LC-biotin 
The lyophilised sulpho-NHS-L-biotin label was stored in sealed aliquots to 
minimise exposure to air and hydrolysis. Labelling of proteins with sulpho-NHS-
LC-biotin is efficient at a broad range of label concentrations and temperatures 
within a pH range of 7-9. Parasite cultures were washed with PBS (pH7.2) and 
transferred to eppendorf tubes. Cells were either treated or mock treated with 
proteases as described in section 7.1.7. Cell surface labelling was carried out simply 
by estimating the pack cell volume and resuspending the cells in 10 volumes of PBS 
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(pH7.2) containing 0.5 mg/mi sulpho-NHS-LC-biotin. Intact cells were incubated 
with the biotin label at RI with gentle agitation for 30 minutes and then washed 
twice with 1 ml of PBS (pH7.2). 
For surface biotinylation in the presence of furosamide the pack cell volume of 
washed cells was estimated and the cell pellet resuspended in 10 volumes of 100 
mM furosamide in PBS supplemented with 0.6 mM CaCl2  and 1 mM MgC12 (PBS-2). 
Cells were incubated in furosamide for 1 minute before adding sulpho-NHS-LC-
bioin to a final concentration of 0.5 mg / ml. Cells were incubated at RI with gentle 
agitation for 30 minutes in the presence of biotin and furosamide. Cells were 
pelleted and resuspended in PBS-2 100 mM glycine. Cells were then washed with 
PBS-2 alone. 
7.3.2 Detergent extraction of proteins 
Cells were washed twice with PBS and transferred to 1.5 ml eppendorf tubes prior 
to lysis on ice with 5 volumes of a solution 150 mM NaCl, 5 mM EDTA, 50 mM tris 
pH8.0, 17o triton-X100 (w/v) and a commercially available protease inhibitor 
cocktail (Complete mini, Roche). The cell lysates were centrifuged at 13 000 rpm in 
a microcentrifuge at 4°C for 10 minutes, the supernatants containing triton-X100 
soluble (IS) fractions were removed to a fresh tube and the triton-X100 insoluble 
pellet resuspended in a solution containing 20 mM tris-HC1 pH 8.0, 150 mM HC1, 
27o (w/v) SDS and a protease inhibitor cocktail (Complete mini; Roche). The 
solubilised TI fraction was pipetted up and down several times to disrupt the 
parasite DNA and the samples centrifuged at 13 000 rpm in a microcentrifuge at 4°C 
for 10 minutes. The SDS soluble TI fraction was transferred to a fresh tube and 
stored at —30 °C. 
7.3.3 Membrane fractionation by osmotic lysis 
Cells were washed twice withPBS and transferred to 1.5 ml eppendorf tubes prior 
to lysis with 10 volumes of a ice-cold solution of 5 mM Na 2HPO4 (pH 8.0) containing 
protease inhibitor cocktail (Roche) (Olivieri et al., 2001). Cell lysates were 
centrifuged in a benchtop microfuge at 13 000 rpm for 10 minutes at 4°C. The 
supernatant was removed and the fluffy layer of erythrocyte membranes removed 
to a fresh tube. The remaining pigmented pellet was either discarded or stored 
directly at - 30°C. The membrane fraction was washed twice with 1 ml of ice-cold 
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5P8 containing a protease inhibitor cocktail (Complete mini Roche) prior to storage 
at —30°C. 
7.3.4 Nuclease treatment of pigment containing fraction 
The pigmented pellet was cleared by resuspending it in 60 tl of bugbuster protein 
extraction reagent (Novagen), a recommended buffer for the genetically engineered 
endonulease from Serratia marcescens, benzonase (Novagen). 30 units of the 
endonuclease were added to each reaction (Novagen). Benzonase is highly active at 
RT such that nuclease treatment could be carried out swiftly (15-30 minutes) at RT. 
Thus avoiding higher temperatures and longer incubation periods at which 
proteolysis would be favoured. The tubes were briefly vortexed 3 times during the 
reaction. 
7.4 SDS-PAGE and Western blotting 
7.4.1 Protein assays 
Protein concentrations were determined using a commercially available detergent 
compatible protein assay kit (Biorad, Hercules, CA, Catalogue number 500-0114) in 
• a microtitre plate following the manufacturers protocol. 
7.4.2 2D SDS-PAGE 
Prior to isoelectric focusing, 25 il aliquots of triton-X-100 insoluble extracts that had 
been solubilised with 2% SDS (w/v) were dialysed against 50 ml of 7M urea 
(Sigma), 2 M thiourea (Sigma) overnight at 4°C. Considering the initial protein 
concentration for each extract an appropriate volume to load 100 tg of protein per 
immobilised pH gradient strip was combined with strip rehydration buffer such 
that the final constituents were 7 M urea, 2 M thiourea, 27o 3-[3-Cholamidopropyl) 
dimethylammonioj-1-propanesulphonate (Amersham), 65 mM. DTE (Sigma), 0.87o 
resolytes pH 4-7 (Amersham), 17o triton-X100 (Amersham) and a trace of 
bromophenol blue (BDH), in a final volume of 125 d. Likewise, 125 g of triton-
X100 soluble extract was combined directly with strip rehydration buffer to a final 
volume of 125 .t1. Extracts were incubated with rehydration buffer for 1 hour at RT. 
Protein samples were then loaded onto immobilised immobiised pH gradient (IPG) 
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strips (7 cm; pH 4-7; Amersham) via the cup loading method. Proteins were 
separated by virtue of their p1 using the conditions described in Table 7.1. 
IPG strips were equilibrated directly for SDS-PAGE or stored at —70°C until directly 
prior to SDS-PAGE. A primary equilibration step with 2 ml of 1.5 M tris, pH 8.8, 6 
M urea, 30% glycerol (vlv) (Sigma), 2% (w/v) SDS (Sigma), a trace of bromophenol 
blue and 1% DTE, was carried out for 15 minutes at RT. A second step followed as 
the first except for 15 10 DTE was replaced with 47o iodoacetamide (Sigma). 
Equilibrated IPG strips were then loaded onto pre-cast 4-127o bis-tris gels with the 
appropriate 2D well format (Invitrogen). Loaded IPG strips were overlaid with 0.8 
ml of molten 17o agarose prepared in SDS-PAGE running buffer containing 50 mM 
MOPS, 50 mM tris-base, 0.1% SDS (w/v) and 1 mM EDTA (pH 7.7). After the 
agarose had hardened pre-stained precision protein molecular weight markers 
(Biorad) were loaded into the designated marker lane and gels were ran at 100 V 
until the dye front arrived at the foot of the gel. 
Table 7.1: Optimised conditions for IPG strips 
Tables shows the conditions used for isoelectric focusing on an Ettan lPGphor isoelectric 
focusing apparatus (Amersham). 
Step Parameter Voltage (V) Time (hours) 
1 Gradient 500V 0.1 
2 Gradient 4000V 2.5 
3 Step and hold 5000V 1.5 
7.4.3 1 D SDS-PAGE 
SDS-PAGE was performed using the NuPAGE precast gel system initially to allow 
greater reproducibility for 2D SDS-PAGE, however due the reliability of the 
gradient gels this system was subsequently used routinely. Bis-tris gradient gels 
were run using a buffer containing 50 mM 3-Morpholinopropanesulphonic acid, 50 
mM tris-base, 0.1% SDS (w/v) and 1 mM EDTA (pH 7.7). A buffer containing 2.5 
mM tricine, 2.5 mM Iris base, and 0.005 % SDS (pH8.24) was used for tris-acetate 
gradient gels. Samples were prepared using a 4X SDS sample buffer containing 106 
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mM tris-HC1, 141 mM tris-base, 27o SDS (w/v), 10% glycerol, 0.51 mM EDTA, 0.22 
mM SERVA® Blue G250, 0.175 mM phenol red (pH 8.5) and 2.87o 3-
mercaptoethanol. Samples were incubated at 90 °C for 10 minute and then 
centrifuged briefly prior to loading. Proteins were separated at 150V for -.1 hour. 
Pre-stained precision protein molecular weight markers (10-250 kDa; Bio-rad) were 
used throughout. 
7.4.4 Western Blotting 
Electrophoretic transfer of proteins from SDS-PAGE gels to Westran ® 
polyvinylidene difluoride (PVDF; Schleicher & Schuell BioScience) membrane was 
performed at 30 V for one hour at RT using a transfer buffer containing 1.25 mM 
bicine, 1.25 mM bis-trs, 0.05 mM EDTA (pH 7.2) and 10 % methanol (BDH). Prior 
to transferring the PVDF membrane onto the gel the membrane was soaked in 100% 
methanol for 5 seconds. Since biotin is present in commonly used biological 
blocking reagents such as dried milk and bovine serum albumin, a number of 
alternative blocking reagents were tried for western blotting with HRP-conjugated 
streptavidin. A commercially available blocking reagent from QIAGEN was found 
to be the most suitable. Unless otherwise stated, this blocking reagent was used for 
all western blots presented in this thesis. Blocking was performed for between 1 
hour and overnight at RT, using a solution of the QIAGEN blocking reagent pre-
heated to 70°C and cooled to RT. HRP-conjugated streptavidin was added directly 
to the blocking buffer to a final concentration of 0.02 tg/m1 and incubated for 1 
hour at RT. Blots were washed twice with PBS/0.1% tween-20 and once with PBS 
alone prior to processing the blot with an enhanced chemiluminescence (ECL) 
detection kit (Amersham). Chemiluminescence was detected using Hyperfilm 
ECL (Amersham). 
The affinity purified anti-ATS (1:000), anti-PfCRMP1 and anti-PfCRMP2 rabbit sera 
were detected using peroxidase conjugated ImmunoPure® Recomb® protein A 
(Pierce Biotechnology) diluted in QIAGEN blocking reagent to a final concentration 
of 2.5 jg/ml. 
7.4.5 Stripping antibodies from PVDF membrane 
Western blots were incubated for 30 minutes at 50°C with agitation in a solution of 
62.5 mM tris-HC1 (pH6.7) containing 2 % SDS (wlv) and 100 mM 3- 
mercaptoethanol. Blots were then washed twice with copious amounts of PBS/0.17o 
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tween-20 for 20 minutes and either immediately blocked prior to re-probing or 
stored at 4°C in PBS/0.1% tween-20 in a sealed polythene bag. 
7.5 MALDI-TOF 
7.5.1 Mass spectrometry compatible silver-staining 
Proteins resolved using SDS-PAGE were stained with silver by sequential 
incubations in the following solutions at RT for the times stated: (1) 407o ethanol 
(BDH) /10% acetic acid (BDH) for 30 minutes; (2) 307o ethanol / 160 mM sodium 
thiosulphate (Fluka) / 490 mM sodium acetate (Fluka) for 30 minutes; (3) three times 
5 minute incubations in distilled water; (4) 15 mM silver nitrate (Fluka) for 20 
minutes; (5) two times 1 minute incubations in distilled water; (6) 236 mM sodium 
carbonate (Sigma)/0.75% (w/v) formaldehyde (BDH) for 2-5 minutes or until 
protein spots visible; (7) 10 minutes in 40mM ethylenediaminetetraacetic acid 
(N2.2H20) (Sigma). Following staining gels were stored at 4 °C in distilled water. 
7.5.2 In-gel trypsin digest protocol (York) 
Protein spots excised from silver-stained gels were transferred to 1.5 ml eppendorf 
tubes and destained using 100 .tl of Farmer's reducing agent (1:1 (v:v) 20% sodium 
thiosulphate and 17o potassium ferricyanide). Gel pieces were washed thrice for 20 
minutes in 100 [Al of 20m mM ammonium bicarbonate/50% acetonitrile (BDH) at 
RT. A Speed Vac was used to dry the gel pieces for 15 minutes using a medium 
drying rate. To dried gel pieces, 10 l of 0.02 pg/il sequencing grade modified 
porcine trypsin (Promega) in 20 mM ammonium bicarbonate/ 0.17o octyl-3-D-
glucopyranoside was added and gel pieces allowed to swell for 10 minutes. 20 .tl of 
20 mM ammonium bicarbonate/0.1% octyl-3-D-glucopyranoside was then overlaid 
over the gel pieces and incubated at 37 °C overnight. The supernatants were 
removed and a fraction stored at -70°C. The gel pieces were washed twice with 50% 
acetonitrile and the washes combined with the remainder of the supernatants and 
dried in a speed vac and stored at —70°C. A fraction of the tryptic digests were used 
directly for MALDI-TOF analysis, whereas the remainder, that had been dried, was 
resuspended prior to analysis and desalted following the procedure described in 
section 7.5.4. 
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7.5.3 SIRCAMS in-gel trypsin digest protocol 
Silver stained proteins resolved by SDS-PAGE were excised from the gel and 
destained. Gel pieces were then washed twice with 100 .tl 50% acetonitrile (BDH) 
for 5 minutes at RT and dried in a Speed Vac using a medium drying-rate for 15 
minutes. 
For proteins resolved by standard one-dimensional (1D) SDS-PAGE, reduction and 
alkylation steps were included prior to trypsin digestion. Dried gel slices were 
covered with 15 .tl of 10 mM dithiothreitol (DTT; Sigma)/0.2% EDTA (w/v) in 100 
mM ammonium bicarbonate (Sigma) and incubated at 56 °C for 30 minutes. This 
solution was then removed and 50 tl of 50 mM iodoacetamide (Sigma) in 100 mM 
ammonium biocarbonate was added. The gel pieces were incubated at RT in the 
dark for 30 minutes. This solution was then removed from the gel pieces. Gel slices 
were washed with 200 tl 100 mM ammonium bicarbonate for 10 minutes and then 
dehydrated by incubating the gel slice twice in 200 RI neat acetonitrile for 10 
minutes. Gel slices were dried as described earlier. Trypsin digestion of washed 
and dried protein spots from 2D SDS-PAGE or reduced and alkylated protein spots 
from 1D SDS-PAGE were carried out as described in section 7.5.2 with the omission 
of octyl-f3-D-glucopyranoside. 
7.5.4 Peptide desalting and application to MALDI plate 
Tryptic peptides were desalted using a 10 l C18 zip-tip (Millipore) and a PlO 
pipette (Gilson). Briefly, a C18 zip-tip was washed twice with 10 il elution buffer 
(1:1 water: 0.17o formic acid in acetonitrile) and then twice with 10 ixl 0.17o formic 
acid before sample loading. Tryptic digest reactions were loaded onto the zip-tip by 
aspirating the sample up and down 10 times and then washing twice with 10 tl of 
0.1% formic acid. Finally, desalted peptides were eluted from the zip-tip with 10 JAI 
elution buffer. Samples were either analysed by MALDI-TOF directly or stored at 
-30 °C. For each sample, 0.7 p.1 of a saturated solution of a-cyano-4-
hydroxycinnamic acid in 507o acetonitrile / 0.3% trifluroacetic acid was placed onto a 
spot of a 100 well stainless steel MALDI plate (Applied Biosystems) and 1.5 p.1 of 
desalted tryptic peptide solution overlaid. 
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7.5.5 SIRCAMS MALDI-TOF data acquisition 
Mass spectra were acquired using a Voyager DEtmSTR MALDI-TOF instrument - 
(Applied Biosystems) with an accelerating voltage of 20000V. For each acquisition 
200 shots were fired using a laser intensity of between 2069 - 2200V. The acquisition 
mass range was set to 800-3000 Da. Spectra were processed manually using Data 
Explorer software. Isotopic peaks were converted into their monoisotopic peak. 
Initially peak detection was set to 07o maximum peak area and then each spectrum 
was split into segments to set an appropriate baseline to allow detection of the 100-
200 most intense peaks per spectrum. Trypsin autolytic peptides were used to 
calibrate each spectrum independently. The resulting mass lists were searched 
against the National Centre for Biotechnology Information non-redundant (NCBInr) 
database via two proteomics web interfaces, MASCOT and MSFIT. 
7.5.6 York MALDI-TOF data acquisition 
An Applied Biosystems 4700 Proteomics Analyzer MALDI-TOF / TOF instrument 
was used to acquire tandem MS data. Calibration was set, prior to acquiring data 
for a plate, using a standard mixture of peptides. For each acquisition 500 shots 
were fired with a laser intensity of between 2000 - 3000V for MS1. The 10 most 
abundant peptides for each tryptic digest from the first round of MALDI-TOF were 
selected for MS2. Spectrum processing was automated and involved steps to 
deisotope and detect peaks over a 2% maximum peak area cut off. Batch MSMS 
data was searched against the NCBInr database using the web interface MASCOT 
(www.matrixscience.com) or MSFIT (http: / / prospector.ucsf.edu ). 
7.5.6 Database mining 
The MSFIT and MASCOT database searching interfaces both score the likelthood of 
a list of tryptic peptides being derived from predicted protein sequences in 
sequence databases using a MOWSE score (Pappin et al., 1993). A MOWSE score is 
a scoring method analogous to c-value assigned to a hit derived through BLAST 
searching sequence databases with a nucleic acid or protein sequence. Although, 
MSFIT and MASCOT use the same scoring systems the numerical value assigned to 
a score is on a different scale. A MSFIT score of over io a MASCOT score of over 50 
is considered a significant hit although the significance may be interpreted 
differently depending on the size of the database. For database searching using 
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spectra from tryptic digests the mass list was searched against all species in the 
NCBInr database. Allowed modifications were the' oxidation of methione and 
acrylamide modifications of cysteines. The maximum number of miscleavages was 
set at 1 and miscleaved peptides were given a pFactor of 0.4. 
7.6 Anti-ATS antibody purification and characterisation 
7.6.1 Immunisation protocol for anti-peptide antibody 
Two New Zealand white rabbits were immunised with the PfEMP1 ATS peptide 
(DITSSESEYEELDINDIC), conjugated to the carrier protein keyhole limpet 
hemocyanin (KLH), using the following schedule. Pre-immune serum was 
collected on day 1 of the immunisation schedule when the rabbits were immunised 
with 200 ig of KLH- peptide conjugate in Complete Freund's Adjuvant. Five 
further immunisations with 100 .tg of KLH-peptide conjugate in Incomplete 
Freund's Adjuvant were carried out with 7-day intervals, starting on day 14. 5 ml 
test bleeds were taken on days 35, 49, 70 and 77. Final bleeds of approximately 85 
ml were taken on day 79. Sera were divided into aliquots and stored at —30°C. The 
peptide was synthesised and immunisations carried out by Sigma Genosys. 
7.6.2 Affinity purification and biotinylation of anti-ATS antibody 
To affinity-purify immune sera against the immunising peptide, the peptide was 
covalently immobilised to a SulphoLink ® column (Pierce Biotechnology) via the 
sulfhydryl group of the carboxyl terminal cysteine residue. This column contains 67o 
cross-linked beaded agarose. 5 mg of peptide was conjugated to a 1.5 ml 
SulphoLink®  column following the manufacturer's instructions. Briefly, the peptide 
was resuspended in 1 ml of the sample preparation buffer provided, to which 2-
mercaptoethylamineHCl was added to a final concentration of 50 mM. This 
solution was incubated at 37°C for 1.5 hours and then allowed to cool to RT. The 
reduced peptide was applied to a PlO desalting column (Amersham) that had been 
equilibrated with 25 ml SulfoLink ® coupling buffer (5 mM EDTA disodium salt/tris 
(hydroxymethyl aminomethane). 3.5 ml of SulfoLink® coupling buffer was then 
added to the column and the peptide collected in a 3 ml fraction after discarding the 
first 0.5 ml of flow through. 
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The reduced and desalted peptide was then applied to a SuiphoLink ® column that 
had also been pre-equilibrated with SulfoLink ® coupling buffer. The column was 
rocked for 15 minutes at RT and allowed to stand for 30 minutes. 6 ml of coupling 
buffer was used to wash the column and free binding sites blocked by applying 2 ml 
of 0.05 M L-cysteine. The column was rocked for 15 minutes at RT, allowed to stand 
for 30 minutes and then washed with 12 ml PBS (pH 7.2). 
Immune sera in 1.5 ml aliquots were affinity-purified on the peptide column by 
incubating the sera on the pre-equilibrated column for 1 hour at RT. The flow-
through was collected and the column washed with 12 ml of PBS (pH7.2). 
Immunoglobulins were eluted by applying 4 ml ImmunoPure® IgG elution buffer 
(Pierce) and were collected in a 3 ml fraction after discarding the first 1 ml. To each 
1 ml of eluent, 50 RI of 1 M Tris, pH 9.5, was added to neutralise the acidic elution 
buffer. The affinity-purified immunogiobulins were buffer-exchanged into PBS (pH 
7.2)10.057o (w/v) sodium azide, and volume reduced to - 0.3 ml, using a 6 ml 
Vivaspin column with a 10 kDa cut off. The average immunoglobulin yield was 0.3 
mg/mi. 
7.6.3 Immunofluorescence assay 
Small aliquots (-10 i) of parasite culture at 50 % haematocrit and 107o' parasitaemia 
were smeared directly onto glass microscope slides (60 mm x 20 mm). Air dried 
smears were immediately fixed by immersion in using ice cold 27o 
paraformaldehyde (Sigma)/PBS (pH7.2) for 5 minutes and then immersion in 907o 
methanol! 107o' acetone (BDH) for 2 minutes at RT. Using a glass pen a 1 cm 2 square 
was scored within the smear and the surrounding cells removed gently with a 
tissue. Slides were air dried once more and pre-equilibrated by overlaying 100 j.tl of 
(Sigma) PBS/0.17o tween-20 and incubating the slides in a humidity chamber for 15 
minutes at RT. All antibody dilutions were made with 5% donkey 
serum/PBS/0.17o tween-20 in a final volume of 100 il and incubations were for one 
hour in a humidity chamber at RT. Following antibody incubations slides were 
washed by immersion in a staining trough containing 100 ml of PBS/0.1% tween-20, 
for 10 minutes at RT, with gentle agitation, this was repeated twice more with buffer 
changes. Primary whole rabbit serum was diluted 200 fold and affinity purified 
rabbit sera 50 fold. The secondary rhodamine red-x-conjugated affinity purified 
donkey anti-rabbit IgG (Jackson Laboratories) was diluted 200 fold. Following the 
final antibody incubation and washes slides were overlaid with 100 111 of 0.1 pg/ml 
4',6-diamidino-2-phenyiindole (DAPI)! PBS/0.1% tween-20 for 5 minutes and then 
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were washed once with PBS prior to mounting. Slides were mounted by overlaying 
one drop of Vectashield mounting medium (Vector Laboratories) and a 22 mm x 22 
mm coverslip. Coverslips were sealed with nail varnish. Immunofluorescence was. 
observed using an Olympus BX-50 microscope. Images were captured with a 
digital camera and OpenLab software. 
7.6.4 Peptide enzyme linked immunosorbent assay 
Wells of a 96-well plate (Immunolon4, Dynatech) were coated with either 200 tg of 
ATS peptide in 100 .tl coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.3) or 
coating buffer alone and incubated overnight at RT while shaking. Wells were 
washed three times with 200 tl washing buffer (PBS/0.05% tween-20) using a plate 
washer and all subsequent washing steps were carried out in this manner. 
Unoccupied protein binding sites were blocked by applying 200 ill of blocking 
buffer (1% Immunoglobulin free BSA (Sigma)/PBS/0.1% tween-20) per well and 
incubating the plate at RT for 2 hours. The plate was then washed. Serum and 
affinity purified immunoglobulin dilutions were prepared with blocking buffer, 100 
tl of which were applied to the appropriate wells, and incubated at RT overnight. 
The plates were washed prior to applying 200 .tl of a 2000 fold dilution of HRP-
conjugated goat anti-rabbit Ig antibody (DAKO Cytomation). The secondary 
conjugate was incubated on the plate for 2 hours at RT and washed once more 
before developing the plate with 0-phenylenediamine dihydrochloride (OPD) 
(Sigma). A solution containing 10 mg of OPD dissolved in 35 ml of 17 mM citric 
acid/37 mM Na2HPO4 /297o' H202 was prepared and 100 .tl applied and incubated 
for 30 minutes at RT before stopping the reaction with 25 .t1 of 2.0 M H2SO4- 
Absorbance was measured at 492 nm. 
7.6.5 Bioti nylation of anti-ATS immunoglobulins 
2 mg of affinity purified anti-ATS immunoglobulins were labelled in 1 ml of PBS 
(pH 7.2) containing 0.3 mM sulpho-NHS-LC-biotin. Using this molar ratio of IgG to 
label was anticipated to result in 8 or more biotin molecules pre IgG molecule. The 
reaction was carried out at RT for 30 minutes. The immunoglobulins were then 
buffer exchanged into PBS alone and concentrated to 0.04 mg/ml using a 6 ml 
vivaspin column with a 10 kDa cut-off. 
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7.7 P. chabaudi, infections, isolates and culture 
7.7.1 P. chabaudi isolates 
The AS P. chabaudi clone used in this study was cloned by serial dilution of isolates 
from wild-caught thicket rats of the species Thamonmys rutilans (Beale et al., 1978). 
The CWOpre clone had been recently derived from Thamnomys rutilans and, 
therefore, had recently undergone mosquito transmission (Mackinnon & Read, 
1999). CWApre and CWVpre were derived from the CWOpre clone, but had 
undergone many serial blood passages through C57B1/6J mice. Blood was 
passaged on day 12 post-infection for 12 passages. During these passages parasite 
clone CWVpre was selected for high virulence and CWApre for low virulence. 
Virulence was defined by weight loss in the mouse (Mackinnon & Read, 1999). 
CWApre and CWVpre also underwent a further 11-13 passages on days 5-8 post 
infection for routine purposes prior to this experiment (Mackinnon & Read, 2004a). 
CWApre, CWOpre and CWVpre were transmitted through Anopheles stephensi 
mosquitoes and the parasites isolated from C57B1/6J mice infected by these 
mosquitoes were designated CWApo, CWOpo and CWVpo. 
7.7.2 AS infections and collection of parasites 
P. chabaudi infected erythrocytes were obtained from infected CBA mice which had 
been used for mosquito feeds for the purpose of an independent long term 
transmission experiment. Two uninfected mice and two mice inoculated with AS 
parasites were sacrificed 7 days post infection. The two AS infected mice and one 
control mouse had been anaesthetised and exposed to bites from Anopheles stephensi 
mosquitoes prior to sacrifice. For the purpose of the transmission experiment for 
which these mice were originallyinfected one control-uninfected mouse was not 
exposed to mosquito bites. The asexual parasitaemia of the AS infected mice was 
40-45 %. Mice were bled at 4 pm and the blood from each mouse cultured for 6 
hours to allow late-ring stage parasites to mature. The four cultures were then 
processed for surface biotinylation and membrane extraction as described below. 
The integrity of the lEs was confirmed following surface biotinylation by 
microscopy of Giemsa stained blood smears. 
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7.7.3 CW infections and collection of parasites 
Six groups of four female C57B1/6J mice aged between 4 and 8 weeks were 
inoculated with 105 parasites per mouse. All mice in each of the 6 groups were 
infected with one of the following isolates, CWApre, CWOpre, CWVpre, CWApo 
CWOpo, and CWVp0. At various time points on days 6-7 post-infection, 
experimental mice and 6 uninfected control mice were sacrificed. Parasitaemias 
ranged from 15-40%. 2 mice from each group plus a control mouse were sacrificed 
in the morning and bled immediately to obtain ring stage lEs. The serum was 
removed following centrifugation of the blood and the ring stage lEs and control 
samples were processed directly for surface biotinylation and membrane extraction. 
The remaining 2 mice in each group were bled in the afternoon immediately after 
sacrifice and the blood from each mouse, following the removal of serum, was 
cultured overnight to allow late-ring stage parasites to mature into schizonts. 
Overnight cultures were processed between 8-9 am for surface biotinylation and 
membrane extraction as described below. 
7.7.4 Short-term in vitro culture of P. chabaudi 
Mice were sacrificed using a CO 2 chamber and cardiac blood was then collected 
using a x gauge needle and 1 ml syringe containing 0.1 ml of citrate saline. Blood 
was transferred into 1.5 ml eppendorf tubes and cells sedimented by centrifugation 
at 2 500 rpm in a microcentrifuge. Serum was removed and cells from one mouse 
cultured with RPMI 1640 medium containing 25 mM HEPES, supplemented with 20 
mM glucose, 2 mM glutamine, 25 !.tg/ml gentamycin and 107o normal mouse serum 
(heat inactivated at 56 °C for 30 minutes; Sigma). The pH of the medium was 
adjusted to between 7.2 and 7.4 with 1 M NaOH. Cultures were set up at 57o 
haematocrit and gassed with 967o nitrogen, 37o carbon dioxide and 17o ' oxygen. The 
length of culture was dependent on the experiment. 
7.7.5 Biotinylation of P. chabaudi lEs 
Cell surface biotinylation of P. chabaudi lEs was carried out as described in section 
6.3.1. Prior to labelling with biotin, cells were washed with once with RPMI 1640 
medium and then PBS. 
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Appendix 1: Source of enzymes, immunoglobulins and non-
standard reagents 
Reagent Supplier Catalogue Number 
FACS 
Goat anti-human IgG DAKO cytomation A0473 
Rabbit anti- goat FITC DAKO cytomation F0250 
IMMUNOFLLJORESCENCE 
ASSAY/E LISA  
Rhodamine 	R e dTMXconjugated 
AffiPure donkey anti-rabbit IgG 
(H+L)  
Jackson ImmunoResearch 711-295-152 
Donkey Serum Sigma D 9663 	- 
Vectashield Mounting Medium Vector Labs H1000 
Peroxidase conjugated goat anti- 
rabbit immunoglobulins  
DAKO cytomation P0448 
2DGE 
Immobine dry strips pH 4-7, 7 cm Amersham 17-6001-10 
IPG resolytes, pH 4-7 Amersham 17-600-86 
IPG sample cups Amersham 80-6459-81 
PlusOne mini dialysis kit, 8 kDa 
cut off, 250 d volume  
Amersham 80-6484-13 
Ettan IPGphor cup loading strip 
holder  
Amersham 80-6459-62 
Immobline 	DryStrip 	reswelling 
tray, 7- 18 cm  
Amersham 80-6371-84 




ImmunoPure® Recomb® Protein 
A-peroxidase conjugated  
Pierce Biochemicals 32400 
Detergent 	compatible 	protein 
assay kit  
Blo-rad Laboratories 500-0114 
lmmunoPure Streptavidin-HRP Pierce/Perbio 21126 
QIAGEN-Blocking Reagent Qiagen 34460 
4-12 % NuPAGE Bis-Tris SDS- 
PAGE gels  
Invitrogen NP0322 
3-8 %Tris-Acetate SDS-PAGE 
gels  
Invitrogen EA03752 
Westran® PVDF Schleicher & Schuell 10413096 
Hyperfilm ECL 18x24cm Amersham RPN3103K 
ECL 	Plus 	Western 	Detection 
Reagent Kit  
Amersam RPN-2132 
Prestained Precision Plus Protein 
(10-250 kDa) 
Bio-rad Laboratories 161 -0372 
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Bugbuster 	protein 	extraction 
reagent  
Novagen 70584-4 
Benzonase endonuclease Novagen 70664-3 
MALDI-TOF 
P10 C18 Zip Tips Millipore ZTC18 S096 
Sequencing 	grade 	modified 
porcine trypsin  
Promega V5111 
Voyager stainless steel sample 
plate, 100 positions  
Applied Biosystems V700666 
MISCELLANEOUS 
Mouse serum Sigma S7273 
Trypin-TPCK Worthington Biochemicals LS003740 
Soya bean trysin inhibitor Worthington Biochemicals LS003570 
EZ-Link Sulpho-NHS-LC- biotin Pierce/Perbio 21335 
Pronase Roche 0165921 
PBS tablets, pH 7.2 Sigma P-441 7 
Complete mini protease inhibitor 
cocktail tablets  
Roche 1836153 
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Appendix 2: Lysine content of PfEMPIs and rifins 
Table 1: Lysine content of 20 PfEMP1 molecules 
SAP 
Number 
Protein ID Lysine number 
 (%) 
1 PFA0005w 239 (11.0%) 
2 PFA0765c 257(11.7%) 
3 PRB0010w 178(10.47o) 
4 PFB1055c 259(11.8%) 
5 PFD0625c 239(10.5%) 
6 PFD1235w 411(11.6%) 
7 PFD1245c 247(11.57o) 
8 PFD0615c 260(11.8%) 
9 PFD0995c 252(11.7%) 
10 PFD1000c 267(12.17,) 
11 PFD1005c 262(12.0%) 
12 PFD1015c 252(11.57,,) 
13 PFD0630c 235(10.2%) 
14 PFD0635c 237(10.2%) 
15 PFD0005w 307(11.6%) 
16 PFDO020c 394(11.4%) 
17 PFE0005w 243(11.07,) 
18 MAL6P1.316 323(11.27,) 
19 MAL6P1.252 295(12.3%) 
20 MAL6P1.1 252(11.3%) 
Average K content of 20 PfEMP1s = 10.84 
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Table 2: Lysine content of 20 rifin molecules 
SAP 
Number 
Protein ID Lysine number 
 (%) 
1 PFA0710c 37(11.5%) 
2 PFA0740w 37(10.17,) 
3 PFA0745w 31( 9.2%) 
4 PFA0760w 36( 9.5%) 
5 PFA0010c 31( 9.4%) 
6 PFA0020w 35( 9.47o) 
7 PFA0030c 35( 9.7%) 
8 PFA0040w 38(11.0%) 
9 PFA0045c 39(11.1%) 
10 PFA0050c 39(10.9%) 
11 PFA0080c 36( 9.8%) 
12 PFA0095c 35(10.2%) 
13 PFBOO15c 28( 8.4%) 
14 PFB1005w 33(10.47o) 
15 PFB1000w 27( 9.6%) 
16 PFB0060w 42(11.6%) 
17 PFB0055c 32(10.37,,) 
18 PFB1050w 31( 9.5%) 
19 B1O4Ow 36(10.4%) 
20 	±PFB1035w 32(10.07o) 
Average K content of 20 rifins = 10.17o 
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Appendix 3: Size distribution of 3D7 PfEMPIs 















Appendix 4: Alignment of 3137 truncated and/or pseudo var 
genes encoding the ATS of PfEMPI 
Part 1 
CBR_1_/_PPAD755 	1 ---------------------------------- -------------------------- 
CRR_1 3_I_PP 1. 3_D 1 ---------------------------------- -------------------------- 
CflP_1_/_PPOl_D1. 	1 ------------------------------------------------------------ 
CflR_5_/_PPB1625 1 ------------------------------------------------------------ 
Cfl_6_/_PPD1D25 	1 ------------------------------------------------------------ 
R_6_/_bAL6P1. 1 ------------------------------------------------------------ 
C_€_/_PPFDO3D 	1 ------------------------------------------------------------ 
CRP._t_/_PPDDD1D 1. ------------------------------------------------------------ 
CR_14_/_PPL4_D 361. 
Ck_12_/_PP1D96 	1 ------------------------------------------------------------ 
co.cn.u. 	 361 
cnR_1_/_PFAD155 	1. 
CBP_L 3_/_PPI 3_D 1. ------------------------------------------------------------ 
CnR_7_/_PPD1_D1. 	1 ------------------------------------------------------------ 
CBk_5_/_PPBI625 I 
cnR_4_/_PP01025 	1. ------------------------------------------------------------ 
CRk_5_/_b(AL6PI. I ------------------------------------------------------------ 
C_6_/_PPDO3D 	1. ------------------------------------------------------------ 
C_4_/_PPDDD10 I 
Cfl._14_/_PF14_0 421. B2REYTVGRERVGNAPAPCBtt&BEEERCEAATAPPXEPAQPA1DTESRIANE 
CBR_12_/_PPL094 	I ------------------------------------------------------------ 
aon.rn.u. 	 621. ------------------------------------------------------------ 
CRR_1_/_PFAD15S 	1 ------------------------------------------------------------ 
Cflk_13_/_PP1. 3_0 I --------- 
CnR_1_/_PPD1_DL 	1. 	----------------------------------- 
CflR_5_/_PFEL625 1 ------------------------------------------------------------ 
Cflk_t_/_PPDL 025 	1. 
Cfl_6_1_bCALGP1 I. ----- ------------------------(.SLAFPLSVGt ALVAA&SPL1R-- 
CRR_6_/_PPPDD3D 	1 ---------------------------------- bCMStAFPLSVGt ?A 	FI1-- 
C_6_/_PFDDD1.D 1. ---------------------------------------------------- FIPPPR--
CP.R_16_/_PL4_D 451 BA KPPEPVRIAQP1 PPPVPPNQSDQPTN,StSDI1SSILFPGEALA1TS I VPLPLRVE 
CP.._12_/_PPLD9t L ------------------------------------------ MItItVtY YEYVR 
aonseXIMUS 	 451. ------------------------------------------------ y-- 1. 
CRP_1_/_PPA0155 	I VKP&ITPGRTNLFLVEDRSBNS YXIPTTRkYVPllESGRCRTIEGEEDD- 
cnk_13_/_PPI 3_D 50 KKPNITSGITNLFB1JLPtSBNV 
C2R_1_/_PP 0 1_Ol. 	26 KKNITSGRTLPRVtDtPQND 
C2R_5_/_PP21625 1. ---------------------------------------------------- MEDYNY 
CR_4_/_PPD1D25 	1 --------------------K.s tE2SPNPDY&GKTYLYV&ERTDDY1Y 
CB_6_/_bCAL6P1 - 25 ---KPXPVD1LRV 
CB.R_6_/_PFPD03D 	25 --- UPRBPV0LLPV DrBXGDYGtPT1ESRNIGTGTtG1.SGDEPX 
CB._4/_PPDD010 8 ---&RPR ------------ LDYDLPTLSPNRYrTSGRGRRYrYLEGD$G'1D-- 
CUR_14_/_PPI4_D 541 
CB.k_12_/_PPL0t 	LP 
con.cn.u. 	 541. ---k-t ----- 
Ck_1_/_PPAo155 	60 tR2ISS01-$$E------- ELDLNDEGSFR&(F1.EVV1EPSRDIF1C 
CBR_13_/_PPI3_D 1.10 VRBSL-1,SSEE ------- BLDLND VGSFB.Y (F LEVV1EPLNDTPN1 
CRR_7_/_FP01_01. 	5 tRDLDLT-$SESE --------BLDLDEVSGSP7.Y {FLEVVLEP1DTPN 
CBR_5_/_PPB1625 1 VGD1SDIT- 	KE ------- -BFOtNDLYPYRSPJ-Y TLLEb(V1NPSS$ -TYD X 
CB._4_/_PPfl1D25 	31 YRDIS DtT-SBS!{RNWt1Mt tPt 	tKX*INCNQA RM 	YUT 1ItVWRI V 
CRR_6_/_bAL6P1. 62 APLTTDV-SS-RSE------- EK0rNDtVFDSPR TLtEVVL2PSGNN'TASG 
C2.R_G_/_PFFDO3D 	52 APMLTTDVT-S-K E --------E(DrNDIVPDSPY TLLEVV1BPSGNN'TA 
C2.R_4_/_PPDDD1D 51. GYTt'YD1T-SS B--------EDtNDtAPRAPJ.Y T1EEVV1EPSGNNTASD 
Ck_1t_/_PP1t_D 59 GTD 	I - j 	B ------- -EDINDtAPRAPRY TLEBVVLBPS N'1!TAG 
CR_12_/_PP1D94 	15 	MP0TTIIUF B--------BtDT---Z2VPR T11.EVVLEPB DTSGD 
acusensum 	 601. ifei-..DT-S. - ------- eeidiudiy--.pkyP.t1Levv1ep.-r-t--1- 
CRR_1_/_PPAD1S5 11.2 D 	 ILTDNE 	WYJDP 	I/rBtGAVPLb(SYXL 
CRR_13_/_PFI3_0 1.62 --------- G3TSTN----------J.TDNE WKDP 2QtM2tGAVPLtbCSYKL 
CR_1_/_PFD1_D1 136 --------- G1T$TN ------- ---RTDNE 	WQDP QYLLGSAVPLVSYL 
CUR_5_/_PPEIL25 	55 DIREDEIEDtDTT'N -------  
	
--- J.IDNE LRX1Y QYLUT------------
CRR_4_/_P701025 96 T --------- 2PSLNL ------- ---ELNGT1 NLR1 TYV2WtL1LMLLSLMtI 
CR_6_/_bCAL6P1. 133 NNTTASGRWrPDTDLQSDGLPSSILB0NE 	LXBP 	 PNDYSG 
CHR_6_/_PPF DO 30 133 NNTT*SGKB'rPLTND IQSDGLPSSI1.TDNE IRREP CLQQ----- 
CR_4_/_PPDD01D 103 N -------- TPTPP ------------ tTDNB 	LRBEP 	XSEQPKDVPBBG 
CNR_14_/_PFI.4_0 651 RN ------- TPSDQNDEQBDGLPSS&rTDNE LKLJBP N'CLQWtQN--TEPNM1GY 
CB.R_12_/_PPID96 125 --------- 1PDDT -------- PNZPTDNE 	LRRDP QE29VLP------DVPT 
661 ---------- p.-.t ----------- kitdnevNqlk-dfl .qyLtli------------- 
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Part 2 
CRR_1_/_PPAD155 152 It 	tP1IP LLWK&NL RQYXIDFL VINZ LII 	- IGIFET 
CRR_13_/PF13_D 203 It IXMP LLWMLNL RQIIDFL VINK LII-------tIPET 
CR_1_/_PPD7_D1. 111 It 	LFNLIP ILWMRNL 2QY&IDFL VINI LIE- ------ tGET 
CU_5_/_PP21 625 
CflR_6_/.FPDI.D25 131 	 ------ IGKPE 	tPPg 
CNR6_/_bCAL6PI. 188 -------- NITh(ST 
CNR_6_/_PFFDD3D 185 0tPFNTQPNTLFDNNqXPP tTtflIRDLYTG-ESY--------NENMSt 
CUR_6_/_PFDDDID 163 -------- 
CR_16_/_PF16_D 102 	DNNPRTiflG-MEERPPtTL2ERNIXTG-EBNY -------- -NMVNS- 
CU_12_/..PPLD6 162 2 PWrL2-MD2RPPtTStDRFLDTGH2ATYNpNWNtPENtNRTT 
121 -i-intqp-€1y----ckpfit.i-dr-Lv-g-e-1-y-1 ------ 
CRRI/_PFAD155 202 -----  LELPMLLRLLVLLEPI 	LLWTVtMM&CP IE &NNLEPNZL -- 
CRR_13_/._9P13_D 253 ------LTLPb(LLREIVYtLEPI I1WTVILLMb(LCPE1NtLEPN1J.I
CRk_l_/PPD1_DL 221 ------PHPCGFEJWNWLNFSX---------SPtNAQIRK IWNTY&KX -- 
CRR_5_/_FFEL 625 
CRR_6_/_PFD1D25 190 RELRI•ç3NYASSNDX GIDLLND1CGNN 	DtYDE14RRNELPVXTU1FNR 
CRR_6_/.MAL6FI 	236 -----DPXDJS-N 	GIDLINDTLS-GN IDttDRKENELFGTNRVXQrJ 
CRR_6_/_FFP 0030 236 -----DFIrJS-N GIDLI1HJ'flS-GN IDEYD2LRRKENELPGTNRVKQTSr 
CRR_6_/_PPD 0 010 1.59 -----UPLGK-NG'r Gt0LtNDTL-GN IDtDELL&RXENELPTNIIVRgT$ 
CUR_16_/..PPI. I_U Gt0LINDS1NGN EDrYDEV1RRXENELPGTNvKQ'r$.zn 
CXR_12_/..)PiD 96 21.8 -----DPXVKSN 	GBLINiKCDDI&NaIG2IENNLTNm--2T 
on.cn.u. 	 751 ----- 
CRR_1_/_PPAD155 255 	ENLRXRIVtI4VStCINGZtJE CA$GtT- RINYtNMNNGEXtMMVVIQVtVTX 
CRR_13_/_PF13_D 306 --1 	RXRIVII4vSICSINGIDL PEESGITSREYYENMKNGLNIMIECW ------- 
CRR_1_/_PPD1_D1 211 --SCRrRNtSRLRPVPMVRTRr# EKQVG------YtTIERbJRTR.SVG------- 
C2R_5_/_9P21625 
CRR_6_/_9PD1025 250 VATTDPtMNNLFRK$LDRRRDIYhGTtkKtCYtY.MXNGIWNtbcNXY ------- 
CRR_6_/_bCAL6P 1. 259 V £DPtflNQLEiFRIWLDRBL'MCEKLKNDNE LAXLK2E ETH.SGN-------
CRR_6_/_PPP DO 3D 289 VARNIT DFLRNQLKLFRKWLDRB.RDMCERLKNDNEIAXLREE NETRGN------- 
CRR_I_/_PPD 0 DID 262 VAKP LDPLRNQIELFRIWLDRDCEK$KNRnE 1911122 ETHSDN------- 
eRR_i 6_/._PP 1.6_U 802 vAKLTNSDPLRN ELPRXWLD RDgCEILZNDNE LAXILER ETRSGN ------- 
CRR_12_L)P1096 211 ZFNRVT$LWXNPLEN -------------------------------------------- 
MQUECUNUE 561. v-v.-tdpi-uqL1 flikir1drhrdick ------ k--------dn-t----------- 
CRR_i_/_FPAD1SS 312 G1RMF1,(X1IERNEWLWt2 WIV 	IWIR--------------------- I 
CRR_13_/_PFI.3_D 351 --- tRR MIF1XLR*1RIS1VQT tVM IPR--------------------- T 
CRR_1_/_PPD1_DL 316 ------ YT IRsrsNtyaYxrrs1TGNppFTTwIN--------------------- I 
CRR_5_/._9FE1625 
CUR_6_/_FPD1025 303 --WRRIIE1ttEI4XYtZIVT1ThVtlTfl1LN --------------------- I 
CRR_6_/_bCAL6PL 362 -------- 'rnPSN*TDSrQLUENPNFZNFN  --------------------- N 
CRR_6_/_PFPDD30 362 -------- TRpDsN$TNrDVrQIn$DwpIPINFN --------------------- N 
CRR_6_/_PFDDDID 295 -------- TRFSDNTNTDVStQIEDNPIFINQFT --------------------- N 
CRR_i 6_/_PP 1. I_D 855 -------- -RPS N*TLNTDS 
CHR_12_/_PPLD9I 
on.cn.u. 	 901 -------- 	i--- 1.-n----------------------------- 
CRR_i_/_PFAD 755 351 KNLPtYRKbCC- tbcbcMbcbTLLs4rYLwr r tZLYtlISLtIR(DRWNNNPIY 
CRR_i 3_i_PP 1 3_D 393 NSDCQISYLVVL-LTzrbal--CAgIYIWIRILMI --- gt IMWF1VVT ER-------- W 
CRR_1_/_9P07_Di 369 YR QLYYRG J-TARKYIYG-----YTPTIPGX9 --- QYN$RGAXFV ------------ 
CRR_5_/_PPE1625 
CRR_6_/_PFDID2S 360 §DQPIS VI19PZtMVYTRIYTQVY1WtE1MY1----- I WTXttMWIT XV 	W 
CRR_6_/_bCAL6Pi. 313 MD LIED DX- NEPYYD--VQDDJYYDVNDXDA TDNA DVPSXVQEEMD NT 1 
CRR_6_/_PPPDD3D 313 MD LIED DX- NE? D--VQDDYYDVNDXDATTDSNA DVP1VQIEMD NT 	I 
CRR_I_/_PPDDDI.0 326 MD tIED DX- IEFYYD--V900 YDVNDRDTTVDNN DVP$RVQIEMD NT N 
CRR_].4_/_PPII_D 901 MD LIED DIP NEPYYYDMYDDD YDVIDXDASTVDSNN DVPS1VQIEMD NT 	I 
CXR_12_/..)PLD9I 
con.cn.u. 	 961. dt- 1. ------------------------------------L--p--v- i---nn-- a.1- 
CRR_1_/_PVAD755 610 RKYGIY----




CRR_6_/_b(A16P1 630 EXYPIADYWDI 
CRR_6_/_PPPDD3O 630 EXYPEADVWDI 
CUR_&../_.PPDDDLO 353 EIYPIADVWDI 
CRR_16_/_PPII_D 961 EXYPIADVWDI 
CRR_12_/_97L096 
1021 --y-i ------ 
where background shading in green highlights completely conserved residues; yellow 
identical residues, cyan similar residues, white different residues. Boxshade default settings 
were used for similarity definitions. The immunising peptide sequence for the anti-ATS 
antibody is the consensus sequence formed and is underlined in the alignment in Part A. 
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Appendix 5: Gel showing location of gel slices from P. 
chabaudi membrane extracts for MALDI-TOF analysis 
















Source Size (kDa) 
ztMSl 3 Uninfected -120 
ztMS2 4 Uninfected 	+ -120 
ztMS3 7 P. chabaudi -120 
ztMS4 8 P. 	Chabaudi 	+ -120 
ztMS5 11 Uninfected -110 
ztMS6 12 Uninfected 	+ -110 
ztMS7 15 P. chabaudi -110 
ztMS8 16 P. 	Chabaudi 	+ -110 
ztMS9 19 Uninfected -37 
ztMSlO 20 Uninfected 	+ -37 
ztMSll 23 P. chabaudi -37 
ztMS12 24 P. 	Chabaudi 	+ -37 
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Abstract 
Background: The ability of Plasmodium falc/parum-infected erythrocytes to adhere to the 
microvasculature endothelium is thought to play a causal role in malaria pathogenesis. Cytoadhesion to 
endothelial receptors is generally found to be highly sensitive to trypsinization of the infected erythrocyte 
surface. However, several studies have found that parasite adhesion to placental receptors can be 
markedly less sensitive to trypsin. This study investigates whether chondroitin sulphate A (CSA) binding 
parasites express trypsin-resistant variant surface antigens (VSA) that bind female-specific antibodies 
induced as a result of pregnancy associated malaria (PAM). 
Methods: Fluorescence activated cell sorting (FACS) was used to measure the levels of adult Scottish and 
Ghanaian male, and Ghanaian pregnant female plasma immunoglobulin G (lgG) that bind to the surface of 
infected erythrocytes. P. folciparum clone FCR3 cultures were used to assay surface lgG binding before and 
after selection of the parasite for adhesion to CSA. The effect of proteolytic digestion of parasite 
erythrocyte surface antigens on surface lgG binding and adhesion to CSA and hyaluronic acid (HA) was 
also studied. 
Results: P. folciparum infected erythrocytes selected for adhesion to CSA were found to express trypsin-
resistant VSA that are the target of naturally acquired antibodies from pregnant women living in a malaria 
endemic region of Ghana. However in vitro adhesion to CSA and HA was relatively trypsin sensitive. An 
improved labelling technique for the detection of VSA expressed by CSA binding isolates has also been 
described. 
Conclusion: The VSA expressed by CSA binding P. falciparum isolates are currently considered potential 
targets for a vaccine against PAM. This study identifies discordance between the trypsin sensitivity of CSA 
binding and surface recognition of CSA selected parasites by serum lgG from malaria exposed pregnant 
women. Thus, the complete molecular definition of an antigenic P. falciparum erythrocyte surface protein 
that can be used as a malaria in pregnancy vaccine has not yet been achieved. 
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Background 
Rapid clearance of parasitaemia following transfusion of 
IgG from malaria immune adults to clinically ill recipients 
illustrates that naturally acquired antibodies have a para-
site clearing role in human malaria infection 11-31. Nei-
ther the nature of the protective immune response nor the 
target antigens and epitopes recognized by infection clear-
ing antibodies are fully understood. Evidence is accumu-
lating to suggest that the acquisition of antibodies binding 
the VSA on infected erythrocytes plays a major role in the 
development of age and exposure dependent immunity 
[4-8]. The evidence for protective anti-VSA responses is 
particularly strong for the PAM syndrome 19,10]. 
PAM is characterized by the sequestration of Plasmodium 
falciparum infected erythrocytes in the intervillous spaces 
of the placenta. Infected erythrocytes adhere to low-sul-
phated forms of CSA present on the extracellular prote-
oglycan matrix of syncytiotrophoblasts 1111. In vitro 
selection of infected erythrocytes for adhesion to CSA con-
comitantly selects for expression of VSA that share charac-
teristics with postnatal placental isolates. Thus plasma 
antibodies from malaria exposed pregnant, or multi-
gravid women, recognize the VSA of CSA binding para-
sites (here referred to as VSA). These sera can also 
block adhesion of CSA-selected infected eiythrocytes to 
CSA in vitro 1121. Interestingly, antibodies that bind GSA-
selected parasites and block adhesion are not acquired by 
malaria-exposed males. There is a striking female-specific 
antibody response recognizing both in vitro GSA-selected 
parasites 112,131 and P. falciparum isolates taken from 
infected placentae at delivesy [14-16]. Furthermore, the 
levels of GSA-adhesion blocking plasma IgG have been 
shown to increase with adult female parity. Recent 
immuno-epidemiological studies also show a strong pos-
itive correlation between the levels of antibodies that rec-
ognize the infected erythrocyte surface[15], the level of 
GSA-adhesion blocking antibody 1171 and positive birth 
outcomes as measured by birth weight. 
PAM is, thus, the clearest example in malaria pathology 
research of a strong association between infected erythro-
cyte sequestration and a particular disease syndrome. The 
VSA recognized by female-specific, parity-dependent anti-
bodies are, therefore, rational and exceptionally interest-
ing candidates for inclusion in an experimental vaccine to 
protect women against PAM, a major cause of stillbirth, 
maternal anaemia and low birthweight. 
To date, the best characterized VSA is P. falciparum eryth-
rocyte membrane protein 1 (PfEMPI), a polymorphic, 
high molecular weight membrane protein (200-450 kDa) 
encoded by the var multi-gene family 118-201. Members 
of the PfEMP-1 family function as adhesion molecules 
binding to various host endothelial receptors. They are sit- 
uated in the knob-like protrusions associated with the 
parasitized eiythrocyte surface. 
Since var genes encode large extracellular domains rich in 
lysine and arginine residues, it is not surprising that 
PfEMP-1 molecules and adhesion to endothelial receptors 
have been reported to be highly sensitive to tlypsin treat-
ment [18,21-24]. Less expected was the finding that para-
site adhesion to the placental receptor GSA, when 
immobilized 125-271 or when cell surface associated 
[28,29], can be relatively trypsin resistant. This study 
investigates the protease-sensitivity profile of the VSA PAM 
expressed by GSA-selected parasite clone FCR3 with 
regard to recognition by antibodies acquired during PAM 
and adhesion to placental receptors. 
Methods 
Parasite isolates 
Parasites were maintained in group 0 eiythrocytes under 
standard conditions [30], using RPMI 1640 medium con-
taining 25 mM HEPES, supplemented with 20 mM glu-
cose, 2 mM glutamine, 25 sg/ml gentamycin and 10% 
pooled normal human serum. The pH was adjusted to 
between 7.2 and 7.4 with 1 M NaOH. Gulture flasks at 5% 
haematocrit were gassed with 96% nitrogen, 3% carbon 
dioxide and 1% oxygen. The laboratory clone FGR3 origi-
nates from peripheral blood collected in the Gambia. 
FGR3GSA was obtained from the Malaria Research and 
Reference Reagent Resource Gentre (ATGG) [31], and was 
confirmed, using genetic markers to be identical to the 
laboratory clone FGR3 kept in the original W.H.O. strain 
registry collection in Edinburgh (D. Walliker, pers. 
comm.). GSA binding was maintained by panning late 
stage infected erythrocytes fortnightly on bovine tracheal 
GSA (10 sg/ml) (Sigma) immobilized on polystyrene 
Petri dishes (Falcon), as previously described [26]. Prior 
to protease treatment and analysis by flow cytometly, cul-
tures were synchronized by sorbitol treatment to obtain 
cultures enriched for late stage parasites. 
Plasma donors 
Serum samples from 20 men living in a malaria endemic 
region of Ghana were pooled to produce the male serum 
pool. Serum samples collected at the time of birth from 
the placentas of 15 women living in a malaria endemic 
region of Ghana were pooled to produce the pregnant 
female serum pool. This pool included five primigravidae, 
nine secundigravidae and one multigravid woman. Serum 
samples from six Scottish malaria naïve individuals were 
pooled and used as a control. 
Protease treatment 
Protease treatment of infected erythrocytes was carried out 
as previously described [26]. Briefly, samples containing 3 
106 cells from sorbitol treated late stage cultures of 8-10 
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% parasitaemia were washed twice with phosphate-buff-
ered saline (PBS) and then incubated with the appropriate 
concentration of tiypsin-TPCK (Worthington Biochemi-
cals) or pronase (Boehringer-Mannheim) in a final vol-
ume of 1.0 ml in PBS, for 10 minutes at 37°C. The 
reaction was terminated either by adding soybean tiypsin 
inhibitor (Worthington Biochemicals) to a final concen-
tration of 1 mg/ml or by adding 10% human serum. Cells 
were washed twice with PBS before ftirther use. 
Analysis of VSA specific antibodies by flow cytometry 
Flow cytometry was used to measure the levels of plasma 
IgC binding to the VSA of late stage parasites essentially 
following the method previously described by Staalsoe et 
a! [13,32]. 3 x 106 cells form late stage P. falciparum cul-
tures of 8-10 % parasitaemia were washed twice with PBS. 
Cells were incubated sequentially with plasma antibodies 
diluted 1:20 in PBS, goat anti-human IgC diluted 1:200 in 
PBS (Dako) and fluorescein isothiocyante (FITG)-conju-
gated rabbit anti-goat (Dako) diluted 1:25 in PBS. All 
incubations were in a total volume of 100 jil for 30 min-
utes at room temperature and were followed by two 
washes with 1 ml of PBS. Samples were analysed immedi-
ately on a FACSCAN apparatus (Becton-Dickinson). F1TC 
fluorescence due to cell surface antibody recognition was 
determined for 5000-10000 ethidium bromide gated 
infected erythrocytes. 
Modified labeling procedure for FACS analysis 
In order to circumvent the non-specific labeling of the 
VSA by the tertiary antibody, new reagents have been 
introduced. The procedure follows the method detailed 
above with the following modifications. A biotinylated 
rabbit anti-human IgG antibody (DAKO) was used 
diluteä 1:25 to replace the secondary antibody. In the 
place of a tertiary antibody, FITC-conjugated streptavidin 
(DAKO) was used at a 1:2000 dilution. In these experi-
ments the control sera was a pool of malaria naïve Danish 
volunteer serum. 
Binding assays 
Human umbilical cord hyaluronic acid (Sigma) and 
bovine trachea CSA (Sigma) were used at a concentration 
of 10 tg/ml in PBS (pH 7.2). 20 jil of each receptor was 
spotted in triplicate onto 5 cm diameter petri dishes (Fal-
con). Receptors were adsorbed onto the plastic petri 
dishes overnight at 4°C. 10 j.g/ml BSA in PBS was simi-
larly adsorbed as a negative control. Plates were then 
blocked by removing the receptor solution and adding 20 
Ill of 2% BSA in PBS. Following the removal of this block-
ing solution late stage parasites, suspended in 2 ml of 
complete RPMI-HEPES medium (8-10% parasitaemia, 
5% haematocrit), were added to the petri dish. Parasites 
were incubated with the immobilized receptor for 60 
minutes at37°Cwith occasional agitation. Unbound cells 
were removed by four gentle washes with incomplete 
RPMI-HEPES medium; bound cells were fixed with 0.5% 
(v/v) glutaraldehyde in PBS for 10 minutes and Ciesma 
Stained. Bound cells were counted by light microscopy. 
Protease treatment of intact cells was carried out as 
described above. 
Statistical analysis 
Statistical analyses were performed using Analyses of Var-
iance in Minitab 13.30 (Minitab Inc.), using protease, 
protease concentration and serum pool as explanatory 
variables. Statistical models were tested for homogeneity 
of variance and normality of error distributions. Where 
possible, maximal models with interactions between 
these variables were fitted first, after which models were 
minimized by removing nonsignificant (p> 0.05) terms. 
Results 
Concomitant selection of a trypsin-resistant VSA following 
parasite selection for CSA adhesion 
It was first established that selection of clone FCR3 for 
adhesion to CSA resulted in the concomitant selection for 
VSA specifically recognized by plasma IgG from malaria 
exposed Chanaian pregnant women (Igcpreg) (figure 1). 
However there was no increase in the binding of IgC from 
a pool of plasma from malaria exposed Ghanaian men 
(IgGmale). The unselected FCR3 clone expressed VSA that 
were equally well recognized by antibodies in the IgCmale 
and IgGpreg serum poois (figure 1). These interactions 
between serum antibody binding and selection for CSA 
adhesion were highly significant (F224 9.5 1  P = 0.004 
The trypsin sensitivity of this VSA/IgG binding interaction 
and of parasite adhesion to GSA was then measured. Par-
asitized eiythrocyte surface trypsinization at a concentra-
tion of 0.1 mg/ml showed that the IgCpreg binding of 
FCR3 GSA was significantly more trypsin-resistant than 
was binding of the same serum to the unselected clone 
(figure 2A &2B; F 1 , 4 16.4, p = 0.015). Although the mean 
surface fluorescence due to the IgCpreg binding of 
FCR3 GSA was slightly reduced by 0.1 mg/mI trypsin this 
reduction was not significant (figure 2k F 12 11.3, p = 
0.078). The effect of 0.1 mg/ml trypsin on VSA recogni-
tion by IgG male and IgGcontrol was comparable before 
and after GSA selection of the parasite (figure 2). 
The effect of a 10-fold higher trypsin concentration and 
the effect of the non-specific protease, pronase, on IgC 
recognition of FCR3CSA was also determined. Trypsiniza-
tion with 1 mg/ml did not significantly reduce the mean 
surface fluorescence due to IgGpreg binding to FCR3 GSA 
(figure 3; F 14 0.35, p = 0.587). However, treatment of the 
intact infected erythrocyte with 0.1 mg/ml pronase did 
significantly reduce IgCpreg recognition of FCR3 GSA 
(figure 3). Pronase treatment also significantly reduced 
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Figure I 
lgG recognition profiles of parasite clone FCR3 
before and after selection for adhesion to CSA. Fol-
lowing selection of parasite clone FCR3 for adhesion to CSA 
the expression of variant surface antigens was investigated 
using FACS. 5000-10000 late stage parasites were gated 
using ethidium bromide and FITC fluorescence due to serum 
lgG binding was measured. Serum samples from six Scottish 
malaria naïve individuals were pooled and used as a control 
(lgGcontrol). Sera from 20 Ghanaian men were pooled to 
produce the malaria exposed male serum pool (lgGmale). 
Sera collected at the time of birth from the piacentas of IS 
Ghanaian women were pooled to produce the malaria 
exposed pregnant female serum pool (lgGpreg). The bar 
chart shows mean and standard error of the means for five 
independent experiments. 
binding of the IgGmale and IgGcontrol serum pools (figure 
3; F 183.1, p = 0.041). 
Surprisingly, IgCcontrol binding to the infected erythro-
cyte surface increased following CSA selection of the par-
asite (figure 1); however, this non-immune recognition 
was found to be significantly more trypsin sensitive than 
IgGpreg recognition (figure 3; F4183.11, p = 0.041). This 
indicates that the epitopes recognized by the IgGcontrol 
serum pool and the epitopes recognized by the IgGpreg 
serum pool are distinct entities. An increase in apparent 
non-immune immunoglobulin binding to the infected 
erythrocyte surface has been observed for a number of 
parasite clones after selection for adhesion to CSA (data 
not shown). The source of this background labelling of 
FCR3CSA by naïve sera was found to be due to non-spe-
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Figure 2 
Serum lgG from malaria exposed pregnant women 
recognises trypsin-resistant surface epitopes. Intact 
infected erythrocytes were treated with 0. I mg/mi trypsin 
prior to FACS analysis. Panels A and B show serum lgG bind-
ing to the surface of FCR3CSA and FCR3 infected erythro-
cytes respectively. Serum pools are the same as those 
described in Figure I. The bar chart shows mean and stand-
ard error of the means for two independent experiments. 
antibody. By using the modified antibody labelling proce- 
dure, which employs a biotin-labelled secondary anti- 
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• no protease 
o 1 mg/mI trypsin 
00.1 mg/mI pronase 
IgGcontrol 	IgGpreg 	 IgGmale 
Figure 3 
FCR3CSA expresses surface antigens exhibiting dif-
ferential protease sensitivity. Intact infected erythro-
cytes were treated with 1.0 mg/mI trypsin or 0.1 mg/mI 
pronase prior to FACS analysis. Serum pools are the same as 
those described in Figure I. The bar chart shows mean and 
standard error of the means for three independent 
experiments. 
A. FCR3CSA 	 B. FCR3 
FITC 	 File 
Figure 4 
A modified antibody labelling procedure for FACS 
analysis of CSA selected parasites. In order to circum-
vent the non-specific labelling of FCR3CSA VSA seen when 
using the FITC rabbit anti-goat tertiary antibody, a bioti-
nylated rabbit anti-human antibody in combination with 
FITC-conjugated streptavidin was used. Panels A and B show 
FCR3CSA and FCR3 infected erythrocytes respectively. In 
these experiments the control serum was a pool of sera 
from malaria naïve Danish volunteers, here shown as a solid 
grey histogram. The lgGmale serum pool is shown as a light-
weight line and the lgGpreg serum pool as a heavyweight line. 
naive IgG to FCR3CSA (mean fluorescence index = 16) 
was comparable to the unselected parasite (mean fluores-
cence index = 17). Thus the recognition of VSA PAM by 
malaria naive IgG was abolished (figure 4). 
Discordance between the protease sensitivity of the CSA 
adhesion interaction and lgG binding 
Following the identification of trypsin-resistant epitopes 
that appear to be concomitantly selected with CSA adhe-
sion, the trypsin sensitivity of CSA adhesion itself was 
determined. FCR3CSA binding to immobilised GSA was 
markedly more sensitive to trypsin than IgGpreg recogni-
tion of the infected erythrocyte surface (figure 5). Parasite 
adhesion was reduced by 81% and 91% following 
treatment with 0.1 mg/ml trypsin and 1 mg/ml trypsin 
respectively (figure 5). A trypsin concentration of 1 mg/mI 
reduced binding as efficiently as 0.1 mg/ml pronase, and 
although 0.1 mg/ml pronase significantly reduced cell 
surface fluorescence due to IgGpreg antibody binding, 1 
mg/ml trypsin had no significant effect on IgGpreg anti-
body binding. There is, thus, significant discordance 
between the high trypsin sensitivity of GSA adhesion and 
the relatively trypsin-insensitive binding of Igcpreg serum 
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Figure 5 
The effect of increasing concentrations of trypsin on 
parasite adhesion to immobilised CSA and HA. Para-
site adhesion to 10 tg/mI human umbilical cord HA and 
bovine trachea CSA, adsorbed onto the plastic petri dishes, 
was determined following protease treatment of the intact 
infected erythrocyte. Bound cells were Giemsa stained and 
counted by light microscopy. Panels A and B show receptor 
binding for FCR3 and FCR3CSA infected erythrocytes 
respectively. The bar chart shows mean and standard error 
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Human umbilical cord hyaluronic acid (HA) was also 
included in these assays to investigate the binding capac-
ity of the CSA selected clone with respect to this receptor. 
FCR3CSA was found to bind both HA and GSA, although 
binding to HA was significantly lower (figure 5B; F 319 
20.44, p < 0.001), at 71% that observed for GSA. Interest-
ingly, as has previously been shown for other P. falciparum 
isolates [27], the trypsin-sensitivity of parasite adhesion to 
HA and CSA differed at low trypsin concentrations (0.01 
mg/mi) (figure 513; F 18 7.7, p = 0.024). Parasite adhesion 
to hyaluronic acid was found to be more sensitive to 
trypsinization than adhesion to GSA. 
Discussion 
The acquisition of antibodies to the surface of placental 
isolates correlates with protection from malaria in 
pregnancy and the targets of these antibodies are potential 
vaccine candidates [13,151. Two variants of the well char-
acterized VSA, PfEMP1, have been shown to have distinct 
GSA-binding domains 129,331 and antibodies raised 
against these domains have been reported to recognize 
the infected erythrocyte surface 1 34 1 and in some cases 
block parasite adhesion [35,36]. However, in a recent 
study of var gene transcription in GSA-selected clones, a 
third potential GSA-binding PfEMP1 (var2csa) was identi-
fied. Var2csa is predicted to possess distinctly different 
DBL domains and appears to be the major var expressed 
by GSA-selected parasites that are recognized by parity-
dependent antibodies 1141. Proteomic analysis of GSA-
selected parasites has also identified four additional 
potential GSA binding PfEMP1 molecules 13 7 ]. The molec-
ular identity of the surface antigens expressed at the 
infected erythrocyte surface remains unclear 1381. How-
ever, the differential protease sensitivity of the epitopes 
described here would allow treatment of the infected 
eiythrocyte surface with trypsin thereby simplifring the 
surface complexity, thus, potentially making proteomic 
approaches more straightforward. 
Although PfEMP1-mediated GSA adhesion appears to play 
a role in placental malaria the molecular interactions trig-
gering this syndrome are more complex than initially 
thought. Several studies implicate additional receptors 
and binding phenotypes of placental parasites, such as 
non-immune 1gM [39], hyaluronic acid 125,27,40] and 
non-immune IgG [411. GSA-binding laboratory clones 
and placental GSA binding isolates also appear to express 
some parasite encoded surface antigens other than 
PfEMP1, such as ring surface proteins 1 and 2 (RSP 1 and 
2)142 ]. Interestingly, a gene knock-out' of the GSA bind-
ing var (FGR3varCSA) in parasite clone FCR3 abolishes 
GSA binding, but the 'knock-out parasites still bind the 
syncytio-trophoblast of ex vivo placental cryosections 1431. 
Monoclonal antibodies raised against the GSA binding 
DBL7 domain also show this domain to be sensitive to 
surface proteolysis using relatively low trypsin concentra-
tions (100 tg/ml) 1341. It is certainly possible that the 
trypsin-resistant VSA described here are not of the 
PfEMP1/CSA binding type. 
Surface epitopes of the FGR3 GSA parasite are both highly 
resistant to trypsin and are recognized by antibodies from 
malaria-exposed pregnant women. This agrees with a 
number of studies that have found parasite adhesion to 
placental receptors to be resistant to surprisingly high 
trypsin concentrations. However, binding assays with the 
parasite clone used in this study showed GSA and HA 
adhesion to be relatively trypsin-sensitive. This is also 
compatible with the results of Beeson and his colleagues 
who demonstrated trypsin-resistant GSA adhesion to be a 
clone dependent phenomenon [271. Another recent study 
by the same group showed sera that is strongly reactive to 
the surface of GSA selected parasites is not always capable 
of inhibiting GSA adhesion [44]. Thus this study supports 
the view that erythrocyte surface epitopes distinct from 
those involved in GSA adhesion may be targets of the anti-
bodies acquired during PAM and suggests that these two 
epitopes could be on different molecules. One further 
implication for vaccine development is that a candidate 
vaccine raising only GSA adhesion blocking antibodies 
may not mimic protective surface reactive gender-specific 
immune responses. 
Conclusion 
This study supports the view that major differences exist 
between VSAPAM and previously characterized VSA. Apart 
from being recognized only by female sera in a parity-
dependent manner, VSApAm  show other distinct character-
istics such as; i) VSAPAM  rarely form infected erythrocyte 
rosettes when compared to GD36 binding VSA [27,45], ii) 
with the exception of rosetting isolates, non-immune 1gM 
binding is a phenomenon only seen with GSA-binding 
clones [39], iii) VSAPAM  do not generally mediate adhe-
sion to GD36 127,461, and iv) VSA pJ, mediated adhesion 
to the placenta and GSA can be resistant to concentrations 
of trypsin known to remove most PfEMPI molecules from 
the infected cell surface. In combination with the findings 
of this study, these distinct properties of VSA PAM suggest 
the involvement of either an unusually protease-resistant 
PIEMP1 structure, such has been shown to exist in the 
A4tres PIEMP1 molecule [47] or an alternative class of VSA 
in placental adhesion. The differential protease sensitivity 
exhibited by VSAPAM can be exploited in comparative pro-
teomic analysis to aid in the identification of the mole-
cules whose phenotype is described here. 
List of abbreviations 
TPCK - L-(tosylamido-2-phenyl) ethyl chloromethyl 
ketone, GSA - chondroitin sulphate A, PfEMPI - P. falci- 
parum erythrocyte protein 1, PAM - Pregnancy associated 
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malaria, VSA - variant surface antigens, VSA 	- variant 
surface antigens expressed by placental 'or CSA binding 
parasites, IgG - immunoglobulin C, DBL-y-Duffr like 
binding domain-gamma, FITC - fluorescein 
isothiocyanate. 
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Abstract 
Improved Plasmodiumfalciparum cDNA expression libraries were constructed by combining mRNA oligo-capping with in vitro recom-
bination and directional cloning of cDNA inserts into a plasmid vector that expresses sequences as thioredoxin fusion proteins. A novel 
procedure has also been developed for the rapid identification of seropositive clones on high-density filters, using direct labelling of P.falci-
parum immune immunoglobulin with fluorescein isothiocynate (FITC). This approach combines the advantages of recombination-assisted 
cDNA cloning with high throughput, non-radioactive serological screening of expression libraries. Production of replicate colony matrices 
allows the identification of antigens recognised by different poois with different specificities from residents of a malaria endemic region. 
Analyses of DNA sequences derived from sero-reactive colonies indicate that this is an effective method for producing recombinant proteins 
that react with antibodies from malaria-exposed individuals. This approach permits the systematic construction of a database of antigenic 
proteins recognised by sera from malaria-exposed individuals. 
© 2003 Elsevier B.V. All rights reserved. 
Keywords: Plasmodium falciparum; eDNA; In vitro recombination; Protein macro-array 
1. Introduction 
Serological screening of expression libraries from mi-
crobial pathogens has a revived role in the exploitation 
of genomic data for development of novel drugs and re-
combinant vaccines. Defining the portion of the pathogen 
proteome recognised by the host immune system—its 
'immunome'—is a necessary step in identifying pathogen 
epitopes that stimulate protective immunity. However, sys-
tematic mapping of the immunome of complex parasites 
requires faster and more efficient methods than those orig-
inally developed for serological screening of expression 
libraries [1-3]. 
Abbreviations: FITC, fluorescein isothiocyanate; CSA, chondroitm sul-
phate A; Ig, immunogobulins; TBS, Tris buffered saline; TBS-TT, Tris 
buffered saline with 0.2% Tween 20 and 0.05% Triton-X 100; PMSF, 
Phenybnethylsulphonyifluonde 
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This approach simplifies the construction of Rfalciparum 
cDNA expression libraries by using recombination cloning 
(RC) [4], resulting in libraries with better representation of 
mRNA species than conventional restriction-ligation depen-
dent cloning [5]. We have combined production of cDNA 
from "oligo-capped" RNA [6] with PCR, to amplify cDNA 
and introduce the 5' attBl and 3' attB2 sites necessary for 
site-specific recombination of the cDNA into a Gateway"' 
donor vector. This oligo-cappingfPCR RC-method is an al-
ternative to the adaptor ligation method for recombination 
cloning developed by Ohara and Temple [5]. 
We have combined these library construction mëth-
ods with a novel antigen detection process. Purified im-
munoglobulins from malaria-exposed donors were directly 
labelled with fluorescein isothiocyanate (FITC) and used 
to screen the expression library derived from P falciparum 
cDNA. Like radio-iodination, direct FITC labelling of anti-
bodies and their subsequent detection is more sensitive than 
secondary-antibody based detection, but FITC labelled an-
tibodies have the advantage of being cheaper to produce, do 
not require radio-chemical handling and disposal and have a 
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longer useful 'shelf life'. By pre-incubating this library with 
unlabelled antibodies from a control pooi with different or 
shared specificities, the library can then be differentially 
screened with FITC-labelled antibodies for specificities 
unique to the labelled antibody or serum pooi [7,8]. 
2. Materials and methods 
followed by 15 cycles at 94°C for 30s, 50°C for 30s and 
68°C for 10mm. A final extension step was carried out at 
68°C for 12 mm. PCR products of less than 300 base pairs 
were removed by PEG 8000 (Gibco) precipitation of the 
reaction mix. Double stranded cDNA was fractionated on 
agarose gels and the purified individual fractions used to 
make size-fractionated "entry" libraries. 
2.4. Generation of the P falciparum cDNA entry library 
2.1. Parasites 
P falciparum SD2H3/5-CSA was cloned by limiting di-
lution from SD2H3, a parasite isolate from a Sudanese fe-
male and cultured using standard methods [9]. The parasites 
were kept under chondroitin sulphate A (CSA) selection in 
order to maintain the CSA adhesion phenotype [10]. A sub-
set of antibodies on infected red blood cells containing these 
parasites are recognised by adult female sera from malaria 
endemic areas, but not by endemic adult male sera. This 
sex-dependent serum recognition profile has been described 
in P falciparum isolates implicated in pregnancy-associated 
malaria [11]. 
2.2. RNA isolation, oligo-capping and reverse transcription 
Total RNA was isolated from 100 pA of the SD2H3/5-CSA 
parasite pellet obtained after centrifugation of saponin lysed 
asynchronous parasites (5 ml culture) using the Trizol extrac-
tion method (Gibco). Extracted total RNA was resuspended 
in RNA Storage Solution (Ambion) before DNAse 1 treat-
ment (Ambion). Aliquots of the isolated RNA were checked 
for genomic DNA contamination using PCR [12]. cDNA was 
synthesised immediately after RNA isolation using a tagged 
oligo dT(Is). Oligo-capping was carried out as described 
[13,14] using a synthetic RNA primer with the sequence: 
5'CGACUGGAGCACGAGGACACUGACAUGGACUG-
AAGGAGUAGAAA3 1 . Total RNA was dephosphorylated 
and the methyl cap removed using tobacco acid pyrophos-
phatase. The synthetic RNA primer was ligated onto the 
de-capped mRNA using RNA ligase. Reverse transcription 
was carried out using a tagged oligo dT primer (GeneRacer, 
Invitrogen) and SuperScript II (Gibco). 
2.3. Second strand synthesis and attachment of 
recombination sites 
Introduction of the auB 1 and attB2 recombination sites 
was carried out during second strand synthesis by PCR, us-
ing a specific forward primer, attB 1IRNA oligo with the se-
quence: 5'GGGGACAAG7I7'GTACAAAAAAGCAGGC17-
GACATGGACTGAAGGAGTA3' and a specific reverse 
primer, the attB2ltagged oligo dT with the sequence: 5'GG-
GGACCACT7TGTACAAGAAAGCTGGGTCGGCATGAC-
AGTGrrrrrITiTI3'. The att sites are italicized. 50 p.! 
PCR reactions were prepared and the custom synthesised 
primers added to a final concentration of 1 p.M. The reac-
tions were cycled as follows: 1 cycle at 94°C for 2mm, 
A tenth of the volume of the PCR amplification re-
action was incubated with 250 ng of the 'donor' vector, 
pDONR-222 (a gift of Dr. Mark Smith, Invitrogen), BP 
Clonase enzyme and reaction buffer (Gateway Cloning 
Technology, Invitrogen). The reaction mix was incubated 
at 25°C for 24 h before precipitation with 0.1 volume of 
3 M sodium acetate pH 5.2, 0.1 volume of glycogen and 
2.5 volumes of ethanol. The pellet was re-suspended in 1 x 
Tris—EDTA and electro-competent ToplO Escherichia coli 
cells (Invitrogen) were transformed with 1 p1 of the mix-
ture. The transformed cells were rescued in SOC medium 
at 30°C for 1 h and immediately spread on LB agar plates 
containing 50 p.g rnl' kanamycin. Transformants were in-
cubated overnight at 30°C. Colonies were picked, used in 
the inoculation of LB containing 50p.gml' kanamycin, 
grown overnight at 30°C and insert sizes checked by PCR. 
The entry library with an insert range of 0.3-3kb was used 
in the production of the expression library. 
2.5. Generation of the cDNA expression library 
The library was constructed in the plasmid pBAD-DEST49 
(Gateway Destination Vector, Invitrogen) a 6.2kb arabinose-
inducible expression vector that fuses an N-terminal thiore-
doxin domain Onto the recombinant protein. The vector 
also fuses a six-histidine polypeptide as a 'tag' to the 
C-terminal of the fusion protein to facilitate detection and 
purification. 10% of the DNA from the entry library was 
incubated with 300ng of pBAD-DEST49 and LR Clonase 
was added following the manufacturers protocol (Invitro-
gen). The reaction mix was incubated at 25°C for 24h, 
precipitated with 0.1 volume of 3 M sodium acetate, pH 
5.2, 0.1 volume of glycogen and 2.5 volumes of ethanol. 
After centrifugation, the pellet was re-suspended in 12 p.1 
of 1 x Tris-EDTA and 1.5 p.1 of the mix used to transform 
100 pA of electro-competent ToplO E. coli (Invitrogen). 
Transformed cells were rescued in 1 ml of SOC medium and 
grown with aeration at 30°C for 1 h before plating aliquots 
on LB agar plates supplemented with 1% glucose and 
300 p.g rnl' ampicillin overnight at 30°C. Transformants 
were subsequently grown in either liquid or semi-solid 
medium with reduced ampicillin (100 p.g 
2.6 Labelling of antibodies 
Two different pools of sera were obtained, with informed 
consent, from 25 males and 25 females between the ages of 
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20-39 residents in Ejisu, a malaria hyper-endemic region 
in Ghana. Pooled malaria naïve serum (used as a negative 
control) was obtained from The Scottish Blood Transfusion 
Centre, Edinburgh, Scotland. Serum immunogobulins (Ig) 
were affinity purified on Protein L columns (Pierce), to 
select IgA, D, E and M, as well as the four subclasses of 
IgG. Eluted antibodies were dialysed against 0.15 M NaCl 
overnight at 4°C, prior to FITC labelling. FITC in 0.5 M 
sodium carbonate-bicarbonate buffer pH 9.0 was added 
to the purified Ig to a final concentration of 0.05mg of 
FITC/mg of protein and incubated at room temperature for 
2 h with gentle agitation. Unbound FITC was removed from 
the Ig solution by overnight dialysis against several changes 
of PBS at 4°C. 
2.7. Bacterial colony growth and induction of protein 
expression on high-densily filters 
Six thousand, nine hundred and twelve colonies were 
picked into seventy-two 96-well plates containing LB 
medium supplemented with 1% glucose, 8% glycerol and 
100 pg ml ampicillin and grown overnight at 30°C prior 
to arraying on filters. Replicate bacterial colony arrays 
were prepared by cutting High Bond-C Extra filters (Amer-
sham) to size .(23 cm x 23cm). The replicate filters were 
inked using filter sterilised black ink, prior to robotically 
spotting bacterial cultures onto the filters using a PBA 
Flexys Gridder and Replicator. The order of colony spot-
ting from the 96-well plates was based on a programmed 
pattern, with each 25 spot square containing 12 dupli-
cated colonies arranged in such a way that no duplicates 
border each other (a 'non-contiguous array'). One blank 
spot was left in each square to facilitate orientation. This 
arraying pattern produced six 'patches', each patch con-
taining duplicated colonies from twelve 96-well plates. The 
colonies were grown by placing the filters on LB agar sup-
plemented with 1% glucose and 100 g ml ampicillin, 
in 24.5 cm x 24.5 cm bioassay dishes (Nunc) overnight at 
30°C. The arrayed filters were transferred from the 1% 
glucose and 100 pg m1' ampicillin supplemented LB agar 
after overnight growth, onto LB agar plates supplemented 
with 0.2% arabinose and 100gml' ampicillin, for in-
duction of fusion protein expression at 37°C for 4 h. 
2.8. Preparation of induced colony arrays for screening 
with antibodies 
After 4 h of induction, the arrayed colonies were lysed 
in situ by placing the filters onto Whatman 3 M filter paper 
pre- soaked with BugBuster HT lysis mix (Novagen), supple-
mented with 0.1 mM PMSF for twenty min at room temper-
ature. Lysis was completed by incubating each filter in 50 ml 
of Lysis Buffer (50mM Tris—HCI pH 7.5,3% BSA, 0.15M 
NaCl, 5mM MgCl2,  0.1 mM PMSF, 40 pg m1' lysozyme 
and 300 units L' benzonase) in different bioassay dishes 
for 3 h at room temperature with gentle agitation. Filters  
were subsequently blocked overnight at 4°C in 3% BSA 
and 0.1 mM PMSF in TBS-Tl' with gentle agitation in in-
dividual bioassay dishes. 
2.9. Detection of antibody positive clones 
After blocking, filters were washed four times for 15 mm 
per wash in approximately 100 ml per filter of Tris buffered 
saline (TBS) with 0.2% Tween 20 and 0.05% Triton-X 100 
(TBS-TT), followed by two washes in 100 mlifilter of TBS 
to remove residual detergent. To detect colonies producing 
recombinant protein, one of the replicate filters was probed 
with HRP-conjugated anti-His tag antibody (Penta His, Qi-
agen, at a 1:2000 dilution of the supplied antibody in the 
blocking buffer provided by the manufacturer for 1 h at room 
temperature). Positive colonies were detected using the ECL 
Plus kit (Amersham). 
To detect malaria seropositive clones, a second replicate 
filter was incubated with FITC-labelled total immunoglobu-
lin from a pool of highly malaria antigen-reactive sera from 
Ghanaian adult female donors (2 ig/ml in 3% BSA, 0.1 mM 
PMSF in TBS-TT) for 3 h at room temperature. Positive 
colonies from this screen were picked and re-arrayed on 
replicate High Bond C-Extra membranes. The re-arrayed 
filters containing a range of malaria Ig-reactive colonies 
from the initial screen, were subjected to a more rigorous 
re-screening after overnight blocking of the filter in 3% BSA, 
0.1 mM PMSF in TBS-fl' in order to screen for female spe-
cific parasite antigens. 
To screen for female specific parasite antigens, unlabelled 
protein L-purified Ig from the male serum pool (0.5 pg/ml 
in 30m1 of 3% BSA, 0.1mM PMSFin TBS-1T), was added 
to the filters, in sealed bags, to allow binding of unlabelled 
antibody to any specifically male-recognised antigens, or 
those antigenic specificities that are well-recognised by both 
male and female adults. Filters were washed in TBS-TT and 
TBS as previously described and antigens specifically recog-
nised only by female antibodies were detected as follows: 
the washed filters were incubated in 30 ml per filter of a so-
lution containing 2 ILg m1 1 of FITC-labelled female Ig in 
3% BSA, 0.1 mlvi PMSF in TBS-TT for 3 h in the dark at 
4°C. After washing the filters, colonies producing recombi-
nant proteins recognised by FITC labelled purified Ig from 
the female pool were detected with the STORM 860 fluo-
rescent imager (Amersham). As a control, the replicate filter 
was screened with FITC-labelled purified Ig from Scottish 
malaria naïve donors in the same way as described above. 
Filters were washed in TBS-1T and TBS as described and 
FITC-labelled colonies were detected using the STORM 860 
fluorescent imager (Amersham). 
3. Results and discussion 
P. falciparum cDNA libraries were constructed using the 
method illustrated in Fig. I. This consisted of oligo-capping 
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5' & 3' modifled ss cDNA 
PCR using attBland astB2 specific primers 











Entry library 	 By-product 
Fig. 1. Flow chart outlining the incorporation of the auB I and auB2 
recombination site sequences with second strand cDNA synthesis and 
integration of double stranded eDNA into the donor vector pDONR-222. 
The auB 1 and auB2 recombination site-specific sequences are depicted 
by the black and hatched boxes respectively. The ccdB gene, the grey 
box in pDONR-222 and by-product of the reaction, is a negative selection 
marker removed by successful reciprocal recombination. The protein it 
encodes interferes with DNA gyrase and is lethal to non-recombinant 
bacteria; ds: double stranded; ss: single stranded. 
total parasite RNA, followed by cDNA synthesis with 
conêurrent introduction of recombination sites by PCR am-
plification and in vitro recombination into a donor vector 
(pDNR-222) to produce an entry library. The entry library 
was then shuttled into an arabinose-inducible plasmid ex-
pression vector, pBAD DEST-49 to produce the expression 
library in E. coli. 6912 cDNA clones were cultured in 
seventy-two 96-well microtitre plates and robotically ar-
rayed onto replica high-density High Bond C-Extra filters, 
using a PBA Flexis robot. The P. falciparum expression 
library had an initial titre of around 100,000cfuml 
with inserts ranging in size from 0.3 to 3.0kb (mean of 
0.8 kb). 
The grid plan for arraying the cDNA library is shown in 
Fig. 2A. Clones were arrayed in duplicate on replica filters 
prior to in situ induction of expression of the recombinant 
proteins, lysis and immuno-screening. One of the replicates 
was probed with HRP-conjugated anti-His antibody. This 
was to detect the presence of the C-terminal His tag, attached 
to recombinant proteins. The second replicate, after blocking 
with 3% BSA and 0.1 mM PMSF in TBS-TI', was probed 
with labelled total immunoglobulin from a pool of highly 
malaria antigen-reactive sera from Ghanaian adult female  
donors. The initial screening process detected many antigens 
common to both adult male and female pooled sera and was 
used to produce a library of clones that react with sera from 
malaria-exposed individuals. These 'enriched' replicate ar-
rays were prepared using the antibody-reactive colonies from 
the initial screen. 
One of the enriched replicate filters was then pre-incubated 
with pooled unlabelled male immune Ig prior to screen-
ing with FITC-labelled pooled female immune Ig, in order 
to detect strongly female pool-specific parasite antigens. 
A control replicate filter was probed with FITC labelled 
malaria naive 1g. Fig. 2B shows the result of one of these 
screens, a typical fluorescence image of FITC-labelled an-
tibodies bound to duplicate reactive clones. A replica filter 
screened with FITC-labelled malaria naive Igs is shown in 
the lower panel of Fig. 2B. 
A number of duplicate clones appeared to react consis-
tently with both FITC-labelled Ghanaian female 'immune' 
sera and Scottish malaria naive sera. These clones were 
re-screened and the plasmid inserts sequenced, to determine 
if this was a screening artifact caused by free FITC binding 
or binding of anti-E. coli antibodies present in both screen-
ing sera. Cross-reacting clones were detected consistently 
and sequencing showed that they all contained P falcipa rum 
sequences rather than E. coli or human sequences. These 
clones recognised by Scottish malaria naive Ig were there-
fore screened with a commercial preparation of naïve human 
1gM (Rockland, USA) and all colonies tested were shown 
to bind this 1gM preparation (data not shown). A modi-
fied protocol including a pre-incubation step with unlabelled 
malaria naïve antibodies therefore seems more selective than 
pre-binding antibodies to E. coli lysates, as recommended 
in some earlier protocols. 
Initial screening with Ghanaian 'malaria immune' Ig re-
sulted in 27% of the library clones reacting positively. This 
was a low stringency screen performed without pre-binding 
of either naive or male malaria specific-Ig and therefore 
was most likely to contain a number of reactivities with 
non-coding "nonsense" clones and some with non-specific 
cross-reactivities. These clones, together with clones of low 
reactivity were removed in an additively stepwise manner 
(see below). The initial apparent sero-reactivity of 27% 
may be overestimated due to these non-specific reactivities, 
but is still a significant increase on the 1-5% sero-reactivity 
detected in earlier expression library immuno-screening 
experiments [2,3]. This increase in efficiency of detecting 
antigenic epitopes from P. falciparum proteins can be as-
cribed to two features of this system: (1) the directional 
cloning scheme that doubles the chances of a cDNA frag-
ment being inserted 'in-frame', thus producing a functional 
fusion protein and (2) the improved efficiency of translation 
and increased protein solubility resulting from fusion to 
the 11 kDa thioredoxin molecule rather than the 112 kDa 
3-galactosidase carrier used in Xgtl 1 expression vectors 
[1-3,7,8]. The reducing environment induced by attachment 
to thioredoxin also aids folding and solubility of the fusion 
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Fig. 2. (A) Schematic diagram of the layout of bacterial colonies on a 23cm x 23 cm high-density filter. The six patches result from duplicate spotting 
of twelve 96-well plates in a non-contiguous pattern. The lower right box illustrates the 8 x 12 lay out of the squares. Twelve duplicated colonies are 
spotted in a 5 x 5 sub-grid (one blank spot for orientation). (B) Scanned image of a differential screening assay in which previously identified female 
scm-reactive expressed recombinant protein from colonies on high density filters blocked with purified unlabelled Ig from pooled adult Ghanaian male 
scm were treated as follows: (i) incubated with FITC-labelled Ig from Ghanaian female serum pools (ii) probed with FITC-labelled Ig from pooled 
malaria naive sera to detect and eliminate cross reactive antigens that may also be recognised by malaria unmune 1g. The inset shows a sub-grid of 12 
duplicated colonies, with one blank spot. The white circles illustrate 'true duplicate positive colonies on the filter screened with malaria immune labelled 
female Igs; the same subgrid from the filter screened concurrently with malaria naive pooled Scottish serum is also shown, highlighting the specificity 
of the malaria immune Igs with the immobilized protein. 
proteins as the intracellular environment of P falciparum is 
known to be thioredoxin-rich [15]. 
One of our aims was to identify clones that react 
strongly with the female malaria immune 1g. Due to the 
marked differences in the intensities of fluorescent an-
tibody binding between clones, two further rounds of 
immuno-screening were performed using decreasing con-
centrations of malaria-exposed female purified Ig (1 and 
0.4 iril 1)  with more stringent filter washes between 
screens. Sero-positive clones could thus be divided into 
'weak' and 'strong' binders. Table 1 summarises the results 
from three rounds of immuno-screening with antibodies 
from Ghanaian malaria endemic sera. Seventy percent of 
the strongly positive sero-reactive clones have been se-
quenced to date. The sequences obtained were compared 
to those in the National Centre for Biotechnology Informa-
tion (NCBI), PlasmoDB and the FULL-malaria databases 
[16]. Eighty-nine percent of 200 strongly antibody positive 
colonies sequenced have cDNA inserts that are identical 
or almost identical to sequences in the recently published  
genome sequence of P falciparum clone 3137A [17]. Table 2 
shows the functional categories into which the sequenced 
immuno-reactive clones fall. Eleven percentage of these 
clones encode antigens previously considered as malaria 
vaccine candidates and a further 5% encode antigens whose 
homologues have been considered as vaccine candidates 
in other parasites. It should be noted that the antigens we 
Table 1 
The proportion of library expressing sero-reactive proteins after three 
rounds of immunoscreening with increasing stringency 
Number of 
colonies (%) 
Total array 6912 (100) 
Low stringency primary 1866 (27) 
malaria endemic Ig screen 
Immunoscreen with l.Op.gmr' female 1120 (16) 
malaria immune Ig (weak binders) 
Immunoscreen with 0.4 sg ml 	female 260 (3.7) 
malaria immune Ig (strong binders) 
272 	 MR Kordai Sowa et al/Molecular & Biochemical Parasifology 133 (2004) 267-2 74 
Table 2 
The range of sequenced P falciparum clones expressing scm-reactive recombinant protein 
Clone ID Accession 
number match 
Expect (E) value/3137 
chromosomal location (c) 
Description of clone based on 
match (functional category) 
lCl 1 AF061080 2.8E-221cl I Circumsporozoite related antigen (VIMTP)' 
1D5 AF348158 2.4E-45/c14 Glyceraldehyde-3 phosphate-dehydrogenase (EIMP) t' 
lG6 X77854 5.1E-84/c2 Serine repeat antigen (VIMTP) 
3A8 PFU21939 1.8E-82/c5 28S rRNA asexual stage type 
3135 PFMAL4P3 5.7E-551c4 Ribosomal protein 
3E2 AF170073 9.9E-29/c12 Sexual stage specific protein kinase (S)* 
6134 AF034389 4.9E-59/c4 Pfs 16 (gMP)" 
7FlO AE014851 6.4E-71/62 DEADIDEAH box (NAP)c 
1 1A9 AF142344 l.OE-152/(NCBI) Histidine rich protein II (SP) 
16F1 PFU27338 1.2E-361c14 P. falciparum erythrocyte membrane proteinl (eMP)" 
18137 PFEI590w 2.5E-106/c5 Early transcribed ring stage membrane protein (rMP' 
21B2 PFIO..0121 3.3E-47/clO Hypoxanthine-guanine-phosphoribosyl transferase (EIMP) 
25H1 AF420310 3.5E-108/c14 Calmodulin gene (S) 
26A3 AF302208 1.6E-97/c12 Translation initiation factor (TAP) 5 
29C4 AF056936 7.3E-87/c5 P falciparum erythrocyte membrane protein2 (eMP)" 
29F10 NP701 198.1 3.8E-171/cll Aquaglyceroporin (VIMTP) 
44E3 M86865 2.9E-46/c6 Histone H2A (NAP) 
44F10 M19753 1.5E-07/c8 Heat shock protein 70 (CA)h 
64H1 1 AE0148481 2.0E-54/c12 Putative macrophage inhibition factor (SP) 
67F2 PF130120w 	-- 5.3E-129/c2 Hypothetical proteins with transmembrane domains (pMP)" 
Expect values are from the PlasmoDB database unless otherwise stated. 
VIMTP: vessicle/membrane trafficking proteins. 
b EIMP: enzyme/metabolic protein. 
S: signalling. 
'e/r/g/pMP: erythrocyte/ringigametocyte/probable membrane protein. 
NAP: nuclear associated proteins. 
SP: secreted protein. 
TAP: translation associated proteins. 
Ii CA: cytoplasmic antigen. 
have identified by our differential screening method are 
a female biased sample, as antigen specificities that were 
strongly recognised by the pool of Ghanaian male sera had 
been excluded by this stage of the screening process. This 
may explain the non-appearance of the prominent class of 
antigens found on the merozoite surface, such as AMA-i 
and MSP-i and 2. 
Approximately 25% of all sequenced inserts have been 
matched to locations in the genome sequence to which no 
function has yet been assigned. These sequences fit criteria 
established by the Malaria Genome Project for 'hypothetical 
proteins' (referred to as 'orphan genes' in the text). 
A proportion of the sero-positive clones detected by both 
male and female Ig pools, were found to encode rRNA, par-
ticularly 28S rRNA. This was not unexpected as total RNA, 
rather than purified mRNA, was used to construct the li-
braries to avoid loss of any P. falciparum mRNA species 
that bind poorly to oligo dT columns [181. Serum reactiv-
ity with colonies containing plasmids with rRNA inserts has 
been previously observed by other malaria researchers, but 
rarely commented on, although the phenomenon has an in-
teresting basis in some other systems. Tenson et al. [191 
demonstrated the presence of a functional peptide encoded 
by an open reading frame (ORF) within E. coli 23S rRNA 
in vitro and Jansson et al. [20] have reported the presence of 
a small ORF that encodes a hemolysin protein in the large  
subunit rRNA of Entamoeba histolytica. The persistent iso-
lation of rRNA-containing clones, particularly 28S rRNA, 
when screening P falciparum expression libraries may be 
explained by some specific anti-parasite response. However, 
natural malaria infections are known to induce anti-host nu-
clear antibodies [21]. An alternative explanation for the de-
tection of colonies containing plasmids with P falcipa rum 
rRNA inserts is that they are recognised by infection-induced 
anti-nucleic acid antibodies. Therefore, at present, the rea-
sons for the strong reactivity of P falciparum rRNA in 
immuno-screened expression libraries remain uncertain. 
Eight percent of the clones sequenced bore no homology 
to any sequence in any database. Since E. coli or other mi-
crobial contaminating sequences would be detected as 'hits' 
in such searches, a non-P falciparum origin for these se-
quences can probably be excluded. Furthermore, since most 
of them contain A + T rich sequences with open reading 
frames and some contain repetitive sequences, a common 
feature of malaria parasite proteins, it is likely that these are 
P.falciparum sequences. Some may originate from the resid-
ual portion of the P falciparum 3D7A genome that has not 
yet been added to the database, or may be on the small, ex-
isting portion of incompletely sequenced chromosomes. For 
example, one of the sero-reactive clones that we identified 
has 100% homology to the Histidine Rich Protein II (HRPH, 
accession number—AF142344) gene sequence of P. falci- 
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Fig. 3. 	Identity with sequence from known P. falciparum proteins 
with assigned function and known chromosomal location; (I!l) identity 
with sequence from known chromosomal location of P. falciparum genes 
but of unknown function; (lI) putative open reading frames; Q identity 
with sequence from known P. falciparum proteins with assigned function 
but unknown chromosomal location. 
parum, which can be found in the NCBI database, but not 
in PlasmoDB. This protein may be localised on one of the 
chromosomes that has not yet attained gap closure, i.e chro-
mosomes 6-8, 10, 11, 13 and 14 [17] and therefore has not 
yet been assigned a locus. It is also likely that some of these 
unidentified sequences are polymorphic in P.falcipa rum and 
are allelic variants or multigene family members present in 
SD 2H3/5-CSA but not in 3137A. Fig. 3 shows the chromo-
somal distribution of the sequenced sero-reactive clones and 
highlights the percentage of sequenced clones with chromo-
somal location but without functional assignation. 
As yet there are no completely predictive correlates of 
immunity to malaria with specific immunological responses 
to particular antigens. The novel combined cDNA library 
construction and antibody screening methods outlined here 
will facilitate efforts to systematically organise data on the 
antibody responses to immunogenic antigens of P falci-
parum and help identify minimal epitopes for incorporation 
into novel malaria vaccine candidates [22]. The data pre-
sented further confirm the view that B cell responses against 
malaria are directed against a large number of antigens 
[2,3,23]. It has also recently been demonstrated that T cell 
responses in humans immunised with irradiated sporozoites 
are not concentrated on a few immuno-dominant epitopes 
but that T cells also respond to a relatively large number of 
antigens [24]. 
Nonetheless there are recent indications that antibody 
responses to variant antigens on the surface of P falci-
parum infected erythrocytes are strongly correlated with 
protection against certain severe malaria syndromes such as 
pregnancy-associated malaria [25]. The extent to which this 
serological screening method can detect such syndrome-
specific immunogenic antigens is under investigation. 
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